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sumiAm
It is well established that staphylococcal 6-haemolysin is 
inhibited by normal mammalian sera and forms a precipitin line on gel 
diffusion with normal sera. The purpose of this thesis was to 
quantitate inhibitory activity against 6-haemolysin and to identify the 
serum factor(s) involved.
The inhibitory titre of normal human serum assayed using 
purified 6-haemolysin with cod erythrocytes as indicators of haemolysis 
was 1/500 - 1/1000.
Fractionation of serum by ultrafiltration, gel filtration in 
Sephadex G-150 end Sepharose 6b and ammonium sulphate precipitation 
indicated that at least two components of molecular weights approximately
300,000 and > 10^ were involved. When affinity chromatography was done 
using 6-haemolysin covalently coupled to Bepharose-^B the selective 
removal of g-lipoprotein from whole serum was shown by immunoelectro- 
phoresis. High density (a-) and low density (g-) lipoproteins were 
prepared by zonal ultracentrifugation of serum using potassium bromide 
density gradients and characterised by polyacrylamide gel electrophoresis, 
immunoelectrophoresis and gel diffusion using monospecific antisera.
Both a- and g-lipoproteins inhibited 6-haemolysin and gave a precipitin 
line on gel diffusion, while fractions which were shown by immunoelectro­
phoresis to be devoid of such lipoproteins were non-inhibitory.
Proteolytic digestion of lipoproteins with trypsin or papain did not 
diminish their inhibitory activity, whereas this was diminished by 
pretreatment with Bacillus cereus phospholipase C. Delta-haemolysin was
Ill
inhibited by phospholipids and pretreatment with phospholipase decreased 
the inhibitory capacity of such phospholipids and also of a serum lipid 
extract.
The results indicated that binding of 6-haemolysin to serum 
lipoproteins was via the phospholipid moiety and the implications of such 
an interaction in terms of in vivo activity of the haemolysin are discussed.
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INTRODUCTION
General remarks
The concept of exotoxins as harmful diffusible products of 
pathogenic bacteria has long been recognised in microbiology. By the 
beginning of this century, the potent exotoxins of diphtheria, tetanus 
and botulism had been demonstrated experimentally and in each case 
immunity to the toxin conferred immunity against the disease; thus the 
importance of extracellular toxins in microbial pathogenicity was 
established.
However, despite the large number of exotoxins recognised, 
only in a few cases are the roles of individual toxins in pathogenicity 
fully understood. The main classes and the purification of bacterial 
toxins have been reviewed by Raynaud and Alouf (l9T0) and van Heyningen 
(1970).
In the case of the staphylococci, a wide range of extracellular 
products with potent biological effects may be formed but only in a few 
instances have extracellular products been shown to contribute to the 
pathogenicity of Staphylococcus aureus. This thesis concerns only one 
of the extracellular products, the 6-haemolysin, but the nature and 
properties of other extracellular products will also be briefly discussed.
Farrer and McLeod (1960) and Shulman and Nahmias (1972) have 
dealt with the clinical aspects of staphylococcal infections.
Staphylococcal extracellular products
Following the postulation of Klebs (I872) that there was a
relationship between pathogenicity and toxin production in bacteria, and 
the demonstration by de Christmas (1888) of toxicity of heated broth 
cultures of staphylococci recovered from lesions in man, much progress 
has been made in ascribing roles to the toxins produced by S. aureus.
Many attempts have been made to correlate staphylococcal virulence with 
these factors. However, in spite of the potent biological activity of 
some toxins there is little clear understanding of virulence in chemical 
terms. Indeed the existence of an unidentified ’Virulence factor” 
produced only du vivo has been postulated by Abramson (1972). However, 
the potential importance of extracellular products in staphylococcal 
pathogenicity cannot be disregarded.
Strains of S. aureus release a large number of extracellular 
enzymes and toxins into their environment during growth. Analytical 
starch gel electrophoresis studies on potentially pathogenic strains 
revealed 12 to l4 different proteins while the culture supernatant fluids 
of non-pathogenic strains contained half as many (Bernheimer and Schwarz,
It
1961), More recent isoelectric-focusing (lEF) studies by Wadstrom (l973a) 
showed that different strains produced quite different protein patterns.
Besides the classical enzymes produced by 8. aureus (Table la) 
and cytolytic toxins (vide infra), other "entities (succinate oxidase 
factor, Lominski, Gemmell and Arbuthnott, 1968: lymphocyte mitogens,
Kreger, Cuppari and Taranta, 1972: leucocyte chemotactic factors and
inhibitors of leucocyte chemotaxis, Russell et 1975) have been 
demonstrated (Table Ib).
Arbuthnott et al (l97l) identified a soluble, extracellular
Table la Properties of some extracellular products of S. aureus
a) Enzymes
Enzyme pi Molecular 
Wt.
Reference
Nuclease
10.1
17,000 Heins et 1967
ti
Wadstrom, I967
Phosphatase 3.8-4.2 58,000 Tirunarayan, I969
Maiveaux & San Clemente,
1969
Protease 9 . k 12,500 Arvidson, Holme & 
Lindholm, 1973
Esterase 4.5 -
I
Wadstrom, 1967
St aphylokinase 5.7,6.3,6.7 ' Vesterberg & Vesterberg,1972
Coagulase 5.9-6.1 44,000 Tirunarayan, 1969 
Duthie & Haughton, 1958
Hyaluronidase 7.9 82,000
It It
Wadstrom & Mollby, 1972 
Abramson & Rautela, 1971
Lipase 9.5 100,000 Vesterberg e;t el, I967
Endo-g-N-acetyl 
glue o s amini das e 9.6 70,000
I
Wadstrom & Hisatsune, 1970
Ami das e 9.8
I
Wadstrom & Vesterberg, 197
Peptidase 10.4 II I
Cholesteryl de- 
esterifying enzyme
9.1 25,500,
175,000
Harvie, 1977
McCartney & Arbuthnott,
1977
Table lb Properties of some extracellular products of S. aureus
b) Other factors
Factor pi Molecular
¥t.
Reference
enterotoxin B 8.55,8.25,9.14 Chang and Dickie, 1971
Metzger, Johnson 
and Collins, 1972
enterotoxin 5.5.5.9,6.T Chang et 1971
enterotoxins A-E 6.8-8.6 28,000-35,000 Bergdoll, 1972
lymphocyte mitogen 5.6-8.8 Kreger £b al, 1972
leucocidin 9.0
Tl
Wadstrom (unpublished 
data quoted by 
Wadstrom, 1974)
epidermolytic toxin 7.0 33,000 Melish et al, 1972
Kondo, Sakura and 
Sarai, 1973
Arbuthnott, Billcliffe 
and Thompson, 1974
protein devoid of haemolytic activity, and demonstrated vivo its 
ability to cause extensive splitting of the epidermis in newborn mice 
similar to that found in Toxic Epidermal Necrolysis (Ritter’s syndrome 
or the scalded skin syndrome: Lyell, 196?: Melish and Glasgow, 1970:
Melish, Glasgow and Turner, 1972). This factor (epidermolysin) is the 
only soluble product of staphylococci (apart from those produced by 
enterotoxic strains) unequivocally shown to play a role in pathogenicity.
Many S. aureus strains also produce ^  vitro various 
haemolysins (cytolytic toxins) which are believed to play a role in the 
infected host. It is now established that S. aureus produces at least 
four different haemolysins (designated alpha, beta, gamma and delta).
The existence of a fifth (epsilon haemolysin) has been proposed (Elek 
and Levy, 1950: Elek, 1959), but to date has not been purified. Alpha-
and 6-haemolysins are more frequently produced by coagulase positive 
strains from human origin, while beta-haemolysin is produced principally 
by strains from animals.
Alpha-haemoly s in
Purified a-haemolysin is a protein (Arbuthnott, 1970) devoid 
of carbohydrate (Watanabe and Kato, 1974) and apparently exists in three 
physical states: a soluble active form, a3S (Bernheimer and Schwarz, 19&3:
Lominski, Arbuthnott and Spence, 19&3: Cooper, Madoff and Weinstein,
1966: Coulter, 1966); a soluble inactive form, al2S (Bernheimer and
Schwarz, 1963: Lominski 1963) and an insoluble inactive form
(Coulter, 1966: Arbuthnott, Freer and Bernheimer, 1967). The inactive
forms were regarded as toxoids since they elicited the formation of
protective antibody and were thongbt to be aggregates of the active a3S 
lysin (Arbuthnott ^  1967). Electron microscopic studies have also
demonstrated aggregation (Bemheimer and Schwarz, 1963: Freer, Arbuthnott
and Bernheimer, I968).
The molecular weight of this haemolysin has been estimated as
21,000 to 1+5,000 daltons by various workers (reviewed by Wiseman, 1975)- 
Madoff (1965) and Coulter (1966) postulated that the lysin associated to 
give polymeric forms in equilibrium to explain the variation in reported 
molecular weights and McNiven, Owen and Arbuthnott (197^) suggested that 
estimates around 30,000 represented mixtures of both a monomer of 22,000 
daltons and a dimer of 4^,000 daltons. Sucrose density-gradient 
electrophoresis (Bernheimer and Schwarz, I963) and IFF (Wadstrom, I968: 
Bemheimer, 1970) have revealed multiple forms of a-haemolysin ; McNiven 
(1973) described four components with isoelectric points of 8.55, 9.15,
7.36 and 6.26 respectively.
Rabbit erythrocytes are particularly susceptible to a-haemolysin, 
whereas human erythrocytes are only slightly susceptible (Arbuthnott, 1970). 
Kinetic studies (Lominski and Arbuthnott, I962) have shown that at low 
concentration, the rate of haemolysis is dose-dependent, and Bernheimer 
(1970) proposed an enzymatic action for a-haemolysin from the effect of 
constant amounts of lysin on varying concentrations of erythrocytes. A 
three-stage reaction sequence of adsorption, loss of selective cell- 
membrane permeability, and lysis has been proposed for a-haemolysin 
(Marucci, 1963: Klainer at 196U: Madoff, Cooper and Weinstein, 196k)
but as yet its substrate on the erythrocyte membrane has not been identified 
nor the nature of the interaction been determined.
Wiseman, Caird and Fackrell (1975) have suggested that alpha- 
haemolysin is produced as a zymogen, which is converted at the cell surface 
to an active form by an activating protease, acquiring proteolytic activity 
in the process. Dalen (1976) obtained supporting evidence for proteolytic 
activity of a-haemolysin but could not rule out the presence of contamin­
ating proteases.
Both cold- and warm-blooded animals are sensitive to the 
haemolysin and the severity of its effects are dose-dependent. Fackrell 
and Wiseman (1976b) determined the mean lethal dose (LD^^) in mice as 
0.68 ± 0,19 Tig or 27 to 3k pg/kg of body weight, similar to the value 
obtained by Arbuthnott (1970). Lominski ^  ^  (1963) obtained minimum 
lethal dose values of 50 pg/kg in mice and 1.3 pg/kg in rabbits injected by 
the intravenous route. LBy^ data obtained by others for mice are 600 pg/kg 
(Goshi, Cluff and Norman, 1963) and about 50 pg/kg intravenously (Watanabe 
and Kato, 197k).
In an investigation into an outbreak of mastitis in 
commercially reared rabbits, Adiam et al (1976, 1977) showed that 
immunisation with purified a-toxoid gave partial protection and reduced the 
lethal haemorrhagic oedematous form of mastitis lesion to a localised 
chronic abscess.
In summarising the main pathological findings, Arbuthnott (1970) 
observed that the haemolysin acted on the peripheral circulation, heart 
and central nervous system.
For comprehensive reviews on the cytotoxicity of a-haemolysin, 
see Arbuthnott (1970) and Jeljaszewicz (1972).
Beta-haemolysin
Numerous studies have shown that B-haemolysin is a protein 
(Haque and Baldwin, 19^9; Jackson, 1962; Mhheswaran, Smith and Lindorfer, 
1967; Wiseman, 1965) and its distinctness from a-haemolysin was first 
shown hy Glenny and Stevens (1935). The various molecular weights 
ascribed to g-haemolysin have been reviewed by Wiseman (1975) and, like 
a-haemolysin, multiple forms have been reported (Maheswaran ^  1967;
Haque and Baldwin, 1969; Mollby and Wadstrom, 1970). The recent report 
by Low and Freer (1977,b) of a molecular weight of 33,000 and isoelectric 
point of 9.3 for the major form are in close agreement with most published 
data.
The characteristic reaction of 3-haemolysin (which it has in
common with the a-toxin of Clostridium perfringens ) is that of "hot-cold"
haemolysis (Bigger, Bolland and O'Meara, 1927) “ haemolytic activity is
enhanced if incubation at 37^0 is followed by incubation at k^C - and the
erythrocytes of sheep, man and rat, in that order, are decreasingly
sensitive to its action. The mechanism is still imperfectly understood,
2+ 2+ 2+but activity is enhanced by Mg , Mh and Co and inhibited by EDTA and 
citrate (Jackson and Mayman, 1958; Wiseman, 1965).
It tf
Recent studies by Smyth, Mollby and Wadstrom (1975) showed that 
haemolysis at 37°C could be induced in ^"haemolysin pretreated cells when 
subjected to EDTA, suggesting that exogenously added and/or membrane-bound 
divalent cations are important for the stability of sphingomyelin-depleted 
membranes.
The discovery by Doery ^  al (1963) that sphingomyelin was 
hydrolysed by the lysin has since been confirmed by many workers 
(Maheswaran and Lindorfer, 1966, I96T; Wiseman and Caird, I966, 1967;
tt It
Fritsche, 1970; Wadstrom and Mollby, 1971a; Low, Freer and Arbuthnott, 
197k), and the high susceptibility of sheep and ox erythrocytes may well 
be attributable to the high content of sphingomyelin in their cell 
membranes (Rouser I968). Despite a report by Chesbro al (1965)
of carbohydrase activity, beta-haemolysin is now agreed to be a sphingo­
myelinase C, and has found use as a tool in membrane studies (Low ^  al,
197k ; Demel et 1975 ).
The most controversial property of 3“haemolysin is that of 
toxicity, and hindsight suggests that conflicting evidence has arisen 
through the use of impure preparations. For rabbits, mice and guinea- 
pigs, 3-haemolysin is 10 to I60 times less toxic than a-haemolysin and 
recent reports by Fackrell and Wiseman (1976,b) and Low and Freer (1977,a) 
show that 100 yg and 150 pg amounts respectively of purified haemolysin 
were neither lethal nor dermonecrotic.
Gamma-haemoly sin
The first indication of the existence of y-haemolysin was made 
by Smith and Price (1938) and its distinctness from a-, 3- and 6-haemolysins 
was confirmed by Marks (l95l). It is inhibited by agar (Jackson, 1962;
tf T!
Guyonnet and Plommet, 1970; Mollby and Wadstrom, 1971; Fackrell, 1973), 
which precluded its detection by blood agar haemolysis by Elek (1959) who 
regarded alpha-2, delta- and gamma-haemolysins as being identical. The 
lysin was inactivated by heating at 55^0 for 10 min and by cysteine or 
ascorbic acid (Jackson, 1962).
10
The haemolytic activity of the haemolysin is reportedly 
inhibited by phospholipids (Taylor and Bemheimer, 19Tk ; Fackrell and 
Wiseman, 1976,b). Gamma-haemolysin acts on human, rabbit and sheep
erythrocytes, but not horse erythrocytes (Guyonnet and Plommet, 1970)
ir 1Î
with rabbit being the most sensitive (Mollby and Wadstrom, 1971; Fackrell 
and Wiseman, 1976,b). The toxicity of y-haemolysin was investigated by
Smith and Price (1938) who reported that crude haemolysin killed rabbits, 
but not mice and guinea pigs, thou^ it was sli^tly dermonecrotic for 
the latter. A 100 pg subcutaneous dose of purified haemolysin was 
innocuous to guinea-pigs and rabbits (Fackrell and Wiseman, 1976,b), as 
was the same dose intraperitoneally to mice. However, a 50 pg intracardial 
injection proved fatal to guinea-pigs (Fackrell and Wiseman, 1976,b). The 
role of y-haemolysin in vivo is unknown but when experimental staphylococcal 
osteomyelitis was induced in rabbits by Kurek ^  (1977), enhanced anti- 
y-haemolysin antibody titres resulted. The staphylococcal strain used 
was isolated from a case of human osteomyelitis and Kurek e;^  ^  suggested 
that y-haemolysin played a role in pathogenesis of osteomyelitis.
Pelt a-h aemoly s in
Purification and physical properties. The discovery of delta-haemolysin 
as a distinct product of S. aureus was made by Williams and Harper (19^7) 
who showed that haemolysis was not suppressed when S. aureus was grown in 
the presence of a- and 3-antitoxins on sheep blood agar. They demonstrated 
its wide spectrum of haemolytic activity and synergistic action with 
g-haemolysin on sheep erythrocytes. Marks and Vaughan (1950) confirmed 
these findings and partially purified the haemolysin by extraction of
11
crude culture supernatants with ethanol, in which delta-lysin was 
soluble. The haemolysin was insoluble in acetone, non-dialysable, 
thermostable (l00°/2 hours), inactivated by formaldehyde and absorbed by 
alumina below pH 8,
Jackson and Little (1958) produced delta-lysin from crude 
culture supernatants adjusted to pH k with acetic acid, by precipitation 
with methanol at -5^C.
Yoshida (1963) crystallised delta-haemolysin from S. aureus 
strain Foggie by chromatography of concentrated, heated culture super­
natants on calcium phosphate gel and DEAE-cellulose. Ultracentrifugation 
showed the preparation to be highly homogeneous (sedimentation coefficient 
6.is) with a molecular weight of 68,230 calculated from an amino-acid 
analysis. Lysine, aspartic acid, phenyl-alanine and isoleucine were the 
amino acids present in greatest amounts, and there were very low levels 
of cysteine, histidine, arginine, proline and tyrosine. Purified delta- 
haemolysin was trypsin-sensitive and insoluble in chloroform/methanol 
(2;l). Subsequent work by Gladstone and Yoshida (196T), using the same 
preparation, revealed, however, the presence of ribonuclease and g- 
haemolysin in undefined but significant concentrations.
Hallander (1968) purified the haemolysin by gel filtration, 
preparative electrophoresis and chloroform/methanol (2:1) extraction. 
Immunodiffusion against antiserum to 6-haemolysin yielded a single immune 
precipitation line.
The dialysis membrane technique devised by Birch-Hirschfeld 
(193k) was used by Marks and Vaughan (1950) for production of delt a-haemolysin
12
Harvesting of the haemolysin was facilitated "because the delta- 
haemolysin was retained on top of the membranes and was separated from 
the non-dialysable ingredients of the medium. Murphy and Haque (196t), 
using dialysis membranes over Brain Liver Heart plates under an 
atmosphere of 10% 00^, overcame the dilution problems present in broth 
cultures and thus obtained concentrated preparations. Kleck and Donahue 
(1968) also employed this cellophane-layer technique, and Murphy and 
Haque (l9Tk) developed it into a large-scale production process. To 
eliminate the possibility of 3-haemolysin contamination encountered by 
Yoshida (1963)Murphy and Haque used S. aureus strain lk6P, a non-3- 
haemolysin producer.
Caird and Wiseman (1970 ) purified the delta-lysin of strain 
E-delta by isoelectric precipitation (pH k.O), ammonium sulphate 
precipitation and DEAE-cellulose chromatography. Purified haemolysin 
obtained in l6% yield with a 32-fold increase in specific activity, 
yielded a single precipitation line on immunodiffusion or immunoelectro­
phoresis against antiserum to 6-haemolysin and the sole N-terminal amino 
acid was proline. A single protein band was noted on polyacrylamide 
gel electrophoresis (pH 9.5) but ultracentrifugation revealed two 
components (2.88 and 9.88).
The property of solubility in chloroform-methanol (2:1) was 
exploited by Heatley (1971) using strain l86X. He purified 5-haemolysin 
by ammonium sulphate precipitation, chloroform-methanol extraction and 
cyclic transfer between organic and aqueous phases of a two phase system 
( chloroform/methanol/water ) by adjustment of the pH. Purified lysin was
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soluble in water, saline or chloroform-methanol (2:l), sparingly 
soluble in methanol, and insoluble in chloroform, acetone or hexane.
A single polydisperse peak (k.9S) was observed on ultracentrifugation, 
while polyacrylamide gel electrophoresis at pH k.6 or pH 8.k showed a 
main diffuse band with a faint diffuse secondary band.
Kreger al (1971) studied Ô-haemolysin from a mutant strain 
of S. aureus Wood k6 which produced little a-haemolysin (Wk6M). The 
haemolysin was purified by adsorption to hydroxylapatite from crude culture 
supernatant and elution with phosphate buffers of increasing molarity.
A soluble and an insoluble form of the lysin were obtained on dialysis 
against water. The latter was poorly soluble in water (<0.05 mg/ml) and 
in a variety of O.IM buffers unless they contained 8M urea. It was 
soluble and stable in O.IM sodium hydroxide and chloroform-methanol (2:1). 
Soluble haemolysin was soluble in water, various buffer solutions, 
chloroform-methanol (2:l), but insoluble in chloroform, methanol or 
acetone. This haemolysin was heterogeneous by gel filtration, sucrose 
density gradient centrifugation, ion exchange chromatography, polyacrylamide 
gel electrophoresis and lEF. Two bands were obtained in polyacrylamide 
gel electrophoresis at pH k.3 and pH 9.5, and on lEF two protein peaks 
(pi 9.5 and 5.0) corresponding to the peaks of haemolytic activity were 
found. Refocusing of the basic haemolysin yielded additional acidic 
haemolysin but the converse did not apply. Electron microscopy of 
fractions of purified haemolysin showed two forms, one a fibrous, high 
molecular weight, 11.98 fraction of pi 5.0 and second a granular, lower 
molecular weight fraction, k.9S with a pi of 9.5. The amino acid 
composition was similar to that reported by Yoshida (19^3) and Heatley (1971) 
but histidine, arginine, proline and tyrosine were not detected (Table 2).
Ik
Table 2 Amino acid composition of Staphylococcal 6-haemolysin
Amino acid Percent of total weight of amino acids
Yoshida
(1963)
Kreger et 
al (1971)
Heatley*
(1971)
Kantor et 
al (1972T
Fackrell & 
Wiseman(1976b)
Lysine 16.55 16.66 13.60 16.20 2.60
Histidine O.kl - tr - o.ko
Arginine 0.9k - — - 2.80
Aspartic acid 12.53 13.k6 10.90 13.60 16.20
Threonine 6.98 8.02 7.50 9.k0 10.60
Serine 5.12 2.k6 3.20 k.30 7.50
Glutamic acid 7.99 k.90 5.20 k .60 7.20
Proline 0.k5 - - - 1.20
Glycine 3.73 3.60 8.10 6.20 6.30
Alanine k.06 3.09 5.90 k.80 5.00
Half cystine - 0.09 - - -
Valine k.55 6.6k 5.50 6.70 6.60
Methionine k.88 k.56 k.30 k.OO -
Isoleucine 9.71 18.17 10.50 17.10 9.90
Leucine 7.kl 6.0k 6.30 k.90 5.90
Tyrosine 1.68 - —  . — 1.20
Phenylalanine 10.ko 7.93 7.60 5.50 6.50
Tryptophan 2.61 3.30 k.OO* 2.50 10.00**
Ammonia 1.63 1.08 7.k0
^Percentages calculated from the data presented, calculated from E^qq data,
assuming k% tryptophan.
^^Percentages calculated from the data presented , calculated from F^gQ data
assuming 10% tryptophan.
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Using the same strain as Kreger at ^  (1971), Kantor, Temples 
and Shaw (1972) purified 6-lysin twenty-fold by adsorption to aluminium 
hydroxide gel and elution at pH 7.2 with 0.5M phosphate buffer. Poly­
acrylamide gel electrophoresis, lEF in the presence of 0.1% Tween 80 and 
gel filtration in 6M guanidine hydrochloride showed a homogeneous 
preparation, but further studies by gel filtration and of sedimentation 
velocity in the presence of increasing amounts of Tween 80, led Kantor's 
group to the conclusion that 6-haemolysin consisted of a basic subunit of 
molecular weight 21,000 daltons, which was itself a tetramer of individual 
polypeptide chains of molecular weight 5,100 - 5,200 daltons. Pentameric 
and decameric association of the basic subunit was assumed to yield 
polymers of molecular weight consistent with those determined in the 
absence of Tween 80 by sucrose gradient centrifugation, analytical ultra­
centrifugation and gel filtration. The amino acid analysis (Table 2) 
was consistent with a molecular weight of 5,200 daltons, and tryptic 
digestion yielded 7~8 peptides, also in agreement with the determined 
seven lysine residues. The model of Kantor ^  (1972) provides a 
reasonable explanation for the conflicting published data on molecular 
weight, sedimentation coefficient, isoelectric point and heterogeneity of 
purified 5-haemolysin (Table 3).
Amino acid analyses of 6-haemolysin consistently show lysine, 
aspartic acid and isoleucine present in high amount, with histidine, 
arginine, proline, cysteine and tyrosine absent, or present as traces.
Caird and Wiseman (1970) however, found the H-terminal amino acid of 
6-haemolysin (strain E-delta) to be proline. Although the amino acid 
composition of delt a-haemolysin is disputed there is general agreement that 6* 
lysin is a simple protein containing little (<1%) lipid, phosphorus and 
carbohydrate (Yoshida, 1963; Kreger ab 1971; Heatley, 1971) and is 
sensitive to proteolytic enzymes (trypsin, pepsin, pronase, chymotrypsin).
IT
The purification procedures of Wiseman and Caird (1968), Kreger et al 
(1971) and Kantor ab ^  (1972) were compared hy Lee al (1976) who
claimed that none of these methods yielded pure preparations of 
6-haemolysin with the S. aureus strain lk6P,
Biological properties. Delta-haemolysin, in contrast to a-, 3~ or y-
haemolysins, displays a wide haemolytic spectrum, and different species 
are more uniformly sensitive (Wiseman, 1970; Jeljaszewicz, 1972). All 
erythrocyte species are to some degree sensitive to 6-lysin (Gladstone, 
1966) and while human red cells have in the past been regarded as the 
most susceptible indicator of haemolytic activity, recent work in this 
laboratory (Chao and Birkbeck, 1978) has shown the cod erythrocyte to be 
four to eight times more sensitive. Synergistic action between 3“ and 
6-haemolysins has been demonstrated with sheep erythrocytes (Williams and 
Harper, 19^7; Marks and Vaughan, 1950; Kreger ej^  1971) and human
erythrocytes (Heatley, 1971). Kapral (l972) has also shown synergism 
between a- and 6-haemolysins on rabbit erythrocytes. It also has an 
injurious effect on a wide variety of cells in culture (Gladstone and
ti
Yoshida, 1967; Hallander and Bengtsson, 1967; Thelestam, Mollby and 
n
Wadstrom, 1973), leucocytes (Jackson and Little, 1957; Gladstone and 
Yoshida, 1967; Hallander and Bengtsson, 1967) and bacterial protoplasts 
and spheroplasts (Bernheimer, Avigad and Grushoff, 1968; Kayser, I968; 
Kreger at 197l). Cellular organelles (lysosomes and mitochondria) 
(Bernheimer and Schwarz, 196k; Gladstone and Yoshida, 1967; Evans and 
Leek, 1969; Kantor al, 1972; Kreger at 1971; Rahal, 1972) and 
lipid spherules (Freer ^  al, I968; Kreger a^ al, 1971) are also disrupted 
by 6-haemolysin. The haemolysin also appears unique amongst bacterial
18
Table k Effects of delta-haemolysin in animals
Animal Dose (mg/kg) 
Lethal
Dose (mg) 
Dermonecrotic
Reference
Mouse 110 (MLD) - Kreger at 1971
Rabbit - 0.5 - 1.0 !t f1
Guinea pig 30 (MLD) 0.5 - 1.0 tt t
Rabbit - 1 tt tt
Guinea pig - v< 1
t tt
Mouse > 10 (iDgg) - Gladstone, 1966
Rabbit - 0.005 - 0.5 11 It
Rabbit 5000 (LD ) - Wadstrom & Mollby, 1972
Mouse > U (LDg^) > 0.1 Fackrell & Wiseman,
1976,b
Guinea pig > 4 (LDyo) > 0.1 tt tt
Adapted from Wiseman, 1975
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toxins in being able to alter water absorption in the ileum while being 
capable of increasing cAMP levels and being cytotoxic (Kapral al, 1976; 
O'Brien and Kapral, 1976). This effect is mediated through a mechanism 
different from that initiated by cholera toxin (O'Brien and Kapral, 1977).
The question of toxicity of delta-haemolysin must be 
approached with caution. Numerous figures have been quoted in the past 
for the effects of the lysin in animals. Marks and Vaughan (1950) 
injected 6-haemolysin intradermally into man and observed slight 
erythematous lesions which disappeared within 48 hours. Larger amounts 
injected into rabbit or guinea-pig skin induced indurated lesions which 
in the guinea pig became necrotic. Similar findings were reported by 
Kreger ^  al (1971), who also found that the minimum lethal doses of 
6-haemolysin for mice and guinea pigs were 110 mg/kg and 30 mg/kg 
respectively. Table k shows the effects of delta-haemolysin in animals 
determined by previous authors.
It is important to bear in mind, however, that any other 
contaminating haemolysin liable to be present in these preparations will 
most probably be a-haemolysin, and at the high levels of 6-haemolysin 
quoted in Table k, sufficient alpha-haemolysin could be present to cause 
the pathological changes attributed to 6-haemolysin.
Mode of action. Several investigators have expressed the opinion that 
surface activity of the haemolysin accounts for lysis of sensitive 
erythrocytes (Bernheimer, 1970, 197k; Heatley, 1971; Kreger and 
Bemheimer, 1971; Bahai, 1972). Kreger ab al (l97l) suggested surface 
activity for the lysin and Rahal (1972) compared the behaviour of lysin 
with that of the detergents Triton X-100 and sodium deoxycholate.
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3Thelestam al (1973) found kinetics of release of E-nucleosides from 
tissue culture cells by 6-haemolysin to be similar to that caused by 
Triton X-100, while Bernheimer (l97k) has compared the activity to that 
of the surfactin of Bacillus subtilis. Freer and Arbuthnott (1976) 
prefer mellitin the principal toxin of bee venom, as a more accurate 
parallel, but recent surface activity studies by Colacicco a^ al (1977) 
showed that unlike mellitin, 6-haemolysin does not resume the a-helix 
conformation on going into film phase from the extended chain in 6M urea, 
and was more versatile in structural dynamics and more surface active 
than 6-toxin. Wiseman and Caird (1968) and Wiseman (l970) have 
suggested an enzymatic mode of action, due to the release of water-soluble 
organic phosphorus from phospholipid extracts of mammalian erythrocytes.
They found that organic phosphorus was liberated from the erythrocyte in 
direct proportion to erythrocyte sensitivity. Phosphatidylinositol was 
postulated as the substrate on the erythrocyte but this remains to be 
confirmed.
Studies by Low and Finean (1976) described the action of a 
phosphatidylinositol-specific phospholipase-C produced by S. aureus, 
distinct from 6-haemolysin which, while of low activity against the 
purified phospholipid hydrolysed 75% of the phosphatidylinositol in ox, 
sheep and cat erythrocyte ghosts. More recently Low and Finean (1977) 
found that in intact erythrocytes phosphatidylinositol was not significantly 
hydrolysed, suggesting that at least 75-80% of the phosphatidylinositol 
was located at the inner leaflet of the membrane. Such a location would 
render it inaccessible for involvement in Wiseman’s scheme or, alternatively, 
Wiseman’s findings might be explained by the presence of this enzyme in
21
small amounts in his 6-haemolysin preparation. Delta-haemolysin 
coupled to Sepharose retained haemolytic activity suggesting that only 
superficial contact between haemolysin and erythrocyte is required for 
lysis (Lee and Haque, 1976).
Inhibitors of 6-haemolysin 
Inhibition of delta-haemolysin by mammalian sera
Marks and Vaughan (1950) first reported that the action of 
delta-haemolysin is inhibited by serum from man, sheep, ox, rabbit and 
guinea-pig. In addition, a more transient lesion vas observed in guinea- 
pigs given an intradermal injection of delta-haemolysin in horse serum, 
than with delta-haemolysin in a corresponding amount of saline. Salting 
out the serum with ammonium sulphate revealed inhibitory activity in both 
the albumin and globulin fractions. The results of Jackson and Little 
(1958) suggested a general capacity of serum proteins to inhibit 6-haemo­
lysin, globulins being the most inhibitory of the fractions studied.
They noted, however, that the whole globulin fraction, considered to 
contain all the antibodies, was less inhibitory than two globulin sub­
fractions, IV-1 and IV-k (Cohn et_ 19k6), which normally do not contain 
antibodies. Gladstone and Yoshida (1967) found that all Cohn fractions 
were inhibitory to delta-haemolysin, especially fractions I, III and IV 
(fibrinogen, 3- and a-globulins respectively), and that sera yielded a 
precipitin line with 6-haemolysin. On immunoelectrophoresis this 
occurred in the a-globulin region (Kantor ^  1972). However,
contrary to Marks and Vaughan (1950) and Gladstone and Yoshida (1967), 
Kapral (1972) found no inhibitory activity with serum albumin.
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A study by Maniar, Weslake and Warner (196T) which showed 
variable amounts of inhibitory activity in the sera of fifty-three 
individuals prompted Donahue (l969,a) to investigate the phenomenon more 
closely. The nearly constant levels he found in 105 individuals and 
its occurrence in foetal calf serum (Donahue, I969,b) suggested that the 
inhibitor was not antibody. In view of the report by Kapral (1972) 
that 6-haemolysin is inhibited by phospholipids, this suggested a role 
for serum lipid in the inhibition, although a systematic and detailed 
investigation into the nature of the serum inhibitor has hitherto not 
been done.
Inhibition of delta-haemolysin by phospholipids
Delta-haemolysin is inhibited by many phospholipids, although 
conflicting reports are found in the literature. Whereas Gladstone and 
van Heyningen (1957) and Caird and Wiseman (l970) found cholesterol to be 
inhibitory, this was not found by Gladstone and Yoshida (1967)9 Kreger 
et ^  (1971) and Kapral (1972). Similarly, lecithin was reported as 
non-inhibitory by Gladstone and Yoshida (1967) but Kreger al_ (1971) 
and Kapral (1972) found that it inhibited 6-haemolysin. The most 
detailed study of the action on delta-haemolysin by phospholipids is that 
of Kapral (1972), following a search for a specific inhibitor of delta- 
haemolysin in mixtures of 6- and a-haemolysins. A summary of his and 
other workers’ results is shown in Table 5* Only natural phospholipids 
were inhibitory; synthetic phospholipids and egg lecithin in which the 
fatty acids were saturated by reduction failed to inhibit delta-haemolysin,
Kapral (1972) concluded that the minimum inhibitory unit was
23
Table 5 Inhibition of 6-haemolysin by phospholipids
Inhibitory phospholipids Reference
Cholesterol Gladstone & van Heyningen, 1957; 
Caird & Wiseman, 1970.
Phosphatidyl choline (lecithin) Kreger ^ al, 1972; Kapral, 1972
Phoephatidic acid (natural) Kreger al, 1971; Kapral, 1972
Phosphatidyl serine ti It t It
Phosphatidyl inositol n It tf ft
Cardiolipin n It t It
Sphingomyelin ir It t It
Phosphatidylethanolamine IT It It t
Non-inhibitory agents
Cholesterol Gladstone and Yoshida, 1967;
Kreger et al. 1971; Kapral, 1972
M[yristic acid Kapral, 1972
Palmitic acid 
Palmitoleic acid 
Stearic acid 
Dipalmitin 
Tripalmitin 
Choline
Phosphocholine
Glycerol
Glycerol phosphate
Phosphatidyl choline (synthetic)
Phosphatidyl choline (egg, 
catalytically reduced)
Phosphatidyl ethanolamine (synthetic)
Cardiolipin (synthetic)
Albumin (human sera)
Inhibitory agents : 
Stimulatory agents :
21-23 C fatty acids 
13-19 C fatty acids
Kapral, 1976
2k
phosphatidic acid, other components attached to this unit did not 
significantly augment or diminish efficacy, and he suggested that 
phospholipids inhibit delta-haemolysin by interfering with its binding to 
the erythrocyte membrane.
Recently, Kapral (1976) observed that addition of saturated, 
straight chain fatty acids of thirteen to nineteen carbons increased the 
activity of delta-lysin, whereas those with twenty-one to twenty-three 
carbons were inhibitory. Palmitic acid was the most stimulatory of 
the fatty-acids, but simultaneous addition of egg lecithin competitively 
antagonised the stimulatory effect.
Other inhibitory systems involving phospholipids and human serum
The literature cites a wide range of inhibitory processes 
involving human serum in which a role for phospholipids have been implicated. 
Many viral haemagglutinins are inhibited either by phospholipid or by 
particular serum lipoproteins. Serum g-lipoprotein has been shown to 
inhibit haemagglutination by rubella virus (Feldman, 1968; Laufs and 
Thomasen, 1968; Haukenes and Aasen, 1971; Chang and Weinstein, 1972; 
Shortridge, Biddle and Pepper, 1972), and Shortridge and Ho (l97k) 
reported that togavirus haemagglutinins were inhibited by 3-lipoprotein.
As in the case of delta-haemolysin and its inhibitor, the 
evidence for the inhibitor of arbovirus haemagglutination is inconsistent. 
Porterfield and Rowe (i960), Salminen (1962) and Gorman (1970) all claimed 
serum lipid to be responsible, but Nicoli and Acker (1965) and Bidwell 
and Mills (1968) implicated 3-lipoprotein. Similarly, earlier work on 
rhabdoviruses such as rabies (Halonen et al, I968; Kuwert et al, I968)
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and vesicular stomatitis virus (VSV) (Halonen, Nikkari and Toivanen,
1969) suggested the inhibitor of haemagglutination was lipid in nature, 
and Halonen, Toivanen and Nikkari (l9Tk) attributed the role to lipoproteins. 
Strains A, C and G of the 3-haemolytic Streptococcus pyogenes produce two 
haemolysins: one oxygen-labile (SLO) and the other oxygen-stable (SLS).
Both are inhibited non-specifically by certain serum components, and SLO 
is inhibited by cholesterol. Streptolysin S closely resembles S. aureus 
6-haemolysin in terms of cytotoxicity, biological activity and lack of 
antigenicity (see below). Stollerman, Bernheimer and MacLeod (l950) 
found that serum inhibitory titres were not elevated during a streptococcal 
infection, suggesting a non-antibody system. Since lecithinase abolished 
inhibitory activity, Stollerman suggested a phospholipoprotein complex to 
be the inhibitor.
Immunogenicity of delta-haemolysin
The question of the antigenicity of 6-haemolysin has been 
raised on many occasions. The ability of normal sera to neutralise the 
haemolytic activity has been observed frequently and since most normal 
sera have been shown to produce a precipitin line on gel diffusion against 
6-haemolysin and to neutralise haemolytic activity, results with sera of 
immunised animals are difficult to interpret. Rusakova (1970) reported 
the production of an antigenic toxoid of 6-haemolysin produced by formolisati 
which induced specific antibodies to the toxin. Elek (1959), McLeod (1963), 
Kayser and Raynaud (1965), Caird and Wiseman (l970) and Lochmann and Vymola 
(197k) all reported the production of specific antibodies to 6-haemolysin, 
although in no instance was there evidence presented that the non-specific
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serum inhibitor had been removed. On the other hand, Gladstone and 
Yoshida (1967), Plommet and Bonillane (1966), Hallander (1968) and 
Kantor al (l972) have all been unable to demonstrate an immune response 
to 6-haemolysin. However, Fackrell and Wiseman (l97k) obtained Y”globulin 
fractions of serum from rabbits immunised intensively with I6 injections 
of 6-haemolysin which yielded specific quantitative precipitin curves 
with 6-haemolysin and a single precipitin line in diffusion against 
purified 6-haemolysin which in blood agar coincided with the edge of the 
lysis zone. However, Kapral (1976) argued that Fackrell and Wiseman’s 
findings did not prove the antigenicity of delta-lysin. Preimmune 
sera will precipitate 6-haemolysin (Kantor e^ al, 1972), and since this 
reaction appears to result from combination with a substance other than 
a globulin, Kapral maintains that no proof was given that the precipitate 
consisted of 6-haemolysin and specific antibody. Recent work by Heatley 
(1977)9 however, demonstrated that antibodies to 6-haemolysin could be 
raised in rabbits. Further observations on the antigenicity of 
6-haemolysin are included with this thesis (Birkbeck and Whitelaw, 1976).
Other inhibitory systems in serum
Although not extensively documented, there are factors in
serum, some of nonimmunoglobulin nature, involved in host defence, which
are capable of precipitation reactions. C-reactive protein (so-called
2+because in the presence of Ca it reacts and precipitates with C-substance, 
a pneumococcal polysaccharide (Tillet and Francis, 1929)) is a protein 
not normally found in circulating plasma of humans but which appears 
early in the course of many infections, following inflammatory conditions 
or where there is tissue damage (Raffel, I96O). Known as an "acute 
phase protein," its appearance indicates an inflammatory reaction somewhere 
in the body.
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There exists in ruminants the protein conglutinin (Bordet and
Streng, 1909), which is antigenically unrelated to the immunoglobulins,
and which causes clumping of complement-coated cells. The determinant
is a mannose peptide, in bound C which has reacted with C_ inactivator
3 3b
" 2't’(Lachmann and Muller-Eberhard, 1968) and binding requires Ca ions.
On the other hand, immunoconglutinins (auto-stimulated antibodies to hidden 
determinants in the complement molecule exposed on fixation) occur 
naturally in most mammals, and their reactivity is predominantly directed 
against bound C^ . They are largely of the IgM class, though immuno­
conglutinins of other immunoglobulin classes can be detected (Henson,
1968). The mechanism involved in this protection is likely to be the 
aggregating effect on complement-coated particles, thereby reducing the 
active invading dose. Another serum protein which could be implicated 
in non-specific reactions is the initiating factor involved in initiation
tt
of the alternative pathway of complement activation (Muller-Eberhard, 1976).
Serum proteins
Since a large proportion of this thesis will be devoted to 
serum proteins and their separation and identification, the characterisation 
of serum proteins will be briefly discussed. Blood plasma is the viscous 
medium through which the erythrocytes and leucocytes are transported and 
the tissues nourished: serum is the fluid left after the removal of a
blood clot, and is similar to plasma except for the absence of proteins 
of the blood clotting system. As components of a metabolically dynamic 
system, the plasma proteins fluctuate in disease, and their determination 
is important in the clinical laboratory. For a general review on plasma 
proteins see Putnam (1975).
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The identification5 characterisation and separation of plasma 
proteins dates from the development of analytical ultracentrifugation hy 
Svedberg and moving-boundary electrophoresis by Tiselius, Tiselius 
identified four components - albumin, and the three globulin bands termed 
alpha, beta and gamma, and Tiselius and Kabat (l939) demonstrated that 
antibodies were y-globulins. Electrophoretic techniques have been 
developed to include paper electrophoresis (Cremer and Tiselius, 1950), 
immunoelectrophoresis (Grabar and Burtin, 1960), crossed-electrophoresis 
(Laurell, I965) and the lipoprotein methods of Peeters and Blaton (1968), 
Two-dimensional electrophoresis of serum in starch gel allowed 22 zones 
to be resolved (Poulik and Smithies, 1958) and led to the discovery of 
genetic variants of haptoglobin and transferrin.
Plasma proteins have proved too numerous and varied (Table 6) 
to be identified and quantitated by any single method and a combination of 
procedures is required. Precipitation with cold ethanol or other solvents 
under rigidly-controlled conditions was developed by Cohn et ^  (1950), 
and precipitation by ammonium sulphate solutions has been widely exploited 
(Cohn and Edsall, 19^2). The immunoelectrophoretic techniques developed 
by Grabar and Williams (1953, 1955) and Grabar and Burtin (196O) allowed 
identification of 30-35 components in serum. A summary of the different 
patterns obtained by various electrophoretic techniques is presented in 
Fig 1.
A further major advance in resolution of serum proteins was 
made by Omstein (196k) and Davis (196k) with the introduction of poly­
acrylamide gel electrophoresis. A total of more than 65 proteins can be 
distinguished by this method.
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Figure 1
Schematic representation of the electrophoretic pattern of normal 
human serum in pH 8.6 buffer as obtained by four methods: (A) Tiselius
or free boundary electrophoresis, (B) paper electrophoresis, (C) starch 
gel electrophoresis and (D) immuno-electrophoresis. The vertical 
arrow indicates the starting point in each case. IgM remains in the 
starting slot in starch-gel electrophoresis but moves to the y- or 
3-range in other methods.
(Modified from Putnam, 1973)
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Table 6 Molecular veights and normal concentration ranges of
human plasma proteins
Protein Molecular Weight Normal Range (mg/ 
100 ml plasma)
Prealbumin (thyroxine-binding 61,000 15-35
Albumin 65,000-69,000 3500-5000
a^lipoprotein
HDLg 435,000 34-117
HDL3 195,000 217-270
apoLp-Gln-II-lipoprotein 17,380 .
«l-acid glycoprotein 44,100 60-120
ax~antitrypsin 45,000-55,000 200-400
Retinol-binding protein 21,400 4-6
Gc-globulin 50,000 30-55
Haptoglobin (Hp l-l) 100,000 30-190
a2-macr0globulin 820,000 170-380
C ae ruloplasmin 132,000-160,000
5-20 X log
27-55
ag-lipoproteins 150-230
p“lipoprotein (LDL) 3-20 X 10& 280-440
Transferrin 76,500 200-300
Hemopexin 80,000 80-100
Complement components
Clq 400,000 10-20
Clr 150,000 —
CIS 79,000 2-4
C2 117,000 1-3
C3 (PiC) 185,000 80-l40
C!+ (PiE) 240,000 20-50
C5 (PpF) 175,000 5-15
06 90,000 -
CT 110,000 -
C8 150,000 < 1
C9 79,000 < 1
Cl esterase inhibitor 104,000 15-35
Coagulation proteins
Fibrinogen 341,000 200-500
Prothrombin 60,000 (5-10)
Plasminogen 143,000 20-40
Immunoglobulins ; IgG 160,000 800-1800
IgA 160,000 + polymers 90-450
IgM 950,000 75-250
IgD ~ 190,000 10
IgE ~ 190,000 0.005-0.5
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Serum comprises too complex a starting mixture for many high 
resolution techniques, and column chromatography is widely used to provide 
less heterogeneous suh-fractions of whole serum. Sober and Peterson 
(195 )^ and Sober e;^  al (1956) developed cellulose derivatives with ionic 
exchange properties (DEAE-cellulose and CM-cellulose) and Tiselius,
Hjerten and Levin (1956) described the use of calcium phosphate (hydroxyl- 
apatite) gels for fractionation of medium to high molecular weight proteins, 
elution being achieved in both cases by increasing ionic concentration to 
displace the adsorbed protein from the gel. Molecular exclusion 
chromatography with dextran or agar gels (Sephadex, Sepharose) has been 
widely used in protein separation and has been reviewed by Tiselius,
Porath and Albertsson (1963).
The Serum Lipoproteins
The serum lipoproteins solubilise and transport cholesterol, 
glycerides and phospholipids throu^ the serum from sites of lipid 
absorption and synthesis to sites of storage and catabolism (Langer,
Strober and Levy, 1970). Four lipoprotein classes can be identified in 
serum by electrophoresis or according to their density: chylomicrons;
very low density lipoprotein (VLDL, pre-g- or a^-lipoprotein); low 
density lipoprotein (LDL, ^-lipoprotein) and high density lipoprotein (HDL, 
a-lipoprotein ). The structure and function of lipoproteins has been 
reviewed by Scanu and Wisdom (1972) and Morriset, Jackson and Gotto (1975) 
and their basic properties are shown in Table 7«
Chylomicrons. Chylomicrons transport glycerides of dietary (exogenous) 
origin from the intestine into the lymph. They are the largest lipo-
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proteins and consist predominantly of glycerides with smaller amounts 
of protein and phospholipid (Lossow et 1969).
Chylomicrons are produced in the intestinal mucosa in response 
to the ingestion of dietary fat and, in man, are normally absent in 
serum after an overnight fast. They pass to the lymph and enter the 
bloodstream via the thoracic duct; in the circulation their half-life is 
only 5-15 min. The site of catabolism is uncertain, but may be the liver. 
In animals, partial hydrolysis of chylomicron glycerides occurs in the 
environment of adipose tissue and skeletal muscle, the liberated fatty 
acids being metabolised or stored as esters (Havel, 19^5), while remnants 
enriched with cholesterol, phospholipids and protein are taken up by the 
parenchymal cells of the liver (Redgrave, 1970).
Very low-density lipoprotein. This comprises a family of macromolecules 
with a broad Sf range (Table 7 ); the density of VLDL is related to the 
protein content (Gustafson, Alaupovic and Furman, 19^5) and the highest 
density fraction comprises 13% protein (Lossow et al, 19&9). Glycerides 
are the predominant lipids, with smaller amounts of phospholipid and 
cholesterol.
Synthesis of VLDL occurs predominantly in the liver (Ruderman 
1968) and also in the intestinal mucosa (Hatch el, I966;
Ockner, Hughes and Isselbacher, 1969). The VLDL particles are a major 
transport vehicle for endogenous triglycerides. Through the action of 
lipoprotein lipase and subsequent triglyceride hydrolysis, VLDL is 
converted into smaller lipoprotein particles (LDL) enriched in cholesterol, 
phospholipid and protein (Levy, Bilheimer and Eisenberg, 1971), but it is
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not established whether all VLDL are degraded into LDL and, conversely, 
whether all circulating LDL are of strictly VLDL derivation: also
unresolved is whether liver and intestinal VLDL have the same metabolic 
fate.
Low density lipoprotein. This can be isolated by preparative ultra­
centrifugation (density range I.OO6 to I.O63 g/ml) and has beta mobility 
in most electrophoretic media. The molecule is a quasi-spherical 
particle of molecular weight 2.1 - 2.6 million (Adams and Schumaker, 1969).
Cholesterol and cholesterol esters account for 40-45% of LDL by weight
with the remainder consisting of approximately 20-25% protein, 25% 
phospholipid, and 10% glyceride (Bragdon, Havel and Boyle, 1956); one- 
half to two-thirds of the plasma cholesterol circulates bound to LDL in 
a normal subject. In man, elevated serum LDL is positively correlated 
with increased incidence and severity of atherosclerosis (Frederickson 
and Sloan, 1972). In abetalipoproteinaemia, abnormalities in red blood 
cells and neural tissues are found suggesting that LDL and cholesterol 
are required for normal maintenance of some cell membranes (Frederickson, 
Gotto and Levy, 1972).
Reticuloendothelial cells, smooth muscle cells (Stein and 
Stein, 1967, 1975) and others take up LDL and inside the cell the 
cholesterol released by hydrolysis of cholesteryl ester regulates
cholesterol metabolism. The main site of LDL catabolism may be the liver,
High density lipoproteins. These are the smallest of the lipoproteins 
with a density range of I.O63 to 1.21 g/ml (Table 7) and a-mobility on 
electrophoresis. High density lipoproteins have been subdivided into
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two classes, EDL^ (density I.O85 - 1 .12) and HDL^ (l.l2 - 1.2l); with 
increasing density, the relative amount of protein and the ratio of 
esterified to free cholesterol increases,while the total cholesterol 
decreases (Glomset 1966). The function of HDL is intimately
associated with that of the plasma enzyme, lecithin-cholesterol acyl 
transferase, which catalyses the estérification of cholesterol (Glomset, 
1968); HDL is thought to act as a scavenger for endogenous cholesterol 
arriving in the bloodstream (Glomset, 1972). Such a role is supported 
by the observation that subjects with Tangier disease, who have a marked 
deficiency of normal HDL, accumulate cholesterol esters in the cells of 
the reticuloendothelial system (Frederickson, Levy and Lees, 1967).
The NMR spectra of the two major lipoprotein subclasses, LDL 
and HDL, are quite similar, and resemble those of lipoprotein-lipids 
sonically dispersed in water. The bulk of the lipids are not tightly 
bound to the apoprotein but are highly mobile, suggesting a micellar 
structure for LDL and HDL (Hamilton ot 197^ ). For the LDL particle, 
it has been suggested that the surface is occupied by both protein and 
phospholipid, while neutral lipids are contained in the hydrophobic core 
(Pollard and Devi, 1971; Deckelbaum, Shipley and Small, 1977).
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OBJECT OF RESEARCH
While previous work has shown that there is a fraction in 
human serum which is inhibitory to 6-haemolysin, conjecture as to its 
identity has not been supported by detailed experimental evidence.
The first objective of this investigation was to produce a 
sufficient quantity of purified 6-haemolysin and to develop a reproducible 
assay for measuring its inhibition by serum and serum fractions.
The second objective was to purify and identify the 
component(s) in human serum that inhibit 6-haemolysin and to investigate 
the mechanism of inhibition.
MATERIALS AND METHODS
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A. Production of (S-haemolysin
1. Organism
S. aureus strain WCTC 1034-5 was used throughout this study.
The organism was maintained by subculture on horse blood agar.
2. Production of crude staphylococcal 6-haemolysin
Haemolysin was produced by a modification of the method of 
Kreger et ^  (l97l). The medium consisted of a dialysis diffus ate of 
yeast extract with added casamino acids, glucose and vitamins (Appendix I).
For haemolysin production S. aureus NCTC 10345 was reconstituted 
from a freeze-dried ampoule and plated on to 10% (v/v) horse blood agar 
(Oxoid).
After overnight incubation at 37^C a haemolytic colony was 
seeded into 50 ml of pre-warmed medium contained in a 250 ml flanged 
Erlenmeyer flask. This was incubated at 37°C in an orbital shaking 
incubator (Gallenkamp, London) at a shaking speed of 150 r.p.m. After 
l8 hours the cells were harvested by centrifugation at 17,000 x g for 10 
min. The cocci were resuspended in 7*5 ml of fresh medium and 1 ml of 
this suspension was used to inoculate 500 ml of prewarmed medium in a 2 
litre Erlenmeyer flask. One ml of a sterile solution of antifoam 
(Appendix I) was added to prevent excessive foaming during the subsequent 
overnight incubation. A total of 6 such 2 litre flasks were processed 
at one time; this yielded 3 litres of crude haemolysin. Supernatant 
fluid containing crude staphylococcal 5-haemolysin was separated from the 
cells by centrifugation at 17,000 x g for 20 min.
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3. Purification of staphylococcal 6-haemolysin
This was "based on the method of Kreger ^  (l9Tl).
Hydroxylapatite (Appendix HI ) was added to crude staphylococcal 6-haemo­
lysin in the ratio 100 g/l500 ml and mixed "by stirring for 48 hours at 
4^0, The hydroxylapatite was then washed with 500 ml amounts of O.OIM 
phosphate buffer, pH 6.8 by centrifugation until the supernatant appeared 
only faintly coloured. The hydroxylapatite was then washed six times 
with 500 ml 0,4m phosphate buffer, pH 6.8, for 30 to 60 min each time, 
after which the adsorbed 6-haemolysin was released by washing the 
hydroxylapatite five times with 400 ml amounts of l.OM phosphate buffer, 
pH 7.4, for 45 min each time. The pooled l.OM phosphate buffer washes 
were dialysed at 4°C for 48 hours against distilled water, with two 
changes. The precipitate of insoluble delta-haemolysin which formed 
at this stage was removed by centrifugation at 47,000 x g for 20 min 
and the supernatant, containing soluble 6-haemolysin, was lyophilised, 
redissolved in O.IM phosphate buffer and solid (NH^ )gBO^  ^ (B.D.H., AnalaH) 
added to a final concentration of 70% (w/v) according to the nomogram of 
Dixon and Webb (1958). After gentle stirring at 4°C for 48 hours, the 
precipitate was harvested by centrifugation at 17,000 x g for 20 min, 
resuspended in O.IM phosphate buffer, and dialysed against distilled 
water for 48 hours at 4^0. The dialysed solution was lyophilised.
B. Assay of haemolytic activity and haemolysin inhibitors
1. Erythrocytes
Rabbit blood was collected by bleeding from the marginal ear
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vein of stock animals housed in this department. Sheep blood was 
removed by jugular venepuncture from sheep from the grazing stock of the 
Veterinary School, Glasgow. Cod blood was obtained by bleeding, from 
the dorsal aorta, freshly caught fish from the Firth of Clyde. In all 
cases sodium citrate (3.8% w/v) was used as an anticoagulant.
In the early part of the investigation, citrated human blood 
group "A" obtained from the Haematology Department, Western Infirmary, 
Glasgow, was used as the source of human erythrocytes. In later stages, 
for reasons discussed elsewhere, blood freshly withdrawn from the 
antecubital vein of the author’s left arm was used for human cells.
Whole blood samples, with the exception of cod blood, see 
below, were stored at 4^C for not more than 5 days. Erythrocytes were 
washed 6 times with citrate dextrose saline (CDS, Appendix II) and 0.8%
(v/v) suspensions in CDS were prepared as follows: 0.9 ml of washed
packed erythrocytes was added to 100 ml CDS and the concentration 
adjusted so that a sample, after haemolysis with saponin powder (B.D.H., 
Poole, Dorset) gave an E^^^ of 0.8 - 0.05 in a PYE Unicam SP500 spectro­
photometer (Pye Unicam, Cambridge) with glass cells of 5 mm light path.
2. . Storage of cod erythrocytes
Whole cod blood was mixed with an equal volume of 20% (v/v) 
dimethyl sulphoxide (DMSO, B.D.H., Poole, Dorset) in CDS, resulting in 
a 10% solution with respect to DMSO. After equilibration for 20 min at 0°C 
the blood was rapidly frozen by dropwise addition to liquid nitrogen and 
the pellets stored in aluminium canisters in liquid nitrogen in a British 
Oxygen Co. CPVSIO liquid nitrogen refrigerator.
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When required, pellets were removed, thawed in 10% (v/v)
DMSO/CDS and washed in progressively decreasing concentrations of DMSO/CDS 
(10, 5, 2.5, 1% DMSO/CDS) and finally washed in CDS alone.
3. Doubling dilution titrations
Haemolysin titres were determined by making serial doubling 
dilutions of haemolysin in 0.4 ml CDS in a WHO tray and adding 0.4 ml 
of erythrocyte suspension to each well. Wells without haemolysin 
served as controls. Samples were incubated at room temperature (approx. 
20°C) for 30 min when cod cells were used, and at 3T°C for 30 min when 
mammalian cells were used. The 50% haemolysis end point was assessed 
visually. The dilution causing 50% haemolysis under these conditions 
was accepted as containing one Haemolytic Unit (HU^^). In titrations 
with sheep erythrocytes, O.OOIM Mg^”* in Dulbecco's PBSA was used to allow 
detection of g-haemolysin.
4. Human serum
At the outset of this project, citrated human blood group A 
obtained from the Haematology Department, Western Infirmary, Glasgow, was 
used as the source of human plasma. Plasma was separated from the blood 
by low speed centrifugation (2,000 x g for 20 min), CaCl^ (final concen­
tration 0.005M) was added and the fibrin clot removed after incubation at 
3T°C for 30 min. Samples of 10 ml were stored at -20°C until required.
Freshly drawn group A blood from the author was used in the 
latter part of the project as a source of human serum; sanples were not 
frozen but were stored at 4^C for not more than 5 days.
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5. Doubling dilution inhibition titration
The inhibitory titre of serum samples was determined by 
making serial doubling dilutions of sample in 0,2 ml amounts of CDS in 
a WHO tray, and adding an equal volume of a standard haemolysin 
preparation containing h HU^^. After incubation at 37°C for 45 min, 
the tray was chilled to 4°C, and 0.4 ml of erythrocyte suspension was 
added to each well. After a further 45 min at room temperature the 50% 
inhibition end point was assessed visually. The dilution causing 50% 
inhibition under these conditions was accepted as containing one 
Haemolytic Inhibitory Unit (HIU). Two wells, one containing no serum 
sample, and one containing no haemolysin served as controls.
C. Physico-chemical properties of purified 6-haemolysin
1. Protein estimations
Protein estimations were done by the method of Lowry al 
(1951) using bovine serum albumin (Pract. V, Sigma Chemical Co., St. Louis) 
as a standard. The protein content of fractions from chromatographic 
columns was monitored by continual measuring of ^280 ^  BKB Uvicord
Ultraviolet Absorptiometer Detector Unit, Type 8303A linked to a control 
unit and chart recorder. The of fractions from isoelectricfocusing
troughs was measured manually.
2. Heat stability of 6-haemolysin
A solution of 6-haemolysin in CDS (lOO yg/ml) in a 6 x i"
test tube was immersed in a boiling water bath. The tube was stoppered
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to minimise evaporation, and 0.2 ml aliquots of lysin were removed at 
various stages and titrated for haemolytic activity against cod 
erythrocytes.
3. Spectral analysis
The ■ultraviolet absorption spectrum was determined with a Pye 
Unicam SP800 spectrophotometer in 1 cm path length silica cells.
4. Polyacrylamide disc gel electrophoresis
i) Acid gels. This was performed by the acid gel system of Reisfeld,
Lewis and Williams (1962) at pH 4.3 in 7.5% polyacrylamide gels. Electro­
phoresis was done at 6 mA per gel until the tracking dye (Pyronin Y,
Difco) reached the final few millimetres, at which time the current was 
increased to 8 mA per gel. Migration was towards the cathode.
The gels were fixed and stained in 1% (w/v) ami do-black in 
7% acetic acid for 1 hr and then electrophoretically destained.
ii) Alkaline gels. The 7% gel electrophoresis technique (separation at 
pH 9.5) described by Davis (1964) was used. Electrophoresis was
performed at 2 mA per gel, with migration towards the anode. The fixation
and staining were done overnight in 1% (w/v) amido-black in 10% acetic 
acid and 50% methanol. Gels were rehydrated in 7% acetic acid and 
destained electrophoretically.
Densitometer traces of gels were made with a Joyce Loebl 
U.V. Polyfrac Scanner (Joyce Loebl & Co., Durham) and were recorded on a 
Kipp & Zonen chart recorder (Bryans Southern Instruments, Mitcham,
Surrey) set at 5.0 V full scale deflection.
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5. Isoelectricfocusing
i) Equipment. A horizontal trough isoelectricfocusing apparatus 
designed by Talbot and Caie (1975) was used with an LKB 3371 DC power 
supply.
ii) Procedure. All procedures were carried out in a 4°C cold room 
and the total power was restricted to a maximum of 0.28 watts. The 
apparatus was allowed to equilibrate at 4°C, 31.2 ml of 1% ampholines 
(pH 3.5 “ 10; LKB Instruments, London) was added, and a pH gradient 
established by isoelectricfocusing for 24 hours at a potential of 600 
volts. The sample (0.8 ml dialysed against 1% glycine) was introduced 
into the three centre troughs and focusing was continued at a potential 
of 800 V for l8 hr and finally at 1,000 V for a further 24 hr. After 
focusing, fractions, including any precipitated material, were removed 
by Pasteur pipette and retained for analysis.
iii) Analysis of fractions. The pH of each fraction was measured with 
a Pye Model 46a Vibret Lab pH Meter with the samples maintained at 4^C 
in a cooled water bath.
The optical density of each fraction was measured at 280 nm 
using a Pye Unicam Model 8P500 spectrophotometer with silica micro-cells 
of 1 cm li^t path. To detect the presence of haemolysin, doubling 
dilution titrations were performed on each fraction with cod, rabbit and 
human erythrocytes.
6. Gel filtration
i) Equipment. A glass K70/26 chromatographic column (Pharmacia, 
Uppsala, Sweden) was used with an LKB Ultrorac 7000 fraction collector and 
LKB Uvichord ultraviolet spectrophotometer (LKB-produkter, Sweden).
kh
ii) Procedure. All procedures were carried out in a 4°C cold room. 
Sephadex G-150 columns of 270 ml bed volume were poured and equilibrated 
with running buffer (Tris-buffered saline, TBS, Appendix H  ). Samples 
of 6-haemolysin were chromatographed with upward elution at a flow rate 
of not greater than 15 ml per hr, and 2,5 ml volume fractions were 
collected.
iii) Analysis of fractions. The optical density of peak fractions 
(shown by Uvicord) was measured at 280 nm using a Pye Unicam Model SP500 
spectrophotometer with silica cells of 1 cm light path, and doubling 
dilution titrations were performed on those fractions showing 
absorbing activity to detect the presence of haemolytic activity against 
cod cells.
7. Amino-acid analysis
This was carried out by Dr. B. Manson, The Hannah Dairy 
Research Institute, Ayr. Three samples of 6-haemolysin (0.4l0, 0.412 
and 0.413 mg) were hydrolysed with 6M HCl (4.0 ml in each case) for 
24, 48 and 72 hr at 110^ iu vacuo in sealed Pyrex tubes. Acid was 
removed by lyophilisation and each residue dissolved in 3 ml citrate 
buffer pH 2.2. Automatic amino acid analysis was carried out following 
the procedure of Spackman, Stein and Moore (1958). Threonine and serine 
content were obtained by extrapolation to zero h hydrolysis and valine 
and isoleucine by extrapolation to infinity. For other amino acids the 
average of three values was taken. Excluding tryptophan and ammonia, 
the recovery from 0.4l0 mg sample was 0.234 mg. Tryptophan was 
determined spectrophotometrically by the method of Spies and Chambers 
(I9lt9).
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D. Estimation of other extracellular staphylococcal products
1. p-haemolysin
The procedure was as described for 6-haemolysin except that 
the diluent (Dulbecco's PBSA) contained 1.0 mM MgSOj^  ; sheep erythrocytes 
were used instead as indicators of haemolysis and titrations were incubated 
at 3T°C for 1 hour and at 4°C for a further hour.
2. d-haemolysin
This was assayed as described for 6-haemolysin, using rabbit 
erythrocytes instead of cod erythrocytes, and titrations were incubated 
at 3T^C for 30 min.
3. Lipase
Saline agar (1.5% (w/v) agar (Oxoid), 0.85% (w/v) NaCl) 
containing 0.01% (v/v) merthiolate was made 1% (v/v) with tributyrin and 
dispensed in 0.5 ml amounts in 5.0 cm x 0.5 cm tubes; 0.1 ml volumes of 
serial doubling dilutions of the haemolysin sample in saline were layered 
onto the surface of the agar and the tubes incubated at 3T°C for l8 hours. 
Lipase activity was indicated by clearing due to hydrolysis of tributyrin.
4. Phosphatase
Phenophthalein phosphate (0.5 ml amounts of a 0.1% (v/v)
solution) was dispensed in 4" x i" test tubes ; 0.5 ml volumes of lysin
2+sample in 0.05M TBS + Mg , pH 7.^ were added and the tubes incubated at 
37°C for 30 min. Solutions were made alkaline by the addition of 0.1 ml
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of O.IM sodium hydroxide to each tube. Phosphatase activity was 
indicated by a pink colouration due to free phenolphthalein. This was 
measured at 550 nm in an SP600 spectrophotometer in cells of 5 mm light 
path. Alkaline phosphatase from E. coli (Sigma, London) was used as a 
standard.
5. Coagulase
Citrated rabbit plasma (0,4 ml) was dispensed in 4" x i” test 
tubes. Palitsch buffer (0.2 ml) (see Appendix II ) was added to each
tube. Serial doubling dilutions of the haemolysin sample in saline were
added (0.2 ml) and the tubes incubated at 3T°C for 6 hours. Coagulase 
activity was indicated by the formation of a clot.
6. Fibrinolysin
Human plasma was diluted 1:10 in saline and made 0.01% (v/v) 
with thiomersal and was dispensed in 0.8 ml volumes in 4" x i" test tubes. 
The plasma was clotted by addition of 0.1 ml (2 units) of thrombin (Sigma, 
London) solution to each tube. 0.2 ml volumes of serial doubling dilutions 
of the haemolysin sample in 0.05M TBS, pH were added and the tubes 
incubated at 3T°C overnight. Fibrinolysin activity was indicated by lysis 
of the clot.
7. Egg yolk factor
An egg yolk extract was made from 20 ml of fresh hen egg yolk 
by mixing with 10 volumes of 0.05M phosphate buffer pH 7.3 containing 5% 
(w/v) NaCl and allowing the mixture to stand for 30 min at room temperature.
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followed by centrifugation at 1000 g for 20 min. This led to the 
formation of a pellet, a middle clear layer and a lipid scum on the 
surface. The middle layer was made 0.01% (y/v) with thiomersal and 2 ml 
amounts were dispensed in 6" x i" test tubes. Serial doubling dilutions 
of the haemolysin sample in saline were added (0.2 ml) and the tubes 
incubated at 37^0 for l8 hours. The degree of turbidity in the egg 
yolk extract was measured at 540 nm in an SP600 spectrophotometer in
0.5 mm cells. Phospholipase C prepared by the method of Smyth and 
Arbuthnott (l97 )^ was used as a standard (to test for sensitivity).
8. Hyaluronidase
Hyaluronidase was assayed by the method of Dorfmann (1955). 
Bacterial samples were compared with an International Standard preparation 
of ovine testicular hyaluronidase (Miles Seravac Ltd., Slough, England), 
standardised by the method of Humphrey (1957).
Dilutions of test solution were made in hyaluronidase diluent 
(see Appendix II). To 0.5 ml volumes of standardised hyaluronic acid 
solution (see Appendix H ) , 0. 5 ml of test solution was added. Tubes 
were then incubated at 37^0 for 4-5 min, after which 5 ml of acid albumin 
was added to each tube. The Eg^^ of each.solution was read in an SP600 
spectrophotometer against an appropriate diluent/acid albumin blank.
9. Protease ,
Phosphate agar (1.5% (w/v) (Oxoid), 0.05M phosphate pH 7.3) 
containing 1% (w/v) casein (BDH) was imde 2 mM with KH^ POj^  and 1 mM with 
CaClg. The solution was made 0.01% (v/v) with thiomersal and dispensed
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in 5 cm diameter Petri dishes. Wells of 5 mm diameter were cut in the 
agar, and were filled with test volumes of haemolysin sample in buffer.
The plates were incubated at 37*^ C overnight. Protease activity was 
detected as a precipitated paracasein band, Subtilisin (Protease, 
type viii. Sigma, London) was used as a standard (to test for sensitivity)
10. Leukocidin
Fresh human blood was allowed to form a clot on a chemically 
cleaned coverslip. The blood clot was washed off with phosphate 
buffered saline (0.05M phosphate, pH 7.5 with 0.85% NaCl) and was placed 
on top of a haemolysin sample in saline. The specimen was examined for 
dead leukocytes, as described by Woodin (1972).
11. Nuclease
Tris-HCl agar (l.5% (w/v) agar (Oxoid) 0.05M Tris/HCl) 
pH 7.^» 12.5 mM with respect to CaCl^ and MgCl^ was made 1% (w/v) with 
salmon testes DNA (Type III, Sigma, London). The agar solution was 
made 0.01% (v/v) with thiomersal and dispensed in 5 cm Petri dishes.
Wells of 5 mm diameter were cut and filled with test volumes of haemo­
lysin sample : the plates were incubated at 37^C overnight and then
flooded with l.OM HCl. Nuclease activity was detected as a zone of 
clearing in the agar surrounding the wells. Micrococcal nuclease (Sigma 
Chemical Co., London) was used as a standard (to test for sensitivity).
E. Protein separation
1. Ammonium sulphate precipitation of human serum
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Human serum vas precipitated by (NH^Ï^SO^ in the following 
stepwise manner: serum in dialysis tubing (Visking. Scientific
Instrument Centre, London) was dialysed at 4-^ C for six hours against 
100 X its own volume of 10% saturated The contents of the
sac were centrifuged at 10,000 x g for 30 min, an aliquot of supernatant 
and pellets were removed for inhibitory assay, and the supernatant was 
returned to dialysis tubing for dialysis against 20% sat. (NH^)280 .^
This procedure was repeated for 20%, 30%, 40%, 50%, 60%, 70% saturations 
of ammonium sulphate respectively, giving a supernatant and pellet 
sample at each concentration of (NH^)g80^ for determination of inhibitory 
activity. Such aliquots were dialysed overnight at 4°C against CDS 
to remove salts prior to titration.
Precipitation of serum at 60% saturation (NH^)280^ alone was 
done by dialysis as above, except that after centrifugation the super­
natant was dialysed for a second time at 60% saturation to facilitate 
maximal protein precipitation.
2. Ammonium sulphate precipitation at pH 5
This was based on the method of Freeman and Smith (1970).
Serum was diluted with two volumes of 0,9% NaCl and adjusted to pH 5.0 
by the addition of glacial acetic acid. Solid (NH^)280^ was added to 
bring the concentration to 1,6M (40% saturation) and stirred ovemi^t 
at 4°C; the solution was then centrifuged at 10,000 g for 1 hr. The 
supernatant was retained, and the deposit was dissolved in a known 
volume of water and subjected to a second precipitation with 40% saturated 
(NH^)2S0^. The supernatants from two such treatments were pooled.
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concentrated by ultrafiltration (UM05 membrane, exclusion limit 5.00 
daltons ; Amicon, U.S.A.) and adjusted to 50% saturation by the addition 
of solid (^B^)g80^. Fractionation at this concentration continued in 
the same manner.
The pellet material and supernatants at both concentrations 
were dialysed against CDS to remove salt prior to inhibitory titrations, 
and aliquots required for immunoelectrophoretic analysis were dialysed 
against barbitone buffer (Appendix II ).
3. Ultrafiltration of human serum
A ten-fold dilution of human serum was subjected to ultra­
filtration in a 50 ml cell (Amicon Corporation, U.S.A.) at 15 p.s.i. 
positive pressure of nitrogen. Aliquots were collected from material 
that passed through a particular membrane, prior to filtration of that 
material through a filter of greater pore size. Thus serum protein 
solutions comprising components of greater than approximately 500, 1000, 
5,000, 10,000, 30,000, 100,000 and 300,000 daltons respectively were 
collected for analysis for inhibitory activity.
4. Gel filtration of human serum in Sephadex G-150
The apparatus and procedure were similar to those already 
described (page 3^). The optical density of peak fractions (2,5 ml) 
was measured at 280 nm using a Pye Unicam Model SP500 spectrophotometer 
with silica cells of 1 cm light path, and doubling dilution titrations 
were performed on those fractions with E^Q^^-absorbing activity to detect 
the presence of haemolytic inhibitory activity against cod cells.
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Fractions for immunoelectrophoretic analysis were dialysed against 
barbitone buffer, pH 8,6.
5. Gel filtration of human serum in Sepharose
Pouring and equilibration of Sepharose 6-B chromatographic 
columns was done in the same way as for Sephadex G-150 columns, using 
the same accessory equipment. Separation was done with upward elution; 
the flow rate at no time exceeded 15 ml/hr, and 2.5 ml fractions were 
collected. From the chart record of the LKB Uvichord spectrophotometer 
peak fractions were identified and the optical density of peak fractions 
was measured at 280 nm using a Pye Unicam Model SP500 spectrophotometer 
with silica cells of 1 cm light path, and doubling dilution inhibition 
titrations were performed on fractions with Egg^-absorbing activity.
Peak fractions from the separation were dialysed against barbitone 
buffer, pH 8.6, at 4^C for 12 hr prior to immunoelectrophoretic analysis.
6. Affinity chromatography of 6-haemolysin inhibitor
One gram of freeze-dried, CNBr-activated Sepharose k -B  
(Pharmacia, Uppsala, Sweden) was swollen in, and washed with 200 ml O.OOIM 
HCl on a sintered glass filter to remove the stabilising additives 
(dextran and lactose) present in the freeze-dried powder. The ligand 
(6-haemolysin : 10 mg) was dissolved in coupling buffer (borate buffered 
saline : Appendix II) and mixed with the gel in a 6" x |" test tube for 
l8 hours at 4^0. Unbound material was removed by washing with three 
50 ml volumes of coupling buffer and remaining active groups were reacted 
with l.OM ethanolamine, pH 8 (Appendix II) for two hours at room 
temperature. Three washing cycles were used to remove non-covalently
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absorbed protein and excess blocking reagent, each cycle consisting of a 
wash at pH 4 (acetate buffered saline; Appendix II) followed by a wash 
at pH 8 (borate buffered saline). The haemolysin-Sepharose conjugate 
was stored at 4°C until required.
1 ml of a l/5 dilution of whole human serum was mixed with 
conjugate for 2 hr at 3T^C with gentle stirring. After the slurry had 
separated on standing into two phases, a sample was removed from the 
supernatant (liquid phase) for immunoelectrophoretic analysis.
7. Zonal ultracentrifugation
This was done in an MSE BXIV titanium rotor in an MSE 65 
superspeed centrifuge by the method of Wilcox, Davis and Heimberg (l97l).
Loading procedure. The rotor was loaded with a KBr gradient 
(containing 350 yM EDTA) from density 1.00 to 1.28 using an MSE gradient 
mixer. Heavy solution (205 ml of 40% w/v KBr) and 365 ml light solution 
(350 yM EDTA) were mixed to form the gradient which was loaded into the 
rotor using a peristaltic pump via the edge feed (flow rate 10 ml/min) 
at a loading speed of 4,000 rpm. An exploded diagram of the loading 
assembly is shown in Fig 2. A fresh serum sample (25 ml) was adjusted to 
40% (w/v) KBr and applied to the dense end. of the gradient, via the edge 
feed, with a hypodermic syringe. Heavy solution was then applied to the 
edge of the rotor until li^t solution emerged from the central feed, 
ensuring no air was present to disturb the gradient. The centrifuge was 
then closed, evacuated and run at 44,000 rpm (147,000 x g) for 24 hr 
at 12°0.
53
Figure 2. Cut-away diagram of the BXIV titanium rotor
From MSE Technical Publication No. 49
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Unloading procedure. After decelerating the centrifuge to loading
speed and releasing the vacuum, the loading assembly vas re-fitted to 
the rotor. Using the same apparatus as before, heavy solution vas 
applied to the edge of the rotor to displace the gradient at a rate of 
10 Bil/min out through the centre feed. The first 50 ml vas collected 
in 5 ml aliquots, and thereafter in 10 ml amounts until the entire 
gradient vas displaced from the rotor. Protein content of the eluate 
vas monitored using an LKB Uvichord scanner as a preliminary screening 
measure. Individual samples vere thereafter tested for a) protein content 
^280 vere carried out on each sample; b) density: using
a 1 ml volumetric pipette, aliquots of each sample vere accurately veighed 
to determine the density gradient.
Pooling of samples. Because of the very large total volume of the 
centrifuged material (65O ml) samples vere pooled according to the protein 
profile and concentrated by ultrafiltration in an Amicon cell through a 
PM 30 membrane. Such concentrated samples vere then dialysed first 
against vater to remove salt and then against barbitone buffer to 
facilitate electrophoretic analysis.
F. Immunological analysis
1. Antisera
The antisera used in this study and their sources are listed 
in Appendix VI,
2. Double diffusion tests
Double diffusion tests vere based on the technique of
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Ouchterlony (1958). Wells, 3 mm in diameter, were cut in 3 mm deep 
Vfo lonagar (Difco) in barbitone buffer, pH 8.6 (Appendix II) in a 5 cm 
diameter plastic petri-dish, A uniform depth of agar was ensured by 
pouring the plates on a levelling table (Shandon Southern Instruments, 
Camberley, Surrey). After introduction of test sanp)le and antiserum to 
the wells, the plates were left at room temperature for up to seven days 
in a moist atmosphere (in a plastic container lined with moistened 
blotting paper).
3. Immunoelectrophoresis
Immunoelectrophoresis was carried out in (w/v) agarose 
in barbitone buffer. A glass microscope slide (75 mm x 22 mm) was 
covered to a depth of 1.5 mm with 2,5 ml molten agarose and allowed to 
set. Two 3 mm diameter wells were cut 1 cm apart at a distance of 15 mm 
from the end of the slide. The wells were filled with sample containing 
bromophenol blue tracking dye and electrophoresis was performed at 80V 
until the dye was 15 mm from the anodal end of the slide.
For development of antigen-antibody precipitin arcs, a 60 mm x 
3 mm broad trough was cut parallel to the direction of migration, between 
the wells, and filled with antiserum (Appendix VI ).
4, Two-dimensional immunoelectrophoresis
This was based on the technique of Laurell (I965). The 
procedure for the first-dimension separation was as for immunoelectrophoresis 
(see above) except that only one well was cut in the agarose, and tracking 
dye was omitted from the test sample. After primary electrophoresis, the
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gel was carefully removed from the slide with a scalpel, and transferred 
to one edge of a square glass plate (80 mm x 80 mm). The transferred 
gel was trimmed with a scalpel until the inward-facing edge was only 2 mm 
from the sample well and the electrophoresed proteins. The second 
dimension was prepared hy adding 1 ml of antiserum to 9 ml agarose (5 ml 
of 2.% (w/v) agarose plus h ml double strength barbitone buffer) at il8°C ; 
after rapid mixing, the molten solution was pipetted onto the plate to a 
depth of 1.5 mm up to the primary separation gel, ensuring no overlap.
When set, the separated proteins from the first dimension were electro­
phoresed at 30V into the antiserum-containing gel for l8 hours to form 
precipitin lines.
5. Washing and staining of gels
Gels were washed for two days in 1^ (w/v) saline and dried 
under Whatman^s No. 1 chromatography paper. Staining solutions are 
listed in Appendix VII,
6. Production of rabbit antiserum to an inhibitory fraction
The inhibitory material was prepared as an emulsion with 
Freund’s complete adjuvant. This was done by dropwise addition of
adjuvant to antigen, with homogenisation between successive additions, 
until the resulting emulsion was composed of equal volumes of the two 
components. The stability of the emulsion was deemed satisfactory if a 
droplet remained coherent when injected into a beaker of water. The 
rabbit was given four intramuscular injections, 0.2 ml, one each on days 
1 , 3, 5 and 11; this was followed by a course of intravenous injections,
0.2 ml being administered on days 50, 52 and 58, and 0.5 ml on days 72 and 
75. The animal was exsanguinated 60 days after the start of the treatment
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7. Concentration of rabbit antiserum
The rabbit yielded 60 ml serum; 30 ml saturated (NH^)g80^ 
was added, bringing the serum to 33% saturation. After 2 hours’ 
stirring at ^°C, the solution was centrifuged at 5000 x g for 30 min, and 
the supernatant decanted. The pellet was taken up in 20 ml Dulbecco’s 
saline (Appendix II), adjusted to 33% saturation (NH^)2B0 ,^ and the 
precipitation procedure repeated as above. In all, three such cycles 
were performed. The third such pellet was dissolved in 10 ml Dulbecco’s 
saline, dialysed overnight at against the same solution, and stored
in 1 ml aliquots at ~20^C until required.
G. Lipids and Lipoproteins
1. Polyacrylamide disc gel electrophoresis of serum lipoproteins
This was performed by the system of Naito ^  (1973) at 
pH 8,9 in 3.6% polyacrylamide gels. Electrophoresis was done at 3mA 
per tube for about 35 min or until the fastest moving stained band 
(a-lipoprotein) was approximately 1 cm from the anodal end of the gel tube. 
The procedure is outlined in Appendix V,
2. Immunocore electrophoresis
Immunocore electrophoresis was done in the same polyacrylamide
system as described by Naito ^  (1973), with an immunocore electro­
phoresis kit (Linton Instrumentation, Harlow, Essex) and electrophoresis 
was performed under similar conditions of constant current, but for a 
longer period because of the longer electrophoresis tubes (Appendix V).
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The central core of the gel was filled either with a 2 mg/ml solution 
of 6-haemolysin in agarose, or a 1:10 solution of antiserum (Appendix VI) 
in agarose. Gels were examined daily for the appearance of precipitation 
hands. A prestained human serum control served as an indicator of the 
relative positions of the lipoprotein species.
3. Gradient centrifugation of g-lipoprotein
This was done hy the method of Havel, Eder and Bragdon (1955), 
hy flotation at raised densities. The lowest density fractions from 
zonal ultracentrifugation were mixed with a stock solution of sodium 
chloride and potassium bromide to give a final density of 1.28 g/ml, and 
were centrifuged at 1+5,000 rpm at 8°C for 20 hr in an MSE swing-out rotor. 
Fractions of 1 ml were collected with the aid of a fraction collector 
(Ultrorac, LKB) through punctures at the bottom of 25 ml polycarbonate 
centrifuge tubes.
4. Delipidation of serum with organic solvents
Serum (2 ml) was extracted twice for 12 hr at 4^C with 50 ml 
diethyl-ether ethanol (3:1, v/v) under magnetic stirring. The lipid 
extract was isolated by centrifugation and purified by the method of Folch, 
Lees and Sloane-Stanley (1957), after evaporation under nitrogen to reduce 
the volume. The pooled extracts after washing were dried down in a 
rotary evaporator, the water bath temperature at no time exceeding 1+5^ 0, 
and after weighing were taken up in a known volume of chloroform.
5. Thin layer chromatography
Thin layer chromatography was carried out on Silica gel G
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(Nach Stahl, Merck, Darnstadt, Germany), A slurry was made hy mixing 
36 g Silica Gel G, 48 ml distilled water and 24 ml ’Analar' methanol in
a stoppered jar for 1 min. The slurry was spread to a depth of 0.4 mm
using a Shandon semi-automatic Unoplan Leveller on glass plates 20 cm x 
20 cm. After air drying, the plates were stored in a desiccator 
cabinet containing cone, H^ SO^  ^and were activated prior to use by heating 
in a drying oven at llO^C for 60 min. Plates were developed with 
chloroform: methanol : water (65:25:4 by vol) and the spots of the separated 
lipids were visualised by exposure to iodine vapour.
The lipids, and their sources, used in TLC and other
experiments are listed in Appendix VI. Before use, a known amount of
sample (50 yg) was evaporated to dryness under N^, and resuspended in 
chloroform. Streak applications were then made on the plate,
6. Inhibition of 6-haemolysin by phospholipids
Each phospholipid was tested as a 0.5 ml volume containing 
1 mg/ml. This was evaporated to dryness under nitrogen, and the lipid 
dissolved in 0.025 ml ethanol, and brought up to 0.2 ml with Dulbecco's 
saline. This solution contains 500yug phospholipid at a concentration of 
12.5% ethanol. Inhibition titration was performed in the usual way with 
cod erythrocytes as an indicator of lysis.
T. FLC pretreatment of inhibitory phospholipids
B. cereus phospholipase C (E.C.3.1.4.3; Boehringer, Mannheim, 
Appendix VI) was used. Specific activity of the preparation was 400 U/mg 
(1 unit hydrolyses 1 yM lecithin/min at 3T°C).
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The enzyme was used in ten-fold excess calculated from the 
phospholipid content of normal human serum (Documenta Geigy, 2.09 mg/ml).
An equal volume of serum (or phospholipid) was mixed with PBS or enzyme 
(l U/ml) and incubated at 3T°C for 30 min. Serial (0.2 ml) doubling 
dilutions were made in PBS, 6 HU50 ô-haemolysin (human erythrocytes) in 
0.2 ml was added to each well, and mixtures incubated at 3T°C for 30 min. 
Washed human erythrocytes (0.4 ml; 0.8% v/v in PBS) were then added, 
and the 50% endpoint assessed visually after 30 min at 3T°C.
8. Proteolytic degradation of lipoproteins
An equal volume of enzyme (trypsin, 1 mg/ml or 62.5 yg/ml ; 
papain, 1 mg/ml. Appendix VI) was added to substrate or PBS and incubated 
at 37°C for 30 min. Serial (0.2 ml) doubling dilutions were made in PBS,
6 HU50 6-haemolysin (cod erythrocytes) in 0.2 ml was added to each well, 
and mixtures incubated at 37°C for 30 min. The trays were chilled to 4^C, 
washed cod erythrocytes (0.4 ml; 0.8% v/v in PBS) were added, and the 
50% endpoint assessed visually after 30 min at 37°C.
RESULTS
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Preparation of purified S. aureus 6-haeinolysin 
Selection of strain
Chao (1976) monitored haemolytic activity of several staphylo­
coccal strains which had been observed to produce high levels of haemolysin 
not neutralisable by anti ô-haemolysin antiserum. By measuring the ratio 
of haemolytic titre against human and rabbit erythrocytes in culture 
supernatants, the relative amount of delta- and alpha-haemolysin produced 
was assessed. These observations showed strain NCTC 103^5 to yield both 
the highest titre against human erythrocytes and the highest titre ratio, 
and this strain was therefore selected for production of delta-haemolysin.
Preparation and characterisation of 5. aureus ô-haemolysin
Delta-haemolysin was purified from 2,5 litres of crude culture 
supernatant according to the method of Kreger ^  al (1971) using 
hydroxylapatite. The supernatants from each washing step were titrated 
for haemolytic activity against rabbit and cod erythrocytes (Table 8). 
Addition of hydroxylapatite to the culture supernatant removed virtually 
all haemolytic activity against cod erythrocytes, and all activity against 
rabbit erythrocytes. By washing the hydroxylapatite with l.OM phosphate 
buffer 52.5% of ô-haemolysin was recovered (Fig 3). On dialysis against 
distilled water, 60 mg insoluble delta-haemolysin of specific activity 
640 HU50/mg was removed. A further loss in activity occurred in the 
concentration steps prior to ammonium sulphate precipitation and 
lyophilisation (Table 8 and Fig 3). Concomitant with this loss was the 
elimination of haemolysin active on rabbit erythrocytes.
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Figure 3 Summary of Purification Procedure
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Table 8 Haemolysin activity in supernatant liquids from the 
purification of ô-haemolysin with hydroxylapatite
Fluid Volume Haemolysin tit 
Rabbit 
erythrocytes e
re (HU/ml) 
Cod 
irythrocytes
Total Activity 
(HU50) 
vs. cod REC
Culture supernatant 2,500 64 512 1 ,280,000
Supernatant after 
addition of 
hyd roxylapat it e 2,500 0 2 5,000
O.OIM PB* washings
(bulked) 2 , 5 0 0 0 2 5,000
0.4m  PB* washings
Supernatant 1 500 8 256 128,000
Tt 2 500 8 256 128,000
" 3 500 8 128 64,000
4 500 2 32 16,000
5 500 2 32 16,000
l.OM PB* washings
Supernatant 1 500 64 1024 512,000
11 2 500 32 128 64,000
1. 3 500 16 128 64,000
4 500 16 64 32,000
Fluid prior to
(NH%)280%
precipitation 1250
Total (IM 
0
washes)
128
672.000
160.000
Protein solution 
prior to freeze- 
drying 90 0 2048 184,000
Final lyophilised 
product : 589 mg ê 320 HU50/mg 188,000
*P.B. ; phosphate buffer
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A final lyophilised preparation of 589 mg soluble delta- 
lysin with a specific activity of 320 HU50/mg was obtained. This 
material was used in all subsequent experiments.
Ultraviolet spectrum of purified ô-haemolysin
The UV spectrum of ô-haemolysin (Fig 4) with absorption 
maxima at 278 nm and 291 nm and with a minimum at 250 nm was similar to 
that of Kayser and Raynaud (1965), Kreger et ^  (l97l) and Chao (1976).
Disc-gel electrophoresis of purified ô-haemolysin
Electrophoresis of purified ô-haemolysin in polyacrylamide 
gels revealed a single broad diffuse band in acidic gels (pH 4,3) (Plate l) 
and two bands in alkaline (pH 9.5) gels. Densitometer traces of gels 
of both systems are shown in Fig 5.
Sephadex gel filtration of purified ô-haemolysin
Upward elution in a G-150 Sephadex column at constant flow 
rate of 15 ml/hour yielded a single peak with molecular weight corresponding 
to approximately 200,000 daltons.
Isoelectricfocusing of purified ô-haemolysin
When ô-haemolysin was subjected to lEF in a broad pH gradient 
(pH 3.5 - 10.0), all haemolytic activity was found in a single peak 
(pi 4 .5), which corresponded to the major peak of E^g^-absorbing material 
(Fig 6). The haemolytic activity of this peak fraction was eight times 
greater versus cod erythrocytes than against human. It had no activity
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Figure 4 Ultraviolet absorption spectrum of ô-haemolysin
The absorption spectrum of purified soluble ô-haemolysin 
(500 yg/ml) was measured in the Pye Unicam SPÔOO spectrophotometer 
in 1 cm path length silica cells.
CN00CNCO
LÜ eoueqjosqv
E
c
O  g  
1 
I
CM
66
Figure 5 Disc gel electrophoresis of purified delta-haemolysin
Densitometer traces
1. 100 pg soluble 6-haemolysin in the pH 4.3, T»5% gel system of
Reisfell et ^  (1962).
Migration is towards the cathode.
2, 100 yg soluble 6-haemolysin in the basic (pH 9.5) T% gel
system of Omstein (1964) and Davis (1964).
Migration is towards the anode.
SG : stacking gel
TD : tracker dye.
1TD
SG
2
TD
SG
0 3 4 521
Distance (cm)
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Plate 1 Acid polyacrylamide gel electrophoresis of 6-haemolysin
50 yg of 6-haemolysin were electrophoresed at pH U.3 by the 
method of Reisfeld e;t ^  (1962).
Left hand gel : blank 
Right hand gel : 6-haemolysin
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against rabbit erythrocytes. Fractions with a pi greater than 6.0 
had no haemolytic activity against rabbit erythrocytes nor any "hot-cold" 
haemolytic activity against sheep erythrocytes, indicating the absence 
of detectable q^uantities of a- or g-haemolysins.
Examination for other staphylococcal products
Purified 6-haemolysin was free from a- and g-haemolysin 
activity, and devoid of protease, coagulase, lipase, nuclease, leukocidin, 
hyaluronidase, phosphatase, fibrinolysin and egg-yolk activity at a 
concentration of 100 yg freeze-dried material/ml.
■Amino acid composition of purified delta-haemolysin
■Amino acid analysis was carried out by Dr. B. Manson ; lysine, 
isoleucine, and aspartic acid were the predominant amino acids and 
histidine, arginine, proline, tyrosine and cysteine were absent (Table 9)* 
■Ammonia was not determined.
Heat stability of purified 6-haemolysin
The haemolysin proved very resistant to prolonged high 
temperature, and after hr at lOO^C, half of the original activity 
remained.
Assay of 6-haemolysin inhibitors 
Inhibition of delta-haemolysin by human serum
In the early part of this study, sera used for inhibition 
analyses were obtained from the blood bank of the Western Infirmary,
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Figure 6 Isoelectricfocusing of 6-haemolysin
Purified 6-haemolysin (1+ mg) was analysed by isoelectric­
focusing, using the apparatus of Talbot and Caie (1975)» and the 
E^8o > pH and haemolytic activity of each fraction assayed.
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Table 9 Amino acid composition of staphylococcal 6-haemolysin
Amino acid Percent of total weight 
of amino acids
Lysine 16,6
Histidine -
Arginine -
Aspartic acid 17.9
Threonine 10.9
Serine 2.9
Glutamic acid 4.8
Proline -
Glycine 2.3
Alanine 2.4
Half cystine —
Valine T.l
Methionine 2.2
Isoleucine 19.6
Leucine 4.3
Tyrosine -
Phenylalanine 5.2
Tryptophan 3.7
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Glasgow. While all samples were inhibitory, with an inhibitory titre 
of between 256 and 1,000, in order to obtain some degree of uniformity 
of sample and eliminate individual variation, all later samples were 
obtained from the author after a 12-hour fast. Such samples invariably 
gave an inhibitory titre of approximately 1,000 in a doubling dilution 
titration.
Standardisation of the inhibitory assay
The conditions required for reproducible results in an 
inhibitory assay had to be such that the amount of 6-haemolysin added to 
the system was neither too great to be neutralised by an inhibitory sample 
nor insufficient to cause lysis of the cod red cell indicator. From the 
result of an experiment using a range of haemolysin concentrations 
against normal serum a concentration of 6 HU50/ml 6-haemolysin was chosen, 
and used in all subsequent titrations. At a lower concentration, there 
was insufficient haemolysin to cause lysis; on the other hand, too high 
a concentration of haemolysin might mask the activity of samples of low 
inhibitory titre. At 6 HU50/ml, the inhibitory titre of whole serum was 
between 512 and 1024 in a doubling dilution titration.
Preliminary studies on the nature of the inhibitor 
Ammonium sulphate precipitation
To ascertain the concentration of that would
precipitate the inhibitory component of serum, a range of concentrations 
of were tested, from 20% to 80% saturation. The results are
shown in Table 10, and indicate that at a concentration of 70% saturation
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Plate 2 Laurell inmiunoelectrophoresis of whole human serum
10 yl of whole human serum were electrophoresed. against 
anti-whole human serum anti serum (Wellcome) by the method of 
Laurell (1965).
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Table 10 Precipitation of serum inhibitor by
Serum vas dialysed against increasing concentrations of 
(NE^)280  ^and the supernatants at each stage tested for inhibitory 
activity against 6-haemolysin.
(EH^igSO^ Fluid Inhibitory titre (HU^^/0.2 ml)
20%* supernatant 1000
30% " 1000
hO% " 1000
50% " 1000
60% ” 1000
70% " 50
80% " 50
serum control 1000
*percentage saturation at
Tl+
of (NE^ÏgSO^, the inhibitory component vas precipitated.
Effect of heat on inhibitor
The inhibitory effect of serum vas not abolished by heating 
at 56°C for 30 min (indicating that the inhibition of 6-haemolysin is 
not dependent on an intact complement system). However, inhibition 
vas totally abolished by 30 min at 80°C.
Ultrafiltration of human serum
An approximate estimation of the molecular veight of the 
inhibitor vas elI s o  made by ultrafiltration of the serum through a range 
of membranes of increasing pore size (Table 11). No inhibitory
material passed through the membrane until a 300,000 M.Wt. membrane vas
used. Inhibitory activity vas then found in the filtrate.
When the filtration cell vas flushed with a large volume of
buffer, still under positive pressure throu^ the membrane, and the 
material retained by the membrane vas resuspended to the original volume 
of serum, inhibitory activity vas still present.
Gel filtration of human serum
Since the inhibitory activity of serum vas present in 60% 
saturated (NH^^supernatants, this vas taken as a convenient starting 
material for further experiments, since many serum proteins had been 
removed by precipitation (Plate 3). Accordingly, a 5 ml sample of 6o% 
(NH^)280^ supernatant vas applied to a Sephadex G-150 column, and 
fractions assayed for inhibitory activity. A result typical of several 
separations is shovn in Fig 7*
75
A peak of inhibitory activity corresponded to the void 
volume of the column, indicating a component in excess of U00,000 M.Wt., 
and a broader band of activity followed immediately behind. No 
inhibitory activity was found in the third protein peak, shown by 
immunoelectrophoresis and Laurell immunoelectrophoresis to be 
predominantly serum albumin.
Gel filtration in Sepharose 6-B
Since almost all inhibitory activity was eluted at the 
void volume using Sephadex G150 the same starting material, a 60%
(NH^lgSO^ supernatant of human serum, was applied to a Sepharose 6-B 
column, and eluted as with G150. In addition to monitoring and
inhibitory activity of all fractions, peak fractions were subjected to 
Laurell immunoelectrophoresis. The results are shown in Fig 8 and 
Plate Two distinct peaks of inhibitory activity were obtained.
Production of anti-inhibitor antiserum
A 2 ml serum sample which had been concentrated by 60% 
(NH^lgSO^ precipitation and ultrafiltration through a PM30 membrane, was 
separated by gel filtration through a Sephadex G-150 column. The 
separation profile is shown in Fig 9. A peak of inhibitory activity 
with a trailing "shoulder" was found on inhibitory assay of the fractions, 
and those fractions which comprised the leading edge of the peak were 
injected into a rabbit to raise anti-inhibitor antiserum.
The antiserum was processed by 33% (NE^)g80^ precipitation 
to separate immune gamma-globulin from the 6-haemolysin inhibitor present
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Table 11 Ultrafiltration of human serum with Amicon (c) membranes
Membrane Exclusion limit 
(daltons)
Inhibitory titre 
retentate
(HIU50)
filtrate
UM5 500 640 0
UMLO 1,000 640 0
PKLO 10,000 640 0
PM30 30,000 640 0
m o o 100,000 640 0
XM300 300,000 l6o 320
A 1:2 dilution of human serum was used throu^out as the filtration 
solution.
All solutions filtered to dryness, and retentate resuspended to 
original volume.
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Plate 3 Laurell immunoelectrophoresis of a 60% (NH^)280^
supernatant of human serum
5 ^ - '  « . [ '
T8
Figure 7 Sephadex G-150 gel filtration of 60% (NH|^ )^ SO^  
supernatant of human serum
An LKB Uvichord profile is shown. 
Fractions were assayed for inhibitory 
activity and peak fractions for
#'----# - transmission at 280 nm.
O  o - inhibitory activity.
HIUso
40
VO'
Fraction no -►
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Figure 8 Sepharose 6-B gel filtration of 60% (NH^Ï^SO^
supernatant of human serum
An LKB Uvichord profile is shown.
Fractions were assayed for inhibitory 
activity and peak fractions for
#--- • “ transmission at 200 nm.
O  o - inhibitory activity.
HIUso
éO
Fraction no. — ►
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Plate k Laurell immunoelectrophoresis of peak fractions
from Sepharose 6-B gel filtration
a) peak 2
t) peak 3.
a)
b)
81
in the rabbit serum (Table 12). Incubation of the antiserum with 
whole human serum for 60 min decreased the 6-haemolysin inhibitory 
activity of the human serum by UO^.
Two dimensional immunoelectrophoresis of the antiserum 
showed the presence of antibodies to five components of human serum 
(Plate 8). Three of these could again be tentatively identified, on 
the basis of their profiles and electrophoretic mobilities, as haptoglobin, 
3-lipoprotein and a-macroglobulin.
Ammonium sulphate precipitation of serum at pH ^.0
The precipitation of serum proteins at low pH had previously 
been documented (Freeman and Smith, 19T0), and by their techniques, the 
behaviour of the inhibitor of 6-haemolysin under such conditions was 
studied.
Serum adjusted to pH 5.0 with acetic acid was precipitated 
at kO% and 50^ saturation with (NH^jgSO^. Immunoelectrophoretic analysis 
showed that all serum proteins remaining in a kO% supernatant were 
precipitated at 50^ concentration (Plate 6), while inhibitory titrations 
on each fraction indicated that inhibitory activity present in a hO% 
supernatant was precipitated when the solution was raised to 50^ 
saturation with (HH^ÏgSO^.
Isoelectricfocusing of serum
A 60^ (HH^ÏgSO^ supernatant of human serum dialysed against 
1% glycine was focused in a broad pH gradient (pH 3.5 ~ 10.O) and all 
inhibitory activity was found in a single peak (pi 5.5) corresponding to
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Figure 9 Sephadex G-150 separation of 60% (ME^lgSO^
supernatant containing serum proteins of 
M. Wt. > 30,000.
N.B. Dotted portion of graph shoving inhibitory 
activity represents fractions chosen to 
raise anti-inhibitor antiserum.
0---0 Inhibitory activity
OJ
HIUSO
40
20
Fraction no
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Plate 5 Laurell iimmmoelectrophoresis of human serum against
partially purified antiserum to the inhibitor
Anti-serum was raised in a rabbit against material from the 
breakthrough peak obtained on separation of human serum by Sephadex 
G-150 gel filtration. After concentration by 33^ saturated
precipitation, whole serum was electrophoresed against 
this anti-serum.
1, - haptoglobin
2, - GLg-macroglobulin
3, - j3“lipoprotein
O
m
814
Plate 6 Laurell immimoelectrophoresis of fractions from 
(53^)280  ^precipitation at pH 5
a) 1-40% supernatant
b) 50% pellet
c) 50  ^supernatant
1 '
b)
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Table 12 Concentration of rabbit antiserum
The rabbit antiserum which was raised against the high 
molecular weight peak from Sephadex G-15O chromatography was 
precipitated three times with 33^ saturated to separate
immune gamma-globulins from the non-specific 6-haemolysin inhibitors 
in the rabbit serum.
Sample Titre (HIU50)
1st 33^ supernatant 6k
2nd " 2
3rd " " 0
33^ precipitate 0
whole human serum 102%
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the major peak of EggQ-ahsorhing material (Fig 10) which by Laurell 
immunoelectrophoresis was shown to comprise a large number of serum 
proteins.
The above preliminary studies indicated that the amount of 
inhibitor in human serum samples obtained under uniform conditions 
(page 71 ) is relatively constant. It was stable at temperatures that 
inactivated complement, and remained in solution at a level of saturation 
of (NH^)g80^ which precipitated immunoglobulins, albumin and a large 
percentage of other serum proteins. The results from gel filtration in 
the two support media and ultrafiltration suggested that more than one 
component of serum was responsible for the inhibition; ultrafiltration 
indicated one inhibitory component of between 100,000 and 300,000 daltons, 
which correlated with the slower-moving inhibitory peaks from both gel 
filtrations. Sephadex G-150 chromatography and ultrafiltration 
suggested a M.Wt. of more than %00,000 daltons for the faster moving 
inhibitory peak and in Sepharose a value in excess of 1,000,000 was 
obtained, but these results cannot determine whether several serum 
components are involved, or aggregates of one basic moiety. Immuno­
electrophoretic studies, however, showed that the high M.Wt. inhibitory 
fractions from gel filtration comprised only a few serum proteins, which 
could be identified as a^-macroglobulin, haptoglobin and g-lipoprotein 
by comparison with the published studies of Freeman and Smith (1970).
Affinity chromatography of 6-haemolysin inhibitor
Purified 6-haemolysin was covalently coupled to CWBr-activated 
Sepharose-%B by a modification of the technique of Axen, Porath and
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Figure 10 Isoelectricfocusing of serum
A 60% supernatant of human serum (0.5 ml) was
analysed by isoelectricfocusing using the apparatus of Talbot 
and Caie (1975) and the pH and inhibitory activity of each
fraction assayed.
D  □ Eggo
pH
♦ inhibitory activity
HIUSO
30-
20-
E280
 —  30 32 34
Fraction no.
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Ernback (1967)» developed by Pharmacia Fine Chemicals. After incubation of 
dilute human serum vith the matrix-immobilised 6-haemolysin, immuno­
electrophoretic analysis of the eluant showed a marked decrease in 
intensity of the g-lipoprotein band (Plate 7)*
Control CNBr-Sepharose gel was prepared in the same manner 
as the experimental gel, except that 6-haemolysin was not coupled to it, 
resulting in total hydrolysis of all available active groups on 
treatment with ethanolamine. No decrease in intensity of the (^lipoprotein 
arc occurred in this gel after mixing with human serum, indicating that 
there was no non-specific removal of g-lipoprotein in the experimental 
system.
Serum lipoproteins 
Zonal ultracentrifugation of human serum
When human serum was ultracentrifuged in a KBr gradient in 
a Titanium BXIV rotor by the method of Wilcox ^  (1971 ) three separate 
peaks of ultraviolet-absorbing activity were obtained (Fig ll). Because 
of the very large volume of fluid to be tested (65O ml), and the very low 
levels of inhibitory activity in small-volume individual fractions, the 
total fluid was bulked into 7 large fractions, each of which was concen­
trated by ultrafiltration through a 30,000 M.Wt. membrane. Titration of 
these seven pooled fractions (Table 13) revealed inhibitory activity in 
the first two UV absorbing peaks, and minimal inhibitory activity in the 
major, third peak.
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Plate T Immunoelectrophoresis of human serum after affinity
chromatography with 6-haemolysin
Serum vas electrophoresed against anti-vhole human serum 
antiserum before and after exposure to 6-haemolysin-linked 
CKBr-Sepharose.
Top : "Whole human serum
Bottom : Serum after affinity chromatography
Arrov indicates g-lipoprotein arc.
(+) Anode Cathode (-)
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Two dimensional immunoelectrophoresis of zonal fractions
The bulked fractions (i.e. fractions 1, 4, 9, T) from zonal 
centrifugation corresponding to peak UV absorbance vere analysed by 
Laurell Immunoelectrophoresis against anti-vhole human serum antiserum 
(Plate 8).
The first peak (fraction 1; density, 1.06) yielded only 
one precipitation line on electrophoresis. This line had the mobility of 
a 3-globulin and on staining vith Sudan black (a stain specific for 
lipoproteins) vas identified as 3-lipoprotein. Against monospecific anti- 
3-lipoprotein serum, the same precipitation peak resulted, confirming its 
identity as 3-lipoprotein (Plate 9)« The second peak (fractions 4 , 5 ;  
density 1.11 - l.l8% also yielded only one precipitation line on Immuno­
electrophoresis, vith an electrophoretic mobility characteristic of an 
a-globulin. This line vas not stained by Sudan black, but did stain 
vith Oil Red, another lipoprotein-specific stain. Similarly, against 
monospecific anti-a-lipoprotein serum, the same single peak resulted, 
confirming its identity as a-lipoprotein (Plate 9).
The third peak, corresponding to a density of 1,21 - 1,28 
(fraction T) yielded many lines on Immunoelectrophoresis, none of vhich 
stained by Sudan Black, the overall appearance of the precipitation arcs 
being that of whole serum minus the lipoprotein components (Plate 8c).
Polyacrylamide disc-gel electrophoresis of zonal fractions
Disc gel electrophoresis vas performed on zonal ultra­
centrifugation fractions by the method of Naito et ^  (1973) using 3.5%
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Figure 11 Zonal Ultracentrifugation of serum
25 ml serum adjusted to hO% (v/v) KBr vas separated on a KEr 
gradient of density 1.0 - 1.28, for 24 hours at 120,000 x g* and 
the density, and inhibitory activity of selected fractions
assayed.
#  - e  density
^280
*by the method of Wilcox ^  (1971 )•
The inhibitory titres of the seven pooled fractions are shown by 
the dotted histograms.
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Table 13 Inhibition titres of zonal ultracentrifugation
pooled fractions
Sample Original
Volume
(ml)
Final
Volume
(ml)
Concentration
factor
Inhibitory 
titre 
(EIU50/0.2 ml)
1 ko 2.T 14.8 16
2 80 3.T 21.6 0
3 125 6,0 20.8 8
h 85 li.O 21.3 32
5 80 1^ .0 20.0 32
6 120 5.5 21.8 8
T 150 7.5 20.0 2
Control 6k
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Plate 8 Laurell iminimoelectrophoresis of fractions from
zonal ultracentrifugation of human serum
a) Fraction 1 (Fig 11, Table 1^)
b) Pooled fractions k and 5
c) Fraction T*
Electrophoresis against anti-vhole human serum antiserum.
a)
cr
•r
1
< »4
b)
t
*
o
i
h
f
1 "
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Plate 9 Laurell immimoelectrophoresis of fractions from
zonal ultracentrifugation of human serum
a) Fraction 1 vs monospecific anti-g- 
lipoprotein antiserum
L) Combine! 
fractions  ^
& 5 vs monospecific anti-a- 
lipoprotein antiserum
b)
'-. • *V.vH . . ' .XK _ t
95
polyacrylamide with samples pre-stained by Sudan Black (Plate 10).
Under these conditions, human serum yielded two darkly staining bands, 
one of rapid mobility (shown by Naito el to be a-lipoprotein) and 
the other a slow-moving band which barely penetrated the separating gel 
(g-lipoprotein). Fraction 1 material from zonal ultracentrifugation 
stained with the lipoprotein-specific stain and migrated as a $-lipo- 
protein; similarly, electrophoresis showed fraction 1+ to be a-lipo­
protein. Fraction T contained a trace of a-lipoprotein, thus explaining 
the low level of inhibitory activity detected in this sample (Table 13).
As already mentioned (page 31 ) several components comprise 
the ^-lipoprotein fraction of human serum. In an attempt to detect these, 
the first four small fractions (lO ml each) which together comprised 
the bulked fraction 1, were individually screened by disc-gel electro­
phoresis (Plate 11). This showed that the fraction of lowest density 
contained three separate components indistinguishable in the bulk fraction.
Attempts to separate these three components by the flotation 
technique of Havel, Eder and Bragdon (1955) at raised densities in a 
swing-out rotor were unsuccessful. Electrophoresis of samples from such 
a flotation indicated an identical g-lipoprotein composition throughout 
the gradient.
Immunocore electrophoresis of serum and zonal ultracentrifugation fractions
The "immunocore” method of electrophoresis was used in two 
different ways, firstly by the classic method of immunoelectrophoresis, 
and secondly by exploiting the ability of 6-haemolysin and its inhibitor 
to form an immune-like precipitate in gels. In both cases, samples were
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Plate 10 Polyacrylamide disc-gel electrophoresis of fractions
from zonal ultracentrifugation
Peak E^gç^-absorbing fractions from zonal ultracentrifugation 
were electrophoresed by the method of Naito ^  (1973).
Left to right : whole human serum
peak 1 (3-lipoprotein) 
peak 3
peak 2 (a-lipoprotein) 
blank
(3-lipoprotein,
a-lipoprotein,
V
I
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Plate 11 Polyacrylamide disc-gel electrophoresis of 
s lib fractions of g-lipoprotein
Fraction 1 from zonal ultracentrifugation was screened for 
lipoprotein content prior to hulking (see text) by the method 
of Naito et al (1973).
Left to right whole human serum 
Fraction 3 
Fraction 2 
Fraction Ij^ 
Fraction 1^ 
Fraction 1^ 
Fraction 1,
decreasing density
Blank
pre-p-lipoprotein
P-lipoprotein“
a-lipoprotein*
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separated by polyaciylamide gel electrophoresis (Naito ^  1973)
except that only one reference sample was prestained with Sudan Black 
(Plate 12a). By the first method a whole serum sample, developed with 
anti-whole human serum yielded a number of immune precipitation lines 
(plate 12b). Comparison with complementary prestained serum samples 
showed the position of the 3- and a-lipoprotein bands. These positions 
were confirmed by immunocore electrophoresis in the same system, of 3- 
and a-lipoprotein purified by zonal ultracentrifugation with development 
of the precipitin lines using homologous antisera (Plate 12c). When, 
however, a 2 mg/ml solution of 6-haemolysin was incorporated in the core 
gel instead of an antiserum, bands of precipitation developed in the 
gel at positions corresponding to the immune precipitates formed by 
purified 3” and a-lipoproteins with their homologous antisera (Plates 
12 and 13).
Effect of rabbit anti-inhibitor serum on zonal a-lipoprotein and 
3-lipoprotein
Zonal fractions of 3-lipoprotein and a-lipoprotein, pure by 
the criteria of disc gel and immunoelectrophoresis, were incubated for 
60 minutes at 37°C with rabbit anti-inhibitor serum prior to titration 
for inhibitory activity. The inhibitory titre of a-lipoprotein was 
unaffected, but that for 3-lipoprotein was totally abolished by 
pretreatment with anti-inhibitor serum.
Laurell immunoelectrophoresis of whole human serum against 
anti-inhibitor anti-serum (Plate 5) indicated the presence of antibodies 
to 5 serum proteins, one of which was 3-lipoprotein (page 83 ). The
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Plate 12 Immunocore electrophoresis of whole serum
a) Appearance of gels after electrophoretic separation. 
Gel number from the left contains prestained serum 
and shows the relative positions of g-(top) and 
a-lipoproteins (bottom). The other gels were not 
prestained.
b) Typical appearance of a section of gel containing 
electrophoresed human serum proteins developed 
against anti-whole human serum anti-serum, showing 
Ag-Ab precipitin arcs.
P-Iipoprotein
a-lipoprotein
Q
100
Plate 12c Appearance of sels from figure a) after l8 hours*
development
The central core of the left hand gel was filled with agar 
containing anti-whole human serum antiserum. Arrows indicate 
positions of the prestained hands which are still visible.
The other U gels were filled with 6-haemolysin in agar at 
concentrations of 2, 1.75, 1.5 and 1 mg/ml respectively.
P-lipoprotein
a-lipoprotein
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Plate 13. Immunocore electrophoresis of a- and g-lipoproteins
cx- and 3-lipoproteins were electrophoresed in the immunocore 
system and developed against their respective monospecific anti-sera 
or 6-haemolysin at a concentration of 2 mg/ml.
Gels 1 and k 
Gel 2 
Gel 3 
Gel 5
Gel 6
Blank
3-lipoprotein vs
a-lipoprotein vs
3-lipoprotein vs
a-lipoprotein vs
6-haemolysin
6-haemolysin
anti-3-lipoprotein 
antiserum
anti-a-lipoprotein 
antiserum
a) Negative illumination Hazy 3-lipoprotein:haemolysin 
precipitation very difficult to 
visualise by photography.
b) Positive illumination
P-lipoprotein
a)
a-lipoprotein
3 56
P-Iipoprotein
b)
O
a-lipoprotein I
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above result confirmed the inhibitory role of g-lipoprotein in the 
protein mixture from which the antiserum was derived.
From the above experiments it was concluded that the factors 
in human serum responsible for the inhibition of S. aureus 6-haemolysin 
were the lipoproteins. However, as discussed previously (page 31 ), 
the serum lipoproteins are a complex group of molecules, composed of 
varying amounts of protein, triglycerides, cholesterol and phospholipid, 
and the investigations thus far did not indicate whether the entire 
lipoprotein complex or a particular moiety interacted with 6-haemolysin. 
Although Kapral (1972) found that some natural phospholipids inhibited 
the action of the haemolysin, the possible involvement of protein could 
not be ruled out.
The approach adopted was to determine whether enzymic 
disruption of a particular part of the lipoprotein complex affected its 
behaviour towards 6-haemolysin.
Effect of trypsin and papain on the serum inhibitors of 6-haemolysin
a) Trypsin
The effect of trypsin on serum, 3-lipoprotein and a-lipoprotein 
inhibition was tested with and without the presence of trypsin inhibitor 
(Table l4). In control titrations neither enzyme nor its inhibitor 
affected cod erythrocytes, and the enzyme above 125 yg/ml inactivated 
6-haemolysin; this effect was abolished by trypsin inhibitor. The 
inhibition of 6-haemolysin by serum or a- and 3-lipoprotein was not 
affected by trypsin treatment.
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Table 1^ The effect of trypsin on the inhibition by 
human serum of 6-haemolysin
Inhibitory titre to 
(a) *
6-haemolysin
(b)
Serum 32 32
Serum + trypsin 32 32
Serum + trypsin + trypsin in­
hibitor 32 32
Serum + trypsin inhibitor 32 32
Trypsin 32 0
Trypsin + trypsin inhibitor 0 0
Trypsin inhibitor 0 0
*a) 1 mg/ml trypsin, and equivalent trypsin inhibitor,
b) 62.5 yg/ml "
10^
"b) Papain
In a similar fashion, papain was found to have no effect on 
cod erythrocytes nor any effect on 6-haemolysin per se. The inhibitory 
effect of a- and ^-lipoproteins and whole serum on ô-haemolysin was not 
abolished by treatment with papain.
Inhibition of 6-haemolysin by phospholipids 
Preparation of serum lipids
As a preliminary step to investigate the role of the 
phospholipid moiety of lipoproteins in the inhibitory process, a serum 
lipid extract was obtained by the method of Folch a^ (1957 ). The 
phospholipid content of this extract was determined by thin layer 
chromatography with commercial lipid standards (Fig 12). Phosphatidyl- 
ethanolamine, phosphatidylcholine and sphingomyelin were identifiable 
after staining under iodine vapour.
Inhibition of 6-haemolysin by phospholipids and serum lipids
Inhibitory activity of phospholipids and serum lipids was 
measured using a slight modification of the standard assay procedure to 
compensate for the insolubility of lipids in aqueous solution (page 59). 
All phospholipids tested were inhibitory to ô-haemolysin (Table 15) the 
highest activity being shown by phosphatidyl glycerol, and the least by 
phosphatidylethanolamine. The serum lipid extract was also inhibitory,
but the apoprotein residue from the extraction was inactive against the 
haemolysin.
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Figure 12 Thin layer chromatography of commercial
phospholipids and serum lipid extract
PC phosphatidylcholine
PE phosphatidylethanolamine
PG phosphatidylglycerol
PI phosphatidylinositol
PS phosphatidylserine
PA phosphatidic acid
C cardiolipin
S sphingomyelin
SL serum lipids
solvent 65 : 25 : h
chloroform methanol water
Solvent front
o
io6
Table 15 Inhibition of 6-haemolysin by phospholipids and 
a serujD lipid extract
Inhibitory Sample Inhibitory titre* 
(HIU50/0.2 ml)
Sphingomyelin 61+
Phosphatidic acid 128
Phosphatidylcholine 512
Pho sphat i dylethanolamine 8
Pho sphat i dylglycerol 1021+
Pho sphatidylinositol 512
Phosphatidylserine 512
Cardiolipin 128
Serum Lipids 61+
*Using cod erythrocytes as indicators of haemolysis
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Preliminary experiments on enzymic degradation of the 
phospholipid inhibitors vere complicated by the observation that B. cereus 
phospholipase C (Fig 13), was very haemolytic towards the cod erythrocytes 
employed in the inhibitory assays (25000 HU/mg). It had no effect, 
however, on human red cells which were substituted for cod cells in the 
haemolysin assay.
Determination of conditions for inhibitory assays using human erythrocytes 
in place of cod
Human erythrocytes were four times less sensitive than cod 
erythrocytes to the action of 6-haemolysin. As a result, with the same 
concentration of 6-haemolysin in the inhibitory assay, a different 
inhibitory titre was obtained with the same serum sample when titrated 
against both species. However, by increasing the concentration of 6“ 
haemolysin in the assay four-fold, the human erythrocyte system yielded 
titres of a level comparable to those obtained with cod erythrocytes.
Effect of B. cereus phospholipase C on inhibition of 6-haemolysin by
phospholipids and zonal ultracentrifugation fractions
B. cereus phospholipase C (E.C.3.1.^.3) under the conditions of 
the assay system employed completely abolished the inhibitory capacity 
of phosphatidylethanolamine and phosphatidylinositol and diminished the 
effects of phosphatidic acid, phosphatidylcholine and phosphatidylglycerol 
and phosphatidylserine. The serum lipid extract was reduced four-fold in 
its inhibitory capacity against 6-haemolysin (Table l6). Sphingomyelin 
and cardiolipin were unaffected by pre-treatment with the enzyme. Serum
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Figure 13 Mode of action of B. cereus phospholipase C
(phosphatidylcholine cholinephosphohydrolase EC 3.1.^.3)
EgCOOCR’
/
COO
\
R CH
EgCO - P OCEgCEgEHg
phosphatidylethanolamine
+
E C O O C E ’
/
ooc
\
COOCE
HgCOE
1,2-Diacylglycerol
+ HO - OCHgCE^EHg
O“phosphorylethanolamine
The hydrolysis of phosphoglycerides hy phospholipase C 
results in the production of a diacylglycerol and a 
phosphorylic hase (Zwaal et al, 1971 )•
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a- and 3-lipoproteins, purified "by zonal ultracentrifugation, both had 
diminished inhibitory activity after enzyme treatment (Table l6).
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Table l6 Reduction of inhibitory activity by pre-treatment
with B. cereus phospholipase C (E. C. 3.1.1+. 3. )
Inhibitor Reduction by 
enzyme
Sphingomyelin 0
Phosphatidic acid X 2
Pho sphat i dylcholine X h
Phosphatidylethanolamine > X 8
Pho sphat i dylglyc erol X 8
Phosphatidylinositol > X 512
Pho sphat i dylserine X l6
Cardiolipin 0
Serum Lipids X
3-lipoprotein X 8
a-lipoprotein X 8
DISCUSSION
Ill
The principal objective of this investigation was to identify 
the factors in human serum involved in the neutralisation of staphylococcal 
6-haemolysin. Many previous studies have recorded this property of human 
serum, and suggested which factors might be responsible. But no 
definitive investigations to identify the inhibitory components have been 
undertaken.
One of the major difficulties envisaged in this study was to 
be able to identify the serum proteins present in any sub-fraction, and 
a large part of the investigation was therefore devoted to the use of 
various immunoelectrophoretic techniques in conjunction with different 
serum fractionation methods.
The inhibitory assay system required purified 6-haemolysin 
and the production, purification and characterisation of 6-haemolysin was 
also a major part of the work. However, determination of the properties 
of purified 6-haemolysin was regarded as secondary to the prime objective 
of investigating the inhibitory serum component.
Preparation of delta-haemolysin
The staphylococcal strain used for the production of 6- 
haemolysin, NCTC 103^5, was chosen on the basis of its high human/rabbit 
erythrocyte titre ratio which reflected production of a large amount of 
6-haemolysin and only a small quantity of a-haemolysin (Chao, 1976).
When 6-haemolysin was purified from crude culture supernatants 
of strain NCTC 103^5 using hydroxylapatite, virtually all haemolytic 
activity against cod and rabbit erythrocytes was removed by hydroxylapatite
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(Fig 3). Of the original haemolytic activity, ^2,3% was recovered on 
elution with IM phosphate buffer and the final yield of 6-haemolysin was 
approximately 236 mg per litre of culture supernatant. The yield of 
purified 6-haemolysin was similar to that obtained by Kreger ^  ^  (1971 ) 
but the total recovered activity ('^ 1^0,000 HU/litre supernatant tested 
using human erythrocytes) was about one-third of that found by these authors.
Properties of purified 6-haemolysin
Sufficient 6-haemolysin was prepared in one batch to be used 
throughout the study, and for this reason the small amount of insoluble 
6-haemolysin produced on dialysis prior to concentrating and freeze-drying 
of the pooled l.OM phosphate washes was discarded. This material, 6o mg, 
constituted 3% of the original activity, and the final lyophilised product 
of soluble 6-haemolysin comprised 13% of the culture supernatant activity. 
Fig 3 also shows that a considerable loss of activity occurred on dialysis, 
concentration by polyethylene glycol and batch freeze-drying but there­
after recovery was constant.
Throughout the study, freeze-dried 6-haemolysin was stored at 
i+°C in a desiccator in the dark as a fluffy, white powder, and over a period 
of l8 months, neither its appearance nor its haemolytic activity altered. 
Adsorption to glass or plastic surfaces was not evident (Heatley, 1971).
The specific activity of the 6-haemolysin preparation used for the 
experiments described in this thesis was 320 HU/mg protein (0.8% cod 
erythrocytes) and 40 HU/mg (0.8% human erythrocytes) which was low compared 
to the preparations of Kreger ^  (l97l) using a similar strain of 
S. aureus and similar purification procedure. However, it had virtually
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no haemolytic effect against rabbit and sheep erythrocytes (Marks and 
Vaughan, 1950) unlike the preparations of Kreger.
Other preparations made in this laboratory (Chao, 1976) and 
a sample provided by Dr. A. Kreger had specific activities comparable 
to that of Kreger ot al (l97l) with a more typical haemolytic spectrum.
The reasons for the lower specific activity and narrower haemolytic 
spectrum were not investigated.
The ultraviolet absorption spectrum (Fig k ) showing a 
maximum at 271 nm with a small shoulder at 291 nm was very similar to 
those reported by Kayser (1968), Kreger ^  al (1971), Heatley (l97l) and 
Chao (1976). The shoulder at 291 nm was consistently found and the 
ultraviolet spectrum was virtually identical to that of the amino acid 
tryptophan which would, in the absence of tyrosine, be expected to 
dominate the ultraviolet spectrum. Amino acid analysis of the 
preparation showed the absence of cysteine, histidine, arginine, proline 
and tyrosine explaining the ultraviolet profile and agreeing with the 
observations of Heatley (l97l), Kreger al (l97l) and Kantor e;^  ^  (1972). 
Fackrell and Wiseman (1976,b), however, reported proline one of the 
amino acids not present in this preparation, as the N-terminus of
5-haemolysin. Their haemolysin also varied in having trace amounts of 
histidine, tyrosine and arginine, but no methionine. Analysis of
6-haemolysin by polyacrylamide gel electrophoresis in acidic or alkaline 
buffers (Fig 5, Plate l), yielded results comparable to those found by 
Kreger ^  al (l97l), Heatley (l97l) and Chao (197&), in that two bands 
were found in alkaline gels and a single diffuse band in acidic gels.
lli+
The secondary hand seen in alkaline gels was faint in comparison to the 
principal band and may have been due to a contaminating protein. This 
seems unlikely, due to the amino acid composition, which would necessitate 
a contaminant devoid of the same amino acids, and since tests confirmed 
the absence of the other S. aureus extracellular products protease, 
coagulase, lipase, nuclease, gelatinase, phosphatase, fibrinolysin and 
egg-yolk activity, A second explanation would adopt the model of Kantor 
et al (1972) which postulates low molecular weight subunits of 6-haemolysin 
which might account for the secondary component.
The preparation was sensitive to trypsin (Kreger 1971)
and very thermostable (Marks, 1951; Gladstone and van Heyningen, 1957; 
Hallander, 1968), Indeed, on one occasion, brief heating at 100°C showed 
an increase in haemolytic activity, suggesting disaggregation of a complex, 
which might explain the overall low specific activity of the preparation.
Like Yoshida's (1963), the preparation was poorly soluble at neutral pH 
and low ionic strength, and it precipitated at its pl, unlike Kreger’s 
preparation. Mg**"** and Ca"*"** ions had no effect on activity. Delta- 
haemolysin eluted from a Sephadex G-I50 column as a single homogeneous 
peak with a molecular weight of approx. 200,000, which agrees closely 
with the value reported by Hallander (1968) and Fackrell and Wiseman (1976,b) 
using the same separation technique.
Purified 6-haemolysin of strain NCTC 103^5 was focused as a 
single peak (pi i+.5) which contained all of the 280 nm-absorbing material 
and haemolytic activity. No cationic 6-haemolysin was detected.
Several authors have reported an isoelectric point of around U.5 for
ti
purified 6-haemolysin (Wadstrom, I968; Kreger et al, 1971; Kantor et al.
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1972). However, in contrast to the reports of Kreger et al 
(1971), Kant or at ^  (1972), McNiven at ^  (l97^) and Fackrell and 
Wiseman (l976,h), no cationic 6-haemolysin was found in the present study. 
However, since refocusing of the cationic component yielded both anionic 
and cationic forms of 6-haemolysin (Kreger 1971) and isoelectric-
focusing in Tween 80 yielded only the anionic form (Kantor et al, 1972) 
it is likely that either total conversion of any cationic form to the 
anionic form had occurred in the present study or that the different 
isoelectric focusing apparatus caused the difference.
Therefore the preparation of 6-haemolysin possessed properties 
broadly similar to those described by Kreger ^  al (1971), Heatley (1971) 
and Kantor ^  (1972), and the distribution of protein and haemolytic 
activity on isoelectricfocusing showed the preparation to be homogeneous, 
with no evidence for contamination with the cationic a-, 3” and Y-haemolysins
Storage of human serum
Initially, whole blood from hospital blood banks was used as 
a source of human serum, but this was deemed unsuitable after immuno­
electrophoretic studies on a freshly-drawn sample and the same sample after 
refrigerated storage showed the disappearance of some serum proteins with 
time. Thus fresh serum, drawn after 12 hours fasting and stored at 
for no longer than 72 hours, was taken as the most uniformly constant 
material available. The reasons for the disappearance of these proteins 
were not pursued, although the appearance of a fine precipitate in the 
serum after prolonged storage or freezing and thawing was thou^t to be a 
possible contributory factor.
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Doubling dilution inhibitory assay of human serum
Some variation in inhibitory activity of different serum 
samples was observed. However, since the haemolytic activity of the 
6-haemolysin preparation remained unchanged throughout the course of the 
investigation, and a constant amount of 6-haemolysin (6 HU^^) was used 
in the inhibitory assay, and since duplicate estimations on any one 
sample yielded identical titres, the variation was judged not to be a 
weakness of the assay itself, but rather a reflection of varying levels 
of inhibitory factor present in different sera. The fluctuation 
observed was similar to that seen by Donahue (l969,a) but much less than 
that of Maniar ^  al (1967), thus underlining the desirability of 
standardising the test material with regard to source as described above.
Preliminary studies on the nature of the inhibitor
While suggestions as to the identity of the serum factors 
which inhibit 6-haemolysin have been made (Donahue, 1969,a,b; Kreger 
at 1971; Kantor at 19T2), none have been accompanied by detailed 
experimental evidence, nor has a specific investigation been done. For 
this reason, an experimental approach was adopted which was not influenced 
by previous unsubstantiated reports, and with no preconceived ideas as 
to the identity of the inhibitor. In this way, it was hoped that the 
discovery of one factor would not preclude the discovery of any other, 
should more than one serum factor be involved.
Blood clotting factors are not involved in the inhibition, 
there being no difference in activity between plasma and serum, nor is an 
intact complement system from the evidence of heat inactivation studies.
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The involvement of an acute phase protein, i.e. C-reactive protein, was 
also eliminated since inhibitory activity was unaffected by the presence 
or absence of Ca"*"*'. Gel filtration and ultrafiltration indicated that 
the inhibitor was of M.Wt. greater than 100,000 daltons. These results, 
in conjunction with those of Laurell electrophoresis on inhibitory and 
non-inhibitory fractions, enabled y-globulin and albumin to be eliminated 
as possible inhibitors. This confirmed the observation of Kapral (1972) 
regarding the inhibitory effect of albumin, a previous study having found 
albumin inhibitory (Gladstone and Yoshida, 1967).
The elution profile observed on Sephadex G-150 chromatography 
suggested that more than one molecular weight species was involved in 
inhibiting 6-haemolysin; one in excess of 1+00,000 M.Wt., the exclusion 
limit for Sephadex G-I50, and one in the region intermediate between this 
value and the M.Wt. of albumin. This was confirmed by chromatography on 
the larger pore gel Sepharose 6-B, which yielded two distinct peaks of 
inhibitory activity, although whether distinct proteins or aggregates of 
the same protein were involved was unclear. A detailed study of the 
behaviour of serum proteins under ammonium sulphate precipitation at pH 5, 
and their chromatographic properties on gel filtration has previously been 
done (Freeman and Smith, 1970). This method precipitated at 50% 
saturation of ammonium sulphate all proteins which had not been 
precipitated in a 1+0% saturated solution. Further, Laurell immuno- 
electrophoresis of the breakthrough peak in Sephadex G-15O gel filtration 
gave a result similar to that reported here; three proteins were present 
which could be positively identified as haptoglobin, a^-macroglobulin and 
3-lipoprotein. Since the fraction containing these serum proteins
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inhibited Ô-haemolysin, it was concluded that one of these proteins was 
inhibitory (assuming the inhibitor to be antigenic).
The first results implicating g-lipoprotein as inhibitory to 
6-haemolysin were obtained by affinity chromatography. Prior to this, 
Laurell immunoelectrophoresis of inhibitory fractions from gel filtration, 
ammonium sulphate precipitation and ultrafiltration had shown 3-lipoprotein 
in inhibitory fractions, thou^ always in the presence of other serum 
proteins, Delta-haemolysin immobilised on an inert matrix of CNBr- 
Sepharose specifically removed 3-lipoprotein from diluted serum (Plate T). 
Kapral (19T2) showed that many phospholipids (as well as human serum) were 
inhibitors of 6-haemolysin and since 3“lipoprotein is only one of a complex 
group of serum proteins whose role in blood is the transport of tri­
glycerides and phospholipids, the possibility that all these proteins 
were capable of inhibiting 6-haemolysin through their phospholipid moiety 
required more detailed investigation.
Zonal ultracentrifugation of human serum
In this study, purified fractions of human serum lipoproteins 
were obtained by the zonal ultracentrifugation method of Wilcox ^  al (1971 ) 
by exploiting the lower density of lipoproteins compared to other serum 
proteins. The resolution obtained by this method was similar to that of 
Wilcox et ^  (1971); 3-lipoprotein migrated to a point in the gradient 
equivalent to density 1,06 g ml and d-lipoprotein to a point corresponding 
to^l.21 g ml ^ . These values agreed closely to the published values of 
1.063 and 1.21 respectively (Langer ^  1970). The peaks of inhibitory
activity against 6-haemolysin corresponded to the two peaks of Eggg-
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absorbing material which corresponded in density to the expected values 
for the two lipoprotein species, with only a residual amount of inhibition 
being present in the major E^QQ^absorbing high density peak (Fig 11).
That the low density peak was 3-lipoprotein was confirmed by 
polyacrylamide gel electrophoresis (Naito 1973) and by the presence
of a single Sudan Black-staining peak on Laurell immunoelectrophoresis 
with anti-whole human serum and monospecific anti-3-lipoprotein antiserum. 
The identity and homogeneity of the a-lipoprotein fraction was similarly 
confirmed. Perhaps most important of all, however, was the demonstration 
that all the inhibitory activity against 6-haemolysin in human serum 
resided in these two protein classes, and that the small amount of activity 
present in the zonal ultracentrifugation fraction containing the remainder 
of the serum proteins could be attributed to the trace amount of a-lipo­
protein remaining in the dense fraction, as shown up by polyacrylamide gel 
electrophoresis (Plate 10; Table 13).
As previously discussed (page 31) 3- and a-lipoproteins are 
simplified terms referring to a family of lipoproteins : "beta"
encompassing the chylomicrons, very-low-density lipoproteins (VLDL) and 
low density lipoproteins (LDL); "alpha" has two subclasses designated 
high-density lipoproteins (HDL^ and EDL^) and a third called the very-high- 
density lipoproteins (VHDL), Limited experiments were attempted to 
separate, in particular, the 3-lipoprotein into chylomicrons, VLDL and LDL, 
but with little success. This was due mainly to the very narrow gradient 
range over which these families are distributed, p < 1.006 - I.O63, and 
in the time available, the part of the molecule responsible for the 
inhibition of 6-haemolysin was at this stage regarded as of prime 
importance and the major aim of the thesis.
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Precipitation studies
Immunoelectrophoresis of the h i ^  molecular weight inhibitory 
peak from Sephadex G-15O electrophoresis indicated that only four or five 
proteins were present in that fraction (Plate 5). A rabbit antiserum 
prepared against this mixture gave a precipitation reaction on radial gel 
diffusion with the mixture, and also abolished the inhibitory effect when 
incubated at 3T°C with the fraction prior to titration. That 3-lipoprotein 
was present in this sample (Freeman and Smith, 1970) was confirmed by 
gel diffusion of zonal-centrifugation-purified 3-lipoprotein against the 
rabbit antiserum and also diffusion of the fraction against commercial 
monospecific anti-3-lipoprotein antiserum, a single line resulting in 
each case. Similarly, gel diffusion with monospecific anti-a-lipoprotein, 
anti-human serum, and anti-human serum albumin confirmed that there was no 
cross-contaminâtion in purified a- and 3-lipoprotein samples or 
contamination with other human serum proteins. Preincubation of 
inhibitory samples with these antisera confirmed that a- and 3-lipoproteins 
were both inhibitory and also eliminated albumin as an inhibitor of 
ô-haemolysin (Gladstone and Yoshida, 1967). In the same way, 
preincubation of the rabbit antiserum abolished the inhibitory effect only 
of 3-lipoprotein on delta: a-lipoprotein remained inhibitory.
Alpha- and 3-lipoproteins were further confirmed as the sole 
serum inhibitors of 6-haemolysin by the immunocore electrophoretic technique 
(Zeineh et al, 1972). Purified zonal ultracentrifugation preparations of 
a- and 3-lipoproteins gave single immune precipitates on electrophoresis 
against whole human serum antiserum, employing the lipoprotein disc-gel
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electrophoretic technique of Naito ^  (1973) in the first dimension. 
Control gels stained specifically for lipoproteins with Sudan Black 
confirmed the relative positions of the two lipoprotein species (Plate 10) 
and their identities were confirmed hy development against monospecific 
antisera (Plate 13). When the antisera in the central cores were 
replaced in subsequent tests with 6-haemolysin, precipitates again formed 
in the gel corresponding to the positions of a- and g-lipoproteins.
Inactivation studies on 6-haemolysin inhibitors
The findings of Kapral (1972), that chromatographic ally pure 
preparations of phospholipids (Fig 12) were inhibitory to the action of
6-haemolysin were confirmed. Phosphatidyl choline, phosphatidyl glycerol, 
phosphatidyl inositol and phosphatidyl serine were all inhibitory at levels 
below 0.2 pg/HD50 (cf. Kapral's 1.5 yg/HD50), sphingomyelin, phosphatidic 
acid and cardiolipin were of similar activity to those found by Kapral, 
and phosphatidyl ethanolamine was the least active of all those phospho­
lipids tested. In addition, a serum lipid extract chromatographically 
shown to contain phosphatidyl choline, sphingomyelin and phosphatidyl 
ethanolamine, completely inhibited the haemolytic activity of 6-haemolysin 
at a level of 1.2 yg dry weight/HD50. In drawing comparisons to Kapral's 
results, however, it must be b o m  in mind that his indicator red cell was 
the human erythrocyte which has been shown (Chao, 1976) to be 1+ to 8 times 
less sensitive to the action of 6-haemolysin than cod erythrocytes, and 
his 6-lysin was of hi^er activity than that reported here. Taking this 
into account, the correlation between those inhibitory levels reported 
here and those of Kapral (1972) may be much closer, assuming a similar 
inhibitory mechanism with both species of erythrocyte. This need not
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necessarily be the case, however, since results of Kapral suggest that 
phospholipids inhibit 6-haemolysin by interfering with its binding to 
the erythrocyte membrane.
Enzyme studies with protease, trypsin and papain, on purified 
a- and 3-lipoproteins eliminated the apoprotein moiety of the phospholipo- 
protein complex as the anti-6-haemolysin component. Trypsin itself is 
inhibitory to delta-haemolysin confirming Kreger’s ^  ^  (l9Tl) findings, 
papain is not, and at the concentrations used in the enzyme assays, 
neither had an effect on the indicator red cell. In addition, the protein 
residue from a serum lipid extraction failed to inhibit the action of 
6-haemolysin, but while this might indicate that apoprotein is non-inhibitory. 
one must consider the possibility that structural conformation changes or 
dénaturation of the protein may have occurred during the lipid extraction. 
However, pretreatment of whole serum, a- and 3-lipoprotein with trypsin 
and papain did not alter the inhibitory properties of the preparation, 
which suggests that apoprotein does not play a role.
The non-protein constituents of serum lipoproteins, as dis­
cussed earlier (pages 31-35), are phospholipids, neutral fats, tri­
glycerides and cholesterol, but from the findings with serum lipid extracts, 
and those of Kapral (1972), phospholipids seemed most likely to be 
responsible for the inhibition of 6-haemolysin. Throughout the study, 
a-lipoprotein was more inhibitory than 3-lipoprotein, and in terms of dry 
weight, the largest non-protein constituent of a-lipoprotein is phospholipid, 
approx. 60% of the total lipid component (Table 7); similarly, 3-lipo­
proteins have a non-protein component predominantly composed of phospholipid 
and cholesterol esters, the latter having been shown to be non-inhibitory
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(Kapral, 1972). Thus, these data when considered together indicate the 
phospholipid moiety as the mediator of inhibition. Enzyme degradation 
by B. cereus phospholipase C confirmed this hypothesis (Table l6). The 
high haemolytic activity of E, cereus phospholipase C on cod erythrocytes 
is compatible with the finding of Addison and Ackman (1971) that lecithin 
is the predominant phospholipid in cod erythrocytes. Bacillus cereus 
phospholipase C cannot degrade phospholipids in intact cells, but produces 
conplete degradation of the main phospholipid classes in erythrocyte 
ghosts with the exception of sphingomyelin (Zwaal ej^  al, 1971); in mixed 
monolayers of lecithin and sphingomyelin, spread at an initial surface 
pressure above 31 dynes/cm, B. cereus phospholipase C cannot act unless 
sphingomyelin is first degraded (Demel at al, 1975). In this study, 
pretreatment of all phospholipids tested with B. cereus phospholipase C 
decreased to some extent the inhibitory action against 6-haemolysin, 
except for sphingomyelin. In the case of phosphatidyl inositol and 
phosphatidyl ethanolamine inhibitory activity was totally abolished.
With the serum lipid extracts, shown chromatographically to contain three 
phospholipids, the reduction was not so dramatic (two-fold) but since the 
predominant phospholipid detected in the extract was sphingomyelin, this 
was not unexpected. Most significant of all, however, was the 
observation that both a-lipoprotein and 3-lipoprotein were reduced in 
inhibitory activity against 6-haemolysin when pretreated with the phospholipas
The results presented in this thesis, therefore, show that a- 
and 3-lipoproteins are the components of human serum which inhibit the 
activity of 6-haemolysin, and that an intact phospholipid moiety of the 
lipoprotein is essential for activity. However, the mechanism by which
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this operates is unclear. Kapral (1972) concluded that the minimal 
inhibitory unit was phosphatidic acid, and later (1976) found that 
straight chain fatty acids of twenty-one to twenty-three carbons also 
inhibited ô-haemolysin. This may well explain the inability seen here 
to totally abolish the inhibitory effect of some phospholipids, since 
cleavage by phospholipase of, e.g. lecithin to phosphoryl choline and 
diacylglycerol would still leave intact on the latter molecule a long- 
chain fatty acid of required length to inhibit 6-haemolysin (assuming 
such a fatty-acid residue was present).
Kapral (1972) also suggested that phospholipids inhibit 
6-haemolysin by interfering with its binding to the erythrocyte membrane, 
although whether this would be sterically possible when the phospholipid 
was in a very high molecular weight complex as it is with serum lipoproteins 
is again uncertain. Streptolysin 8 (SLS) from Streptococcus pyogenes is 
a haemolysin which closely resembles 6-haemolysin in terms of cytotoxicity, 
biological activity and difficulty of proving antigenicity, and has also 
been found to be inhibited by a serum phospholipoprotein complex 
(Stollerman ^  al, 1950). As is reported here, lecithinase abolished 
inhibitory activity against SLS which suggests that activity against SLS 
also resides within the phospholipid moiety. Streptolysin 0 (SLO) is 
inhibited by cholesterol, in this case the mechanism appearing to involve 
exposed cholesterol molecules on peptide fragments of the whole molecule 
(Watson, personal communication), and perhaps a similar reaction involving 
phospholipid may be in operation with 6-haemolysin.
Identification of a- and 3-lipoproteins as the inhibitors of
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6-haemolysin explains some of the inconclusive results obtained during 
the early stage of the investigation. Thus for Sephadex G-150 
chromatography the two M.Wt, species involved in inhibition were 
respectively above and below the exclusion limit for the gel. Similarly, 
the fact that despite exhaustive filtration inhibitory activity was 
retarded by a 300,000 M.Wt. membrane, can also be explained by the 
presence of two M.Wt. species. Isoelectricfocusing also was of limited 
value, since a~ and 3-lipoproteins focus at pi 5.5 and 5.^ respectively, 
which coincides with a large majority of other serum proteins.
Pathogenic importance of 6-haemolysin
In view of the above results, it is interesting to speculate 
on the pathogenic importance of 6-haemolysin, and a possible role for 
it in S. aureus infections. While it is apparent that 6-haemolysin is 
neutralised in vitro by human serum, such a situation in vivo need not 
necessarily follow. It is possible that although inhibition by lipo­
protein might appear to be an efficient substitute for an immune response, 
with lipoprotein binding with the haemolysin to give a product similar to 
an immune complex, such an interaction may be weak, and the haemolysin 
may be released intact from its lipoprotein carrier at sites of lipo­
protein catabolism. Alternatively, the fate of a lipoprotein-haemolysin 
complex may be phagocytosis by macrophages, or removal by the liver or 
spleen. Under such conditions, 6-lysin may be able to exhibit its 
diverse activity against tissue cells and cause damage within these organs
There is a veterinary problem which in some respects is not 
dissimilar to the phenomenon involving 6-haemolysin. A current working 
hypothesis adopted in schistosomiasis research ('bilharziasis' in man) 
is that there are antigens of host origin that serve to protect the
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parasite from immune attack. This is achieved by attachment of the host 
protein to the surface of the parasite, completing the immunological 
disguise of the adult worm and protecting it from immune attack (Terry and 
Smithers, 1975). In this way the parasite remains viable. The situation 
with 6-haemolysin may perhaps be viewed in a similar way : a disguising
association with serum lipoprotein may in effect make it "not foreign" to 
the host’s immune mechanisms, and leave its biological potential undiminished, 
Thus from the point of view of the host, a true immune response to 
6-haemolysin may be a desirable event.
Elucidation of the factors in serum responsible for the 
neutralisation of 6-haemolysin made it possible to stimulate an antibody 
response to the haemolysin (see appended paper). The reported non­
antigenicity of delta-haemolysin (Gladstone and Yoshida, 1967; Hallander, 
1968; Kantor ^  1972) can now be ascribed to the removal of the
antigen by lipoproteins before induction of the immune response. Further, 
the presence of non-specific haemolysin inhibitors in sera from animals 
in which an immune response had been elicited have hindered detection of 
immune precipitin lines in immunochemical and serological tests. We have 
shown that the presence of antibodies to 6-haemolysin can be more easily 
demonstrated by the removal of lipoproteins from immune sera prior to 
immunochemical analysis.
REFERENCES
127
ABRAMSON, C. (1972) Staphylococcal enzymes. In The Staphylococci, 
pp 187-2^8" Edited by J.O. Cohen, London : Wiley-Interscience.
ABRAMSON, C. and RAUTELA, G.S. (l97l) Purification and crystallisation
of staphylococcal hyaluronate lyase. Bacteriological Proceedings, p 81. 
ADAMS, G.H. and SCHUMAKER, V.N. (1969) Rapid molecular weight estimations 
for low-density lipoproteins. Analytical Biochemistry, 117-129. 
ADDISON, R.F. and ACKMAN, R.G, (l97l) Erythrocyte lipids of Atlantic cod, 
Gadus morhua. Canadian Journal of Biochemistry, U9., 873-876.
ADLAM, C., THORLEY, C.M., WARD, P.D. and COLLINS, M. (1976) Staphylococcal 
mastitis in rabbits : description of a natural outbreak of the 
disease and attempts to reproduce the disease in the laboratory.
In Proceedings of the Third International Symposium on Staphylococci 
and Staphylococcal Infections, Warsaw 1975, pp 761-771. Edited by 
J. Jeljaszewicz, Stuttgart, Gustav Fischer Verlag.
ADLAM, C., WARD, P.D., McCARTNEY, A.C., ARBUTHNOTT, J.P. and THORLEY, C.M. 
(1977) Effect of immunisation with highly purified alpha- and beta- 
toxins on staphylococcal mastitis in rabbits. Infection and Immunity,
17, 250-256.
ARBUTHNOTT, J.P. (l970) Staphylococcal alpha-toxin. In Microbial Toxins, 
Vol. Ill pp 189-236. Edited by S. Kadis, T.C. Montie and S.Ajl.
New York: Academic Press.
ARBUTHNOTT, J.P., BILLCLIFFE, B. and THOMPSON, W.D. (197%) Isoelectric- 
focusing studies of staphylococcal epidermolytic toxin. FEBS Letters,
%6» 92-95.
ARBUTHNOTT, J.P., FREER, J.H. and BERNHEIMÉR, A.W. (I967) Physical states 
of staphylococcal alpha-toxin. Journal of Bacteriology, 9%, 1170-1177.
128
ARBUTHNOTT, J.P., KENT, J., LYELL, A. and GEMMELL, C.G. (l9Tl) Toxic 
epidermal necrolysis produced by an extracellular product of 
Staphylococcus aureus. British Journal of Dermatology, 1%5~1%9*
ARVIDSON, S., HOLME, T. and LINDHOLM, B. (l9T3) Studies on extracellular 
proteolytic enzymes from Staphylococcus aureus. I Purification and 
characterisation of one neutral and one alkaline protease, Biochimica 
et Biophysica Acta, 302, 135~1%8.
AXEN, R., PORATH, J. and ERNBACK, S. (1967) Chemical coupling of peptides 
and proteins to polysaccharides by means of cyanogen halides. Nature, 
21%, 1302-130%.
BERGDOLL, M.S. (1972) The Enterotoxins. In The Staphylococci. Edited 
by J.O. Cohen, ch 12, pp 301-331. Wiley Interscience : New York,
London, Sydney, Toronto.
BERNHEIMER, A.W. (l970) Cytolytic toxins of bacteria. In Microbial
Toxins, Vol I pp 183-212. Edited by 8.J. Ajl, S. Kadis and T.C. Montie. 
New York : Academic Press.
BERNHEIMER, A.W. (197%) Interactions between membranes and cytolytic 
bacterial toxins. Biochimica et Biophysica Acta, 3%%, 27-50.
BERNHEIMER, A.W. and SCHWARZ, L.L. (1961) Extracellular proteins of
staphylococci. Proceedings of the Society for Experimental Biology and 
Medicine, IO6, 776-780.
BERNHEIMER, A.W. and SCHWARZ, L.L. (1963) Isolation and composition of 
staphylococcal alpha-toxin. Journal of General Microbiology, 30, 
%55-%68.
BERNHEIMER, A.W. and SCHWARZ, L.L. (196%) Lysosomal disruption by 
bacterial toxins. Journal of Bacteriology, 87, 1100-110%.
129
BERNHEIMER, A.W., AVIGAD, L.S. and GRUSHOFF, P. (1968) Lytic effects 
of staphylococcal alpha-toxin and delta-haemolysin. Journal of 
Bacteriology, 96, %87"%91*
BIDWELL, D.E. and MILLS, G.L. (1968) Serum non-specific inhibitors of 
arbovirus haemagglutination. Journal of Comparative Pathology, 78, 
%69-%76.
BIGGER, J.W. , BOLLAND, C.R. and O'MEARA, R.A.Q. (1927) A new method of 
preparing staphylococcal haemolysin. Journal of Pathology and 
Bacteriology, 271-277.
BIRCH-HIRSCHFELD, L. (193%) Veber die Wirksamkeit der Extracts von auf 
zellophanagar gezuchteten Staphylokokken. Z. Immunitaetsforsch. Allerg. 
Klin. Immunol. 260-285.
BIRKBECK, T.H. and WHITELAW, D.D. (1976) Immunogenicity of staphylococcal 
delta-haemolysin. Proceedings of the Society of General Microbiology,
12.
BORDET, J, and STRENG, 0. (1909) Les phenomenes d'absorption et la
conglutine du serum de boeuf. Centralblatt fur Bakteriolog. %£, 260-276,
BRAGDON, J.H., HAVEL, R.J. and BOYLE, E. (1956) Human Serum Lipoproteins.
I Chemical composition of four fractions. Journal of Laboratory and 
Clinical Medicine, %8, 36-%2.
CAIRB, J.D. and WISEMAN, G.M. (l970) Purification of the delta-toxin of 
Staphylococcus aureus. Canadian Journal of Microbiology, 3^, 703-708.
CHANG, P.C. and DICKIE, N. (1971) Fractionation of staphylococcal
enterotoxin B by isoelectricfocusing. Biochimica et Biophysica Acta,
236, 367-375.
CHANG, B.C., YANO, Y., DIGHTON, M. and DICKIE, N. (1971) Fractionation 
of staphylococcal enterotoxin C^ by isoelectricfocusing. Canadian 
Journal of Microbiology, 17, 1367-1372.
130
CHANG, T. and WEINSTEIN, L. (1972) Studies of non-specific inhibition of 
rubella virus and isolation and identification of inhibitor.
American Journal of Medical Sciences, 263, 233-239.
CHAO, LIN PC (1976) Assay of ô-haemolysin using fish erythrocytes.
M.Sc. Thesis, University of Glasgow.
CHAO, L.P. and BIRKBECK, T.H. (1978) Assay of staphylococcal delta- 
haemolysin using fish erythrocytes. Journal of Medical Microbiology, 
in the press.
CHESBRO, W.R., HEYDRICK, P.P., MARTINEAU, R. and PERKINS, G.N. (19&5) 
Purification of staphylococcal beta-haemolysin and its action on 
staphylococcal and streptococcal cell walls. Journal of Bacteriology
89, 378-389.
COHN, E.J. and EDSALL, J.T. (l9%2) Proteins, amino acids, and peptides 
as ions and dipolar ions. New York, Reinhold Publishing Corporation. 
COHN, E.J., GURD, F.R.N., SURGENOR, D.M. , BARNES, B.A. , BROWN, R.K., 
DEROUAUX, G., GILLESPIE, J.M. , KAHNT, E.W., LEVER, W.F., LIV, C.H., 
MITTELMAN, D. , MOUTON, R.F., SCHMID, K. and UROMA, E. (l950) A system 
for the separation of the components of human blood: Quantitative
procedures for the separation of the protein components of human plasma. 
Journal of the American Chemical Society, 7^, %65-%7%.
COLACICCO, G. , BASU, M.K., BUCKELEW, A.R. and BERNHEIMER, A.W. (1977) 
Surface properties of membrane systems : Transport of staphylococcal 
6-toxin from aqueous to membrane phase. Biochimica et Biophysica Acta,
%65, 378-390.
COOPER, L.Z., MADOFF, M.A. and WEINSTEIN, L. (1966) Heat stability and 
species range of purified staphylococcal alpha-toxin. Journal of 
Bacteriology, 91, I686-1692,
131
COULTER, J.R. (1966) Production, purification and composition of
staphylococcal alpha-toxin. Journal of Bacteriology, 9 ^ , l655~l662.
CREMER, H.D. and TISELIUS, A. (l950) Elektrophorese von Eiweiss in 
Filtrierpapier. Biochemische Zeitschrifb 320, 273-283.
DALEN, A.B. (1975) Multiple forms of staphylococcal a-toxin. Acta 
Pathologica Microbiologica Scandinavica, 561-568.
DAVIS, B.J. (196%) Disc electrophoresis II. Methods and application to 
serum proteins. Annals of the New York Academy of Sciences, 121,
%0%-%27.
de CHRISTMAS, M.J. (1888) Recherches expérimentales sur la suppuration. 
Annales Institute Pasteur, Paris, %69~%78.
DECKELBAUM, R.J., SHIPLEY, G.G. and SMALL, D.M. (1977) Structure and
Interaction of lipids in human plasma low density lipoproteins. Journal 
of Biological chemistry, 252(2), 7%%"75%.
DEMEL, R.A., VAN KESSEL, W.S.M.G., ZWAAL, R.F.A., ROELOFSEN, B. and VAN 
DEENEN, L.L.M. (1975) Relation between various phospholipase actions 
on human red cell membranes and the interfacial phospholipid pressure 
in monolayers. Biochimica et Biophysica Acta, %06, 97*107.
DIXON, M. and WEBB, E.C. (196%) Enzyme isolation-fractdonation methods, 35-5C 
In Enzymes. Longmans, London.
DOERY, H.M. , MAGNUSSON, B.J., CHEYNES, I.M., GULASEKHARAM, J. (1963) A 
phospholipase in staphylococcal toxin which hydrolyses sphingomyelin. 
Nature, 3^, 1091-1092.
DONAHUE, J.A, (l969,a) Antistaphylococcal haemolysins and delta- 
haemolysin inhibitor in adult human serum. Canadian Journal of 
Microbiology, 15, 957*959.
132
DONAHUE, J.A. (19^9,b) Biological characteristics of staphylococcal heat- 
stable haemolysin. Bacteriological Proceedings, 93.
DORFMAN, A. (1955) Mucopolysaccharides. In Methods in Enzymology, Vol. 1 
Edited by Colowick, S.R. and Kaplan, N.O, Academic Press, New York, 
pp 166-173.
DULBECCO, R. and VOGT, M. (l95%) Plaque formation and isolation of pure 
lines with poliomyelitis viruses. Journal of Experimental Medicine,
99, 167-199.
DUTHIE, E.S, and HAUGHTON, G. (1958) Purification of free staphylococcal 
coagulase. Biochemical Journal, 70., 125-13%.
ELEK, S.D. (1959) Staphylococcus pyogenes and its relation to disease. 
Churchill Livingstone: Edinburgh.
ELEK, S.D. and LEVY, E. (1950) Distribution of haemolysins in pathogenic 
and non-pathogenic staphylococci. Journal of Pathology and Bacteriology, 
5%l-55%.
EVANS, L. and LECK, C.H. (I969) The action of staphylococcal delta- 
haemolysin on lysosomes and lymphocytes. Life Science, 667-68I.
FACKRELL, H.B. (l973) Studies with gamma-haemolysin of Staphylococeus 
aureus. Ph.D. Thesis, University of Manitoba, Winnipeg, Canada, cited 
by Wiseman (1975).
FACKRELL, H.B. and WISEMAN, G.M, (l97%) Immunogenicity of the delta- 
haemolysin of Staphylococcus aureus. Journal of Medical Microbiology,
7, %11-%1%.
FACKRELL, H.B. and WISEMAN, G.M. (1976,a) Production and purification of 
the gamma-haemolysin of Staphylococcus aureus, ’’Smith 5R”. Journal of 
General Microbiology, 92, 1-10.
133
FACKRELL, H.B. and WISEMAN, G.M. (1976,^ ) Properties of the gamma- 
haemolysin of Staphylococcus aureus "Smith 5R”. Journal of General 
Microbiology, 9^, 11-2%.
FARRER, 8.M. and McLEOD, C.M. (1960) Staphylococcal infections in a 
general hospital. American Journal of Hygiene, 7^, 38-58.
FELDMAN, H.A. (1968) Removal by Heparin MnCl^ of non-specific rubella 
haemagglutination inhibitor. Proceedings of the Society for 
.Experimental Biology and Medicine, 127, 570-573.
FOLCH, J., LEES, M. and SLOANE-STANLEY, G.H. (1957) A simple method for 
the isolation and purification of total lipids from animal tissues. 
Journal of Biological Chemistry, 226, %97~509.
FREDERICKSON, D.S., LEVY, R.I. and LEES, R.S. (1967) Fat transport in 
lipoproteins - an integrated approach to mechanisms and disorders.
New England Journal of Medicine, 276, 3%*%%.
FREDERICKSON, D.8., GOTTO, A.M. and LEVY, R.I. (1972) In The metabolic 
basis of inherited disease. Edited by Stanbury, J.B., Wyngaarden, J.B. 
and Frederickson, D.S. McGraw-Hill, New York, pp %92-530.
FREDERICKSON, D.S. and SLOAN, H.R. (1972) In The metabolic basis of 
inherited disease. Edited by Stanbury, J.B., Wyngaarden, J.B. and 
Frederickson, D.S. McGraw-Hill, New York, pp 5%5~6l%.
FREEMAN, T. and SMITH, J. (1970) Human serum protein fractionation by gel 
filtration. Biochemical Journal, II8, 869-873.
FREER,J.H. and ARBUTHNOTT, J.P. (1976) Biochemical and Morphological
alterations of membranes by bacterial toxins. In Mechanisms in Bacterial 
Toxinology, pp 169-193. Edited by Bernheimer, A.W., New York: John 
Wiley and Sons.
13%
FREER, J.H., ARBUTHNOTT, J.P. and BERNHEIMER, A.W. (1968) Interaction of 
staphylococcal alpha-toxin with artificial and natural membranes.
Journal of Bacteriology, 95., 1153-1168.
f!
FRITSCHE, D. (l9T0) Untersuchungen zur Funktion des Beta-Hamolysins
tt
von Staphylococcus aureus. Zentralblatt fur Bakteriologie, Parasitenkunde, 
In fekt i on skrankhe it en und Hygeine. Abteilung I: Originale Reihe B,
213, 3%8-355.
GLADSTONE, G.P. (1966) Staphylococcal haemolysins. Postepy. Mikrobiol,
5, 1%5-I6l.
GLADSTONE, G.P. and van HEYNINGEN, W.E. (1957) Staphylococcal leucocidins.
British Journal of Experimental Pathology, 123-137.
GLADSTONE, G.P. and YOSHIDA, A. (1967) The cytopathic action of purified 
staphylococcal delta-haemolysin. British Journal of Experimental 
Pathology, 11-19.
GLENNY, A.T. and STEVENS, M.F. (1935) Staphylococcus toxins and antitoxins.
Journal of Pathology and Bacteriology, %2» 201-210.
GLOMSET, J.A. (1968) The plasma lecithin ; cholesterol acyltransferase 
reaction. Journal of Lipid Research, 9., 155*167.
GLOMSET, J.A. (1972) In Blood Lipids and Lipoproteins : Quantitation, 
Composition and Metabolism, Edited by Nelson, G.J., pp 7%5, New York: 
Wiley Interscience.
GLOMSET, J.A., JANSSEN, E.T., KENNEDY, R. and DOBBINS, J. (1966) Role of 
plasma lecithin : cholesterol acyltransferase in the metabolism of high 
density lipoproteins. Journal of Lipid Research, 639“6%8.
GORMAN, B. (1970) Lipid inhibitors of arbovirus haemagglutination.
Journal of General Virology, 6, 305*313,
135
GOSHI, K., CLUFF, L.E. and NORMAN, P.S. (19^3) Studies on the pathogenesis 
of staphylococcal infection. V Purification and characterisation of 
staphylococcal alpha-haemolysin. Bulletin Johns Hopkins Hospital,
112, 15-30.
GRABAR, P. and BURTIN, P. (1960) In Analyse immunoelectrophoretique.
Applications aux liquides biologiques humains. Masson and Oie: Paris.
GRABAR, P. and WILLIAMS, C.A. (1953) Methods permettant 1'etude conjuguée 
des propriétés electrophoretiques et immunochimiques d'un melange de 
protéines. Application au serum sanguin, Biochimica et Biophysica 
Acta, 10, 193-19%.
GRABAR, P. and WILLIAMS, C.A. (1955) Méthode immunoelectrophoretique 
d'analyse de melanges de substances antigeniques, Biochimica et 
Biophysica Acta, ]/[, 6T“T%.
GUSTAFSON, A., ALAUPOVIC, P. and FURMAN, R.H. (19^5) Studies of the 
composition and structure of serum lipoproteins : isolation, 
purification and characterisation of Very Low Density Lipoproteins of 
Human Serum. Biochemistry, _%, 596-605.
GUYONNET, F. and PLOMMET, M. (1970) Hemolysine gamma de Staphylococcus 
aureus : purification et propriétés. Annales Institute Pasteur, Paris,
118, 19-33.
HALLÀNDER, H.O, (1968) Characterisation and partial purification of 
staphylococcal delta-lysin. Acta Pathologica Microbiologica 
Scandinavica, 72, 586-6OO.
HALLANDER, H.O. and BENGTSSON, S. (1967) Studies on the cell toxicity 
and species specificity of purified staphylococcal toxins. Acta 
Pathologica Microbiologica Scandinavica, 70, 107-119.
136
HALONEN, P.E., MURPHY, F.A., FIELDS, B.N. and REESE, D.R. (1968) 
Haemagglutinin of rabies and some other bullet-shaped viruses. 
Proceedings of the Society for Experimental Biology and Medicine, 127, 
1037-10%2.
HALONEN, P.E., NIKKARI, T. and TOIVANEN, P. (I969) Non-specific serum 
inhibitors of rabies and vesicular stomatitis virus haemagglutinins.
The Scandinavian Journal of Clinical and Laboratory Investigation
108-111.
HALONEN, P.E., TOIVMEN, P. and NIKKARI, T. (l97%) Non-specific serum 
inhibitors of activity of haemagglutinins of rabies and vesicular 
stomatitis viruses. Journal of General Virology, 309-318,
HAMILTON, J.A., TALKOWSKI, C., CHILDERS, R.F., WILLIAMS, E., ALLERHAND, A. 
and CORDES, E.H. (197%) Rotational and segmental motions in the lipids 
of human plasma lipoproteins. Journal of Biological Chemistry, 2%9> 
%872-U878.
HAQUE, R. and BALDWIN, J.N. (1969) Purification and properties of
staphylococcal beta-haemolysin. II Purification of beta-haemolysin. 
Journal of Bacteriology, 100, 751-759.
HARVIE, N.R. (1977) Cholesteryl de-esterifying enzyme from Staph, aureus: 
separation from alpha-toxin, purification, and some properties. 
Infection & Immunity, 863-870.
HATCH, F.T., ASO, Y. , HAGOPIAN, L.M. and RUBINSTEIN, J.J. (1966)
Biosynthesis of lipoprotein by rat intestinal mucosa. Journal of 
Biological Chemistry, 2%1, l655“l665.
HAUKENES, G. and AASEN, J. (l97l) Rubella haemagglutination inhibitors : 
Their separation from antibodies. Acta Pathologica et Microbiologica 
Scandinavica, B 79, 679-685.
137
HAVEL, E.J. (1965) In Handbook of Physiology, Section V: Adipose
Tissue, Edited by Renold, A.E. and Cahill, G.E. p %%9* Waverley Press, 
Baltimore, Maryland.
HAVEL, R.J., EDER, H.J. and BRAGDON, J.H. (1955) The distribution and 
chemical composition of ultracentrifugally separated lipoproteins in 
human serum. Journal of Clinical Investigation, 3|+> 13%5-1353.
HEATLEY, N,G. (l97l) A new method for the preparation and some properties 
of staphylococcal delta-haemolysin. Journal of General Microbiology, 69,
269-278.
HEATLEY, N.G. (1977) Production of antibody to staphylococcal delta- 
haemolysin in the rabbit. British Journal of Experimental Pathology, 
%00-%ll.
HEINS, J.N., SURIANO, J.R., TANIUCHI, H. and ANFINSEN, C.B. (1967)
Characterisation of a nuclease produced by Staphylococcus aureus. Journal 
of Biological Chemistry, 2%2, 1016-1020.
HENSON, P.M. (1969) Immunoconglutinins of different immunoglobulin classes 
demonstrated by the antiglobulin reaction. Immunology, 1^, 107-121.
HODGKINS, H.O. and RIDGWAY, G.J. (196I+) Preservation of trout and salmon 
erythrocytes for blood typing by freezing with dimethylsulphoxide.
Nature, 201, 1336-1337.
HUMPHREY, J.H. and PORTER, R.R. (1957) An investigation on rabbit
antibodies by the use of partition chromatography. Biochemical Journal,
93-99.
JACKSON, A.W. (1962) Staphylococcal gamma-lysin and its differentiation 
from delta-lysin. In N.E. Gibbons (ed.). Recent progress in 
microbiology: symposia. University of Toronto Press, Toronto.
JACKSON, A.W. and LITTLE, R.M. (1957) Leukocidal effect of staphylococcal 
delta-lysin. Canadian Journal of Microbiology, 3, 101-102.
138
JACKSON, A.W. and LITTLE, R.M. (1958) Staphylococcal toxins, II. Factors 
affecting haemolysis by delta-lysin. Canadian Journal of Microbiology, 
%, 1+35-%%%.
JACKSON, A.W. and MAYMAN, D. (1958) Staphylococcal toxins, IV. Factors 
affecting haemolysis by beta-lysin. Canadian Journal of Microbiology, 
k , %T7-%86.
JELJASZEWICZ, J. (1972) Haemolysins. In The Staphylococci, pp 2%8-280. 
Edited by J.O. Cohen, London : Wiley Interscience.
KANTOR, H.S., TEMPLES, B. and SHAW, W.V. (1972) Staphylococcal delta-
haemolysin, purification and characterisation. Archives of Biochemistry 
and Biophysics, 151, 1%2-156.
KAPRAL, F.A. (1972) Inhibition of Staphylococcus aureus delta-haemolysin 
by phospholipids. Proceedings of the Society for Experimental Biology 
and Medicine, 11%, 519-521.
KAPRAL, F.A. (1976) Effect of fatty acids on Staphylococcus aureus delta- 
toxin haemolytic activity. Infection and Immunity, 1 3 , 11%-119.
KAPRAL, F.A., O'BRIEN, A.D., RUFF, P.D. and DRUGAN, W.J, (1976) Inhibition 
of water absorption in the intestine by Staphylococcus aureus delta- 
toxin. Infection and Immunity, IB, 1%0-1%5.
KAYSER, A. (1968) L'hemolysine staphylococcique G. Action sur les
erythrocytes et les stromas, sur les spheroplastes bacteriers et sur 
les jaune d'oeuf. Bulletin de la Société de Chimie Biologique, 50, 
1797-1808.
KAYSER, A. and RAYNAUD, M, (I965) Etude d'une deuxième hemolysine
(distincte de 1'hemolysine alpha) présente dans les filtrats de culture 
de la souche Wood %6 de Staphylococcus aureus (hemolysine G ou delta). 
Annals de 1 'Institut Pasteur, IO8, 215-233.
139
KLAIWER, A.S., MADOFF, M.A., COOPER, L.Z. and WEINSTEIN, L, (196%)
Staphylococcal alpha-haemolysin, detection on the erythrocyte membrane 
by immionofluorescence. Science, 1%^, 6l%-6l5.
KLEBS, E. (1872) Beitrage zur pathologischen Anatomie der Schussvunde, 
pp 10%-122. Liepzig.
KLECK, J.D. and DONAHUE, J.H. (1968) Production of thermostable haemolysin 
by cultures of Staphylococcus epidermidis. Journal of Infectious 
Diseases, I81, 317-323.
HONDO, I., SAKURAI, S. and SARAI, Y. (1973) Purification of exfoliâtin 
produced by Staphylococcus aureus of bacteriophage group 2 and its 
physicochemical properties. Infection and Immunity, 156-16%.
KREGER, A.S. and BERNHEIMER, A.W. (1971) Disruption of bacterial protoplasts 
and spheroplasts by staphylococcal delta-haemolysin. Infection and 
Immunity, 603-605.
KREGER, A.S., KIM, K.S., ZABORETSKY, F. and BERNHEIMER, A.W. (I97l) 
Purification and properties of staphylococcal delta-haemolysin.
Infection and Immunity, _3, %%9“%65.
KREGER, A.S., CUPPARI, G. and TARANTA, A. (1972) Isolation by electro- 
focusing of two lymphocyte mitogens produced by Staphylococcus aureus. 
Infection and Immunity, 723-727.
KUREK, M., PRUJMA, K. , BARTKOWSKE, S. and HECZKO, P.B. (1977) Anti-
staphylococcal gamma-haemoly sin antibodies in rabbits with staphylococcal 
osteomyelitis. Medical Microbiology and Immunology, 163, 6I-65.
KÜVJERT, E., WIKTOR, T.J., SOKOL, F. and KOPROWSKI, H. (1968) Haemagglut­
ination by rabies virus. Journal of Virology, 1381-1392.
fi
LACHMANN, P.J. and MULLER-EBERHARD, H.J. (I968) The demonstration in human 
serum of "conglutinogen-activating factor" and its effect on the third 
component of complement. Journal of Immunology, 100, 691-698.
1%0
LANGER, T., STROBER, W. and LEVY, R.I. (1970) The metabolism of plasma 
lipoproteins. In Plasma protein metabolism - regulation of synthesis, 
distribution and degradation. Edited by Rothschild, M.A., Academic 
Press, New York and London, p %03.
LAUFS, R. and THOMASSEN, R. (1968) Inhibition der Rubellavirus - 
haemagglutination I Eigenschaf en eines in fetalem Kalberserum 
vorkommenden. Inhibitors der Rubellavirus - Hammagglutination in
It
vitro. Archiv. fur die gesamte Virusforschung, 181-191.
LAURELL, C-B. (I965) Antigen-antibody crossed electrophoresis.
Analytical Biochemistry, 3^, 358-361.
LEE, S. and HAQUE, R. (1976) Lysis of erythrocytes by Sepharose - 
Staphylococcal delta toxin complex. Biochemical and Biophysical 
Research Communications, 6^ , III6-III8.
LEE, S., SARAUSKAS, T., HOY, E.S. and HAQUE, R. (1976) Purity of
staphylococcal 6-haemolysin obtained by three different procedures. 
Journal of Medical Microbiology, £, 371-377.
LEVY, R.I., FREDRICKSON, D.S. and LASTER, L. (1966) The lipoproteins and 
lipid transport in abetalipoproteinaemia. Journal of Clinical 
Investigation, 531-5%1.
LEVY, R.I., BILHEIMER, D.W. and EISENBERG, J. (l97l) The structure and 
metabolism of chylomicrons and very low density lipoproteins ( VLDL). 
Biochemical Society Symposium, 3-17.
LOCHMANN, 0. and VYMOLA, F. (l97%) Some properties of Staphylococcus aureus 
alpha- and delta-lysins. Journal of Hygiene, Epidemiology, Microbiology 
and Immunology, iR, 229-233.
LOMINSKI, I. and ARBUTHNOTT, J.P. (1962) Some characteristics of
staphylococcus alpha-haemolysin. Journal of Pathology and Bacteriology,
83, 515-520.
1%1
LOMINSKI, I., ARBUTHNOTT, J.P, and SPENCE, J.B. (1963) Purification of 
staphylococcal alpha-toxin. Journal of Pathology and Bacteriology,
86, 258-262.
LOMINSKI, I., GEMMELL, C.G. and ARBUTHNOTT, J.P. (I968) A staphylococcal 
toxic complex affecting particular areas of the mitochondrial electron 
transport system (rat liver). Journal of General Microbiology, 52,
107-117.
LOSSOW, W.J., LINDGREN, F.T., MURCHIO, J.G., STEVENS, G.P. and JENSEN, L.C. 
(1969) Particle size and protein content of six fractions of the Sf 20 
plasma lipoproteins isolated by density gradient centrifugation.
Journal of Lipid Research, 1^, 68-76.
LOW, D.K.R., FREER, J.H. and ARBUTHNOTT, J.P. (l97%) Consequences of 
sphingomyelin degradation in erythrocyte ghost membranes by 
staphylococcal beta-toxin (sphingomyelinase C). Toxicon, 3B, 279-285. 
LOW, D.K.R. and FREER, J.H. (1977,a) Biological effects of highly 
purified g-lysin (sphingomyelinase C) from Staphylococcus aureus.
FEMS Microbiology Letters, 2 , 133-138.
LOW, D.K.R. and FREER, J.H. (1977,b) The purification of &-lysin
(sphingomyelinase C) from Staphylococcus aureus. FEMS Microbiology 
Letters, 2^, 139“1%3.
LOW, M.G. and FINEAN, J.B. (1976) The action of phosphatidyl-inositol-
specific phospholipase C on membranes. Biochemical Journal, 15%, 203-208, 
LOW, M.G. and FINEAN, J.B. (1977) Modification of erythrocyte membranes 
by purified phosphatidylinositol-specific phospholipase C ( St aphyloc o ecus 
aureus). Biochemical Journal, 162, 235“2%0.
LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. and RANDALL, R.J. (1951) Protein 
measurement with the Folin phenol reagent. Journal of Biological 
Chemistry, 193, 265-275.
1%2
LYELL, A. (1967) A review of Toxic Epidermal Necrolysis in Britain,
British Journal of Dermatology, 79, 662-67I.
MADOFF, M.A. (19^5) In Discussion p 122 of Bernheimer, A.W. (1965),
Staphylococcal alpha-toxin. Annals of the New York Academy of Science, 
128, 112-123.
MADOFF, M.A. , COOPER, L.Z. and WEINSTEIN, L. (196%) Haemolysis of rabbit 
erythrocytes by purified staphylococcal alpha-toxin. III. Potassium 
release. Journal of Bacteriology, 1%5“1%9.
MAHESWARAN, S.K. and LINDORFER, R.K. (1966) Studies on the mode of action 
of purified staphylococcal beta-haemolysin. Bacteriological 
Proceedings, %%.
MAHESWARAN, S.K. and LINDORFER, R.K. (1967) Staphylococcal beta-haemolysin.
II. Phospholipase C activity of purified beta-haemolysin. Journal of
Bacteriology, 1313-1319.
MAHESWARAN, S.K. and LINDORFER, R.K. (1971) Physico-chemical and biological 
properties of purified staphylococcal beta-haemolysin. Bacteriological 
Proceedings, 80.
MAHESWARAN, S.K., SMITH, K.L. and LINDORFER, R.K. (1967) Staphylococcal 
beta-haemolysin. I. Purification of beta-haemolysin. Journal of 
Bacteriology, 300-305.
MALVEAUX, F.J. and SAN CLEMENTE, C.L. (1969) Staphylococcal acid
phosphatase: extensive purification and characterisation of the loosely 
bound enzyme. Journal of Bacteriology, 97, 1209-121%.
MANIAR, A.C., WESLAKE, C. and WARNER, P. (1967) Prevalence of staphylo­
coccal anti-delta lysin in man. Canadian Journal of Microbiology, 13,
925-929.
1%3
MARKS, J. (1951) The standardisation of staphylococcal alpha-anti-toxin 
with special reference to anomalous haemolysins including delta-lysin. 
Journal of Hygiene (London), 52-56.
MARKS, J. and VAUGHAN, A.C.T. (1950) Staphylococcal delta-haemolysin.
Journal of Pathology and Bacteriology, 597-615.
MARUCCI, R.A. (1963) Mechanism of action of staphylococcal alpha-haemolysin 
II. Analysis of the kinetic curve and inhibition by specific antibody. 
Journal of Bacteriology, 86, 1189-1195*
MASORO, E.J. (1968) In Physiological chemistry of lipids in mammals.
Philadelphia : Saunders. "
MELISH, M.E. and GLASGOW, L.A. (1970) The staphylococcal scalded-skin 
syndrome, development of an experimental model. New England Journal 
of Medicine, 282, l l l k - 1 1 1 9 .
MELISH, M.E. , GLASGOW, L.A. and TURNER, M.D. (1972) The staphylococcal 
scalded-skin syndrome : Isolation and partial characterisation of
exfoliate toxin. Journal of Infectious Diseases, 125, 129-1%0.
METZGER, J.F., JOHNSON, A.D. and COLLINS, W.8. (1972) Fractionation and 
purification of Staphylococcus aureus enterotoxin B by electrofocusing. 
Biochimica et Biophysica Acta, 257, I83-I86.
tt tt
MOLLBY, R. and WADSTROM, T. (1970) Studies on the haemolysins of
Staphylococcus aureus by the method of isoelectricfocusing. Protides of 
the Biological Fluids, Proceedings of the 17th Colloquium, Bruges. 
Section Cl pp %65-%69. Pergamon Press, Oxford.
ft Tt
MOLLBY, R. and WADSTROM, T. (1971 ) Separation of gamma-haemolysin from 
Staphylococcus aureus Smith 5R* Infection and Immunity, 633-635. 
MORRISETT, J.D., JACKSON, R.L. and GOTTO Jnr, A.M. (1975) Lipoproteins : 
structure and function. Annual Review of Biochemistry, %%, I83-207.
ll+%
MULLER-EBERHARD, H.J. (1976) In Textbook of Immunopathology Vol. I,
It
pp %5. Edited by P.A. Meischer and H.J. Muller-Eberhard. New York : 
Grune and Stratton.
MURPHY, R.A. and HAQUE, R. (1967) Purification and properties of
staphylococcal delta-haemolysin. I. production of delta-haemolysin. 
Journal of Bacteriology, 9%j 132T-1333.
MURPHY, R.A. and HAQUE, R. (l97%) Large scale production of staphylococcal 
delta-haemolysin by the dialysis membrane technique. Canadian Journal 
of Microbiology, IO61-IO63.
McCartney, A.C. and ARBUTHNOTT, J.P. (1977) cholesterol esterase activity 
in the culture supernatant of Staphylococcus aureus NCTC 7121.
EEMS Microbiology Letters, 1 , 63-66.
McLEOD, J.W. (1963) Thermostable staphylococcal toxin. Journal of 
Pathology and Bacteriology, §6^, 35-53.
McNIVEN, A.C., OWEN, P. and ARBUTHNOTT, J.P. (1972) Multiple forms of
staphylococcal alpha-toxin. Journal of Medical Microbiology, 2» 113-122, 
NAITO, H.K., WADA, M., EHRHART, L.A. and LEWIS, L.A. (1973) Polyacrylamide- 
gel disc-electrophoresis as a screening procedure for serum lipoprotein 
abnormalities. Clinical Chemistry, 19, 228-23%.
NICOLI, J. and ACKER, P. (1965) Les inhibiteurs seriques de l'hémagglut­
ination par les arbovirus. Annales de l'Institut Pasteur, Paris, IO6,
22-32.
O'BRIEN, A.D. and KAPRAL, F.A. (1976) Increased cyclic adenosine 3', 5’- 
monophosphate content in guinea pig ileum after exposure to 
Staphylococcus aureus delta-toxin. Infection and Immunity, 13, 152-162, 
O'BRIEN, A.D. and KAPRAL, F.A. (1977) Effect of Staphylococcus aureus delta 
toxin on Chinese hamster ovary cell morphology and Y-1 adrenal cell 
morphology and steroidogenesis. Infection and Immunity, I6, 812-816.
1%5
OCKNER, P.K., HUGHES, P.B. and ISSELBACHER, K.J. (1969) Very low
density lipoproteins in intestinal lymph : origin, composition and
role in lipid transport in the fasting state. Journal of Clinical 
Investigation, , 2079-2088.
ORNSTEIN, L. (196%) Disc electrophoresis. I. Background and theory.
Annals of the New York Academy of Science, 121, 321-3%9*
OUCHTERLONY, 0. (1958) Diffusion in gel method for immunological analysis.
Progress in Allergy, 2» 1-78.
PEETERS, H. and BLATON, V. (1968) Lipid fatty acid relationships in
electrochromatographic lipoprotein fractions. In Progress in 
Biochemical Pharmacology, 1%%~152. S. Karger : Basel.
PLOMMET, M. and BOUILLANNE, C. (1966) Production des hemolysines 
staphylococcique8 delta et gamma. Annales de biologie animale, 
biochimie et biophysique, 529-532,
POLLARD, H.B. and DEVI, S.K. (l97l) Construction of a three dimensional 
iso-density map of the low-density lipoprotein particle from human 
serum. Biochemical and Biophysical Research Communications, 593-599. 
POLLARD, H.B., SCANU, A.M. and TAYLOR, E.W. (1969) On the geometrical 
arrangement of the protein subunits of human serum low-density lipo­
protein : evidence for a dodecahedral model. Proceedings of the 
National Academy of Science USA, 30%-310.
POULIK, M.D. and SMITHIES, 0. (1958) Comparison and combination of the 
starch-gel and filter-paper electrophoretic methods applied to human 
sera; two dimensional electrophoresis. Biochemical Journal, 68, 636-6%3. 
PORTERFIELD, J.8. and ROWE, C.E. (1960) Haemagglutination with arthropod- 
borne viruses and its inhibition by certain phospholipids. Virology,
11, T65-T70.
Ike
PUTNAM, F.V, (1973) In Protides of the Biological Fluids, Proceedings 
of the 21st Colloquium, Bruges, pp 3-18. Edited by H. Peeters,
Oxford : Pergamon.
PUTNAM, F.W. (1975) The plasma proteins; structure, function and genetic 
control. Edited by F.W. Putnam, New York: Academic Press.
RAFFEL, S. (i960) The J. Bums Amberson Lecture, Aspects of contemporary 
research in immunology. American Review of Respiratory Diseases, 82, 
%6l-%68.
RAHAL, J.J.Jr. (1972) Comparative effects of purified staphylococcal 
alpha and delta-toxin on mitochondrial metabolism. Journal of 
Infectious Diseases, 126, 96-103.
RAYNAUD, M. and ALOUF, J.E. (1970) In Microbial Toxins, Vol. 1. pp 67-II8. 
Edited by S.J. Ajl, S. Kadis and T.C. Montie. New York: Academic Press
REDGRAVE, T.G. (1970) Formation of cholesteryl-ester-rich particulate 
lipid during metabolism of chylomicrons. Journal of Clinical 
Investigation, %65~%71.
REISFELD, R.A., LEWIS, V.J. and WILLIAMS, D.E. (1962) Disc electrophoresis 
of basic proteins and peptides on polyacrylamide gels. Nature, 195,
281-263.
ROUSER, G., NELSON, G.J., FLEISCHER, B. and SIMON, G. (1968) Lipid 
composition of animal cell membranes, organelles and organs. In 
Biological Membranes Physical Fact and Function. Edited by D. Chapman, 
New York : Academic Press.
RUDERMAN, N.B., RICHARDS, K.C., VALLES, D.E., BOURGES, V. and JONES, A.L. 
(1968) Regulation of production and release of lipoprotein by the 
perfused rat liver. Journal of Lipid Research, 613-619.
RUSAKOVA, E.V. (1970) Obtaining and properties of staphylococcus delta- 
toxoid. Zhumal Mikrobiol. Epidemiol. Immunobiol. 96-101.
1%T
RUSSELL, R.J., McINROY, R.J., WILKINSON, P.O., McKAY, S. and McCARTNEY, C, 
(19T5) Effects of staphylococcal products on locomotion of human 
blood neutrophils and monocytes. Proceedings of the Society for 
General Microbiology, 11, 73.
SALMINEN, A. (19^2) Chemistry of non-specific inhibitors of haemagglutin­
ation by arthropod-borne viruses. Virology, 36, 201-203.
SCANU, A.M. and WISDOM, C. (1972) Serum lipoproteins ; structure and 
function. Annual Review of Biochemistry, 703-730.
SHORTRIDGE, K.F., BIDDLE, F. and PEPPER, D.S. (1972) Rubella virus 
non-specific haemagglutination inhibitor: evidence for the role of
glycolipid bound to low density (3) lipoprotein. Clinica Chimiea 
Acta, %2, 285-29%.
SHORTRIDGE, K.F. and HO, W.K.K. (197%) Human serum lipoproteins as
inhibitors of haemagglutination for selected togaviruses. Journal of 
General Virology, 2 3  ^II3-II6.
SHULMAN, J.A. and NAHMIAS, A.J. (1972) Staphylococcal infections,
clinical aspects. In The Staphylococci, pp %57-%8l. Edited by J.O. 
Cohen, London : Wiley Interscience.
SMITH, M.L. and PRICE, S.A. (1938) The combining power of staphylococcus 
toxoid. Journal of Pathology and Bacteriology, %6, 289-302.
SMYTH, C.J. and ARBUTHNOTT, J.P. (l97%) Properties of Clostridium 
perfringens (welchii) type A a-toxin (phospholipase C) purified by 
electrofocusing. Journal of Medical Microbiology, %, %l-66.
t! M
SMYTH, C.J., MOLLBY, R. and WADSTROM, T. (1975) Phenomenon of Hot-Cold 
haemolysis: chelator induced lysis of sphingomyelinase-treated
erythrocytes. Infection and Immunity, 12, 110%-llH.
1%8
SOBER, H.A., GUTTER, F.J., WYCKOFF, M.M. and PETERSON, E.A. (1956) 
Chromatography of proteins. II. Fractionation of serum protein on 
anion-exchange cellulose. Journal of the American Chemical Society, 
78, 756-763.
SOBER, H.A. and PETERSON, E.A. (195%) Chromatography of proteins on 
cellulose ion-exchangers. Journal of the American Chemical Society,
76, 1711-1712.
S0RENSEN, S. (1909) Enzymstudien, II Biochemische Zeitschrift, 21,
131-200.
SPACKMAN, D.H., STEIN, W.H. and MOORE, S. (1958) Automatic recording 
apparatus for use in the chromatography of amino acids. Analytical 
Chemistry, 1190-1205.
SPIES, J.R. and CHALMERS, B.C. (l9%9) Chemical determination of 
tryptophan in proteins. Analytical Chemistry, 12%9-1266.
STEIN, 0. and STEIN, Y. (1967) The role of the liver in the metabolism 
of chylomicrons, studied by electron microscopic autoradiography. 
Laboratory Investigation, 17, %36-%%6.
STEIN, 0. and STEIN, Y. (1975) Conparative uptake of rat and human serum 
low-density and high-density lipoproteins by rat aortic smooth muscle 
cells in culture. Circulation Research, 36, %36-%%3.
STOLLERMAN, G.H., BERNHEIMER, A.W. and MacLEOD, C.M. (1950) The
association of lipoproteins with the inhibition of streptolysin S by 
serum. Journal of Clinical Investigation, 29, l636-l6%5.
TALBOT, P. and CAIE, 1.8. (1975) A horizontal trough apparatus for 
isoelectricfocusing. In Isoelectricfocusing. pp 7%”77. Edited by 
J.P. Arbuthnott and J.A. Beeley, London : Butterworth.
TAYLOR, A.G. and BERNHEIMER, A.W, (197%) Further characterisation of 
staphylococcal gamma-haemolysin. Infection and Immunity, 5%-59.
1%9
TERRY, R.J. and SMITHERS, S.R. (1975) Evasion of the immune response ’by- 
parasites. In Symbiosis. Symposium of the Society of Experimental 
Biology.
It tf
THELESTAM, M., MOLLBY, R. and WADSTROM, T. (1973) Effect of staphylococcal 
alpha, beta, delta, and gamma-haemolysins on human diploid fibroblasts 
and HeLa cells : evaluation of a new quantitative assay for measuring 
cell damage. Infection and Immunity, 8_ï 938“9%6.
TILLET, W.8. and FRANCIS, T. (1929) Cutaneous reactions to the poly­
saccharides and proteins of pneumococcus in lobar pneumonia. Journal 
of Experimental Medicine, 687-701.
TIRUNARAYANAN, M.O, (1969) Investigations on the enzymes and toxins of 
staphylococci. Activity of phosphatase on-sugar phosphates, 
nucleotides and other esters. Acta pathologica microbiologica 
Scandinavica, 75, 125-138.
TISELIUS, A. and KABAT, E.A. (1939) An electrophoretic study of immune 
sera and purified antibody preparations. Journal of Experimental 
Medicine, 119-131.
TISELIUS, A., HJERTEN, S. and LEVIN, 0. (1956) Protein chromatography on 
calcium phosphate columns. Archives of Biochemistry and Biophysics, 
g_, 132-155.
TISELIUS, A., PORATH, J. and ALBERTSSON, P-A. (I963) Separation and 
fractionation of macromolecules and particles. Science, 1%1, 13-20.
VAN HEYNINGEN, W.E. (l970) General characteristics. In Microbial Toxins,
Vol. 1, pp 1-28. Edited by T.C. Montie, S. Kadis and S.J. Ajl, New York : 
Academic Press,
150
VESTERBERG, G., WADSTROM, T., VESTERBERG, K., SVEÏÏSSON, H. and MALMGREW, B. 
(1967) Studies on extracellular proteins from Staphylococcus aureus I. 
Separation and characterisation of enzymes and toxins by isoelectric 
focusing, Biochimica et Biophysica Acta, 133, %35“%%5*
VESTERBERG, K. and VESTERBERG, 0. (l972) Studies on staphylokinase.
Journal of Medical Microbiology, 2s %%1~%50.
II
WADSTROM, T. (1967) Studies on extracellular proteins from Staphylococcus 
aureus II. Separation of deoxyribonucleases from Staphylococcus aureus 
by isoelectricfocusing. Purification and properties of the enzymes. 
Biochimica et Biophysica Acta, 1%7, %%l-%52.
II
WADSTROM, T. (1973,a) Separation of Australia antigen and some bacterial 
proteins by isoelectricfocusing in polyacrylamide gels. Annals of 
the New York Academy of Science, 209, %05”
II
WADSTROM, T. (l973,b) Bacteriolytic enzymes from Staphylococcus aureus.
In Microbiology and Immunology. Vol. 1. Staphylococci and 
Staphylococcal Infections p 397. Basel : Karger Press.
II
WADSTROM, T. (l97%) Biological properties of extracellular proteins from 
staphylococcus. Annals of the New York Academy of Science, 236, 3%3-36l,
I
WADSTROM, T. (1968) Studies on extracellular proteins from St aphyloc o ecus 
aureus. IV Separation of alpha-toxin by isoelectricfocusing.
Biochimica et Biophysica Acta, I68, 228-2%2.
I
WADSTROM, T. and HISATSUNE, K. (1970) Bacteriolytic enzymes from
Staphylococcus aureus. Purification of an endo-p-N-acetylglucosamini- 
dase. Biochemical Journal, 120, 725-73%.
If
WADSTROM, T. and VESTERBERG, 0. (1971 ) Studies on endo-3-N-acetylglucosam- 
inidase, staphylolytic peptidase, and N-acetyl-muramyl-L-alanine amidase 
in lysostaphin and from Staphylococcus aureus. Acta pathologica et 
microbiologica Scandinavica, 79, 2%8-26%.
151
WADSTROMj T. and MOLLBY, R. (1971,a) Studies on extracellular proteins 
from Staphylococcus aureus. VII. Studies on g-haemolysin. Biochimica 
et Biophysica Acta, 2 k 2, 308-320,
ti II
WADSTROM, T. and MOLLBY, R. (1971,t) Studies on extracellular proteins 
from Staphylococcus aureus. VI, Production and purification of heta- 
haemolysin in large scale. Biochimica et Biophysica Acta, 2U2, 288-307.
It M
WADSTROM, T. and MOLLBY, R. (1972) Some biological properties of purified 
staphylococcal haemolysins. Toxicon, ]^, 511-519.
WATANABE, M. and KATO, I. (l97^) Purification and properties of
staphylococcal alpha toxin. Japanese Journal of Medical Science and 
Biology, 86-89.
WILCOX, E.G., DAVIS, D.C. and HEIMBERG, M. (1971) The isolation of
lipoproteins from human plasma by ultracentrifugation in zonal rotors. 
Journal of Lipid Research, ]^, 160-I72,
WILLIAMS, R.E.O. and HARPER, G.J. (19^7) Staphylococcal haemolysins on 
sheep blood agar with evidence for a fourth haemolysin. Journal of 
Pathology and Bacteriology, 69-97.
WINDMÜELLER, E.G. and LEVY, R.I. (1968) Production of g-lipoprotein by 
intestine in the rat. Journal of Biological Chemistry, 2U3, U878-U88U.
WISEMAN, G.M. (1965) Some characteristics of the beta-haemolysin of
Staphylococcus aureus. Journal of Pathology and Bacteriology 187-207.
WISEMAN, G.M. (1968) The nature of staphylococcal beta-haemolysin. II.
Effect on mammalian cells. Canadian Journal of Microbiology, 179-181,
WISEMAN, G.M. (1970) The beta and delta toxins of Staphylococcus aureus 
In Microbial Toxins, Vol III pp 237-263. Edited by S. Kadis, T.C.
Montie and S.Ajl. New York and London : Academic Press.
152
WISEMAN j G.M. (19T5) The haemolysins of Staphylococcus aureus. 
Bacteriological Reviews, 317-3%%.
WISEMAN, G.M. and CAIRD, J.D. (1966) Canadian Society for Microbiology,
Abstracts, l6. Cited by Wiseman, G.M. (1970).
WISEMAN, G.M. and CAIRD, J.D, (1967) The nature of staphylococcal beta-
haemolysin. I. Mode of action. Canadian Journal of Microbiology,
13, 369-376.
WISEMAN, G.M. and CAIRD, J.D. (1968) Phospholipase activity of the delta- 
haemolysin of Staphylococcus aureus. Proceedings of the Society for 
Experimental Biology and Medicine, 128, %28-%30.
WISEMAN, G.M. , CAIRD, J.D. and FACKRELL, H.B. (1975) Trypsin-mediated 
activation of the alpha-haemolysin of Staphylococcus aureus. Journal 
of Medical Microbiology, 8^, 29-37.
WOODIN, A.M. (1970) Staphylococcal leucocidin. In Microbial Toxins,
Vol. Ill, pp 327-355. Edited by Montie, T.C. eb el, New York :
Academi c Press.
YOSHIDA, A. (1963) Staphylococcal delt a-haemoly sin, I. Purification and 
chemical properties. Biochimica et Biophysica Acta, 71, 5%%~553.
ZEINEH, R-A., BARRETT, N., NIEMIROWSKI, L. and FIORELLA, B.J. (1972) 
Turnover rate of orosomucoid in the dog with sterile abscess.
American Journal of Physiology, 222, 1326-1332.
ZWAAL, R.F.A., ROELOFSEN, P., COMFURIUS, P. and van DEENEN, L.L.M. (I97l) 
Complete purification and some properties of phospholipase C from 
B. cereus. Biochimica et Biophysica Acta, 233, %7%-%79.
APPENDIX
153
Appendix I 
Media
Yeast diffusate medium (Bernheimer and Schwarz, 1963)
Yeast extract diffusate 3200 ml
Bacto Gasamino Acids (Difco) 6% g
Glucose 8 g
Nicotinic Acid 3.7 mg
Aneurine hydrochloride 0.% mg
The pH was adjusted to 7.1 with IN NaOH and the medium autoclaved at 
15 Ib/in^ for 15 min.
Yeast extract diffusate
Yeast extract (Difco) 200 g
Distilled water 500 ml
Yeast extract was dissolved in distilled water by steaming and after 
cooling was poured into a 50 cm length of 2.3/%" Visking dialysis tubing 
(Scientific Instrument Centre, London) previously soaked in 70^ ethanol 
to minimise contamination. The dialysis sac was immersed in l600 ml 
distilled water in a 5 1 beaker and stirred for %8 hours at %^C. The 
dialysis sac and contents were discarded and the diffusate was made up 
to l600 ml with distilled water. Duplicate batches of diffusate were 
normally prepared to yield 3200 ml of diffusate,
"Antifoam" (l ml of a 1/20 dilution/500 ml culture media; Silcolapse 
5000, I.e.I. Stevenson, Ayrshire) was added to prevent frothing.
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Appendix II 
Buffers and Diluents
Citrate/Dextrose/Sodium chloride solution (CDS, Hodgkins and Ridgway, 196%)
Dextose (Glucose) 2.05 g
Trisodium citrate 0.80 g
Sodium chloride 0.%0 g
Distilled water to 100,00 ml
The solution was sterilized by membrane filtration.
Dulbecco's A phosphate buffered saline (Dulbecco and Vogt, 195%)
NaCl 8 g
KCl 0.2 g
Na^HPO^ 1.15 g
KH^ POj^  0.2 g
Distilled water to 1000 ml
The pH was adjusted to 7.3 if necessary and the buffer autoclaved at 
15 Ib/in^ for 15 min.
Potassium phosphate buffers
i) l.OM phosphate (pH 7.%) buffer.
Stock soins :
A: l.OM solution of potassium dihydrogen orthophosphate
(13.6 g KHgPO^ in 100 ml distilled water).
B: l.OM solution of potassium hydrogen orthophosphate
(17.% g K^HPO^ in 100 ml distilled water).
Nineteen ml of solution A and 8l ml of solution B were mixed and the pH
adjusted by adding either stock solution until a pH of 7.% was obtained.
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ii) 0.%M phosphate (pH 6.8) buffer.
Stock solutions were obtained by dilution of the above l.OM 
stock solutions.
Approximately %5 ml of solution A and 55 ml of solution B were mixed and 
the pH adjusted to 6.8 by adding either stock solution.
iii) O.OIM phosphate (pH 6.8) was obtained by l/%0 dilution of the
0.%M phosphate buffer.
Sodium phosphate buffers, O.IM, O.OIM and O.OOIM, pH 6.8 (Sorensen, 1909)
A: O.IM sodium dihydrogen orthophosphate (l3.9 g Na^HPO^/l in
distilled water),
B: O.IM disodium hydrogen orthophosphate (35.8 g Na^HPO^.lPHgO/l
in distilled water).
Five hundred and ten ml of solution A and %90 ml solution B were mixed 
and the pH adjusted to 6.8,
The O.OIM and O.OOIM buffers were obtained by dilution of the above buffer 
in distilled water.
Tris HCl buffer
Stock solutions 
A; 0.2M Tris (2%.2 g made up to 1 litre)
B: 0.2M HCl (17.15 ml cone HCl made up to 1 litre)
50 ml A + X ml B diluted to a total of %00 ml gives a 0.05M 
solution at the pH shown below:
X pH
5.0 9.0
8.1 8.8
12.2 8.6
16.5 8.U
21,9 8.2
26.8 8.0
32.5 7.8
38.1+ 7.6
1+1.1+ 7.1+
1+1+.2 7.2
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Tris-buffered saline (TBS), pH 8.0
To the appropriate solution above, 67.5 g NaCl vas added, and 
made up to 1 litre with buffered solution.
Palitsch buffer for coagulase assay
Solution A : (0.05M sodium tetraborate)
NagB^O^.lOHgO 19.069 g
Distilled water to 1,000 ml 
Solution B : (0.2M basic acid salt solution)
H^EO^ 12.308 g
NaCl 2.925 g
Distilled water to 1,000 ml 
1.2 ml A plus 8,8 ml B gives 10 ml buffer at pH 7.%.
Hyaluronidase diluent
0.2M Na^HPO^ 5 ml
0.2M NaH^ POj^  5 ml
l.OM NaCl 7.7 ml
Bovine serum albumin fraction V 10 mg
Adjust pH to 6.9 if necessary with IM NaOH or IM HCl 
Distilled water to 100 ml.
Acid-albumin solution for hyaluronidase assay
Glacial acetic acid U.56 ml
Sodium acetate 3.26 g
Bovine serum albumin (Armour) 1.00 g
Distilled water to 1 litre.
Adjust pH to 3.75 with glacial acetic acid.
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Borate buffer
Solution A : boric acid, 12.% g
Distilled water to 1,000 ml 
Solution B : borax, Na^B^O^.lOH^O 19*05 g
Distilled water to 1,000 ml 
For O.IM buffer, pH 8.0, containing l.OM NaCl, 58.% g NaCl is added to 
250 ml of solution A plus 2%.5 ml of solution B, and made up to 1,000 ml 
with dist. HgO.
For O.IM Buffer, pH 8.3, containing 0.5M NaCl, 29.2 g NaCl is added to 
250 ml of solution A plus 50 ml of solution B, and made up to 1,000 ml 
with dist. HgO.
Acetate buffer
O.IM acetate buffer, pH %,0.
Solution A : glacial acetic acid 11.55 ml
Distilled water to 1,000 ml 
Solution B ; sodium acetate, CE^COONa l6.% g
Distilled water to 1,000 ml 
For O.IM buffer, pH %.0, add %10 ml of solution A to 90 ml of solution B 
and add dist. H^O to 1,000 ml.
Acetate buffer plus sodium chloride
O.IM acetate, pH %.0 containing l.OM NaCl.
NaCl was added to the above buffer at a concentration of 58.% g/1.
Barbitone buffer, pH 8.6
Barbitone (diethylbarbituric acid) 1.8% g 
Barbitone sodium 10.31 g
Distilled water to 1,000 ml.
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Appendix III
Preparation of hydroxylapatite (Tiselius at 1956)
Solutions
i) CaClg 0.5M 2 litres
ii) Na^HPO^ 0.5M 2 litres
iii) Phosphate buffers, pH 6.8 “ see appendix II
iv) NaOH {kO% w/w) 100 ml
Procedure
Calcium phosphate has been shown to exist in several crystalline 
forms including brushite and hydroxylapatite. Tiselius at ^  (1956) 
showed that hydroxyl apatite could be prepared from brushite. Brushite was 
prepared by allowing 2 litres of aqueous solutions of CaCl^ and Na^HPO^ 
to run at an equal flow rate (120 drops/min) into a glass beaker under 
stirring. The supernatant was removed by décantation and the precipitate 
washed four times by décantation with distilled water, resuspended to % 1 
with distilled water and 100 ml freshly prepared (w/w) NaOH was added. 
The brushite was boiled under stirring for one hour and very fine material 
was removed by décantation. The precipitate was washed by décantation 
four times with distilled water, resuspended in 3 litres of O.OTM phosphate 
buffer (pH 6.8) and heated just to boiling. The supernatant was decanted 
and fresh phosphate buffer added and the suspension boiled for 5 min.
The supernatant was again decanted and the suspension boiled for 15 min, 
in fresh O.OIM buffer and then boiled twice in O.OOIM phosphate buffer for 
15 min to convert the brushite to hydroxylapatite. The suspension was 
stored in O.OOIM phosphate buffer at %°C.
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Appendix IV
Reagents for Protein Estimation (Lowry £b ad, 1951)
Reagent A 
Reagent B 
Reagent C 
Reagent D
Reagent E
2% sodium carbonate (Na^CO^) in O.IN sodium hydroxide,
0.5% copper sulphate (Cu80^.5Hg0) in distilled water. 
1% aqueous solution of potassium sodium tartrate. 
Equal volumes of reagents B and C were mixed and 1 ml 
added to 50 ml of reagent A. The solution was 
discarded after one day.
Folin-Ciocalteau reagent (B.D.H., Poole, Dorset).
The Folin reagent was standardised by titration 
against IN NaOH using phenolphthalein indicator and 
diluted to give a IN solution.
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Appendix V 
Disc Gel Electrophoresis
Ahhreviat ions
BIS N,N’-imethylenehisacrylaniide (B.D.H., Poole, Dorset)
Tris Tri s(hydro xymethyl)aminomethane (Pnriss, A.P., Koch-Light,
Colnhrook, Bucks.)
TEMED N,N,N',N'-tetramethylethylenediainine (B.D.H., Poole, Dorset) 
SDS sodium dodecylsulphate (Koch-Light, Colnhrook, Bucks.)
i) Acid system (pH %.3 - 7.5% acrylamide)
I Stock solutions
a ) in Potassium hydroxide %8 ml
Acetic acid (glacial) 17.2 ml
TEMED %. 0 ml
Distilled water to 100 ml
B) in Potassium hydroxide %8 ml
Acetic acid (glacial) 2,87 ml
TEMED 0.%6 ml
Distilled water to 100 ml
C) Acrylamide 30 g
BIS 0.8 g
Distilled water to 100 ml
D) Acrylamide 10 g
BIS 2.5 g
E) Riboflavin % mg
Distilled water to 100 ml
F) Ammonium persulphate 0,28 g
Distilled water to 100 ml
G) Sucrose (B,D,H,, Analar) %0 g
Distilled water to 100 ml
l6l
Preparation of separating gel
Solution A 2 ml
Solution C % ml
Distilled water 2 ml
Solution F 8 ml
The solution was mixed well and 1.0 ml volumes pipetted into 7.5 x 0.5 cm 
(internal diameter) disc gel tubes sealed at one end with parafilm. The 
solution was carefully overlaid with 0.1 ml distilled water and the gels 
allowed to polymerise for 30 min in the dark.
II Preparation of large pore solution (pH 6.8)
Solution B 0.5 ml
Solution D 1.0 ml
Solution E 0.5 ml
Distilled water 2 ml
Water was removed from the gel tubes by inversion onto absorbant paper
and each tube was rinsed with large pore solution and carefully overlaid 
with 0,15 ml large pore solution and 0.1 ml distilled water. Large pore 
gels were photopolymerised for 15 min.
III Tray buffer (pH %.5)
L-alanine 31.2 g
acetic acid (glacial) 8 ml
Distilled water to 1000 ml 
The buffer was diluted 10 fold for use.
Staining solution
Ami do black {Vfo) in 7% acetic acid.
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Destaining gel
Solution A 1 ml
Solution C 2 ml
Distilled water 1 ml
Solution F % ml
Destaining solution
Acetic acid (T%) in distilled water.
ii) Alkaline system (pH 8.9 - 7% acrylamide)
I. Stock solutions
A) IN HCl %8 ml
Tris 36.6 g
TEMED 0.23 ml
Distilled water to 100 ml
B) IN HCl %8 ml
Tris 5.98 g
TEMED 0.U6 ml
Distilled water to 100 ml
C) Acrylamide 28 g
Bis 0.735 g
Distilled water to 100 ml
D) Acrylamide 10 g
Bis 2,5 g
Distilled water to 100 ml
E) Riboflavin %.0 mg
Distilled water to 100 ml
F) Ammonium persulphate 0,1% g
Distilled water to 100 ml
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G) Sucrose %0 g
Distilled water to 100 ml
II Preparation of separating gel and large pore solution
The procedure was exactly as for the acid gel system except 
that the solutions specified above were used.
III Tray buffer (pH 8,3)
Tris 6 g
Glycine 28.8 g
Distilled water to 1000 ml 
The buffer was diluted 10 fold for use.
Staining solution, destaining gel and destaining solution
These were as described for the acid gel system.
Disc gel electrophoresis of serum lipoproteins 
Alkaline system (pH 8.9 - 3.6% acrylamide)
I Stock solutions
A) Tris 36.6 g
TEMED 0.%6 ml
dilute HCl (l mol/l) %8 ml
Distilled water to 98 ml
pH to 8.9 with IM HCl 
Distilled water to 100 ml
16%
B) Tris 5.98 g
TEMED 2.3 ml
Dilute HCl (1 mol/l) %8 ml
Distilled water to 98 ml
pH to 6.6 with IM HCl 
Distilled water to 100 ml
C) Acrylamide 9.6 g
Bis 0.252 g
Distilled water to 100 ml
D) Acrylamide 10.0 g
Bis 2.5 g
Distilled water to 100 ml
E) Riboflavin %.0 mg
Distilled water to 2,000 ml
F) Riboflavin 15.38 mg
Distilled water to 1,000 ml
G) Ammonium persulphate 0,1% g
Distilled water to 100 ml
H) Sudan Black B 10 mg
Ethylene glycol 10 ml
Prepare two weeks before use and store in the dark.
165
Reservoir buffer (pH 8.%)
Tris %.0 g
glycine 19.2 g
Distilled water to 1,000 ml
Preparation of separating gel
Solution A 2 ml
Solution C 6 ml
Solution G 8 ml
The solution was mixed well and 1.0 ml volumes pipetted into 8 x 0.6 cm 
(internal diameter) disc gel tubes sealed at one end with parafilm. The 
solution was carefully overlaid with 0.2 ml distilled water and the gels 
allowed to polymerise for 30 min.
Preparation of spacer gel
Solution B 1 ml
Solution D 2 ml
Solution E 5 ml
Water was removed from the gel tubes by inversion onto absorbant paper, 
and each tube overlaid with 0.1 ml spacer gel. Water was again carefully 
applied to prevent a meniscus, and the gel photopolymerised under a 
fluorescent lamp for about 30 min.
Preparation of sample gel
Solution B 1 ml
Solution D 2 ml
Solution F 0.65 ml
* Working Sudan Black B Solution 2.35 ml
*Made by mixing 1.2 ml Solution H with 8.8 ml ethylene glycol.
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The water overlay was removed as before, and 0.2 ml sample gel added to 
each tube, followed by 20 pi of sample, The tubes were covered with 
parafilm, and inverted about ten times to mix sample and gel. After 
overlaying with reservoir buffer, the gels were photopolymerised for 
about %5 min,
Immunocore electrophoresis
Alkaline system (pH 8.9 - 3.6% acrylamide)
Stock solutions : as for electrophoresis of serum lipoproteins.
Disc gel tubes 125 mm x 6 mm (internal diameter) were filled with the 
same quantities of separating, spacer and sample gel as described above, 
the presence of the central rod (l85 mm x 3 mm) .resulting in a longer 
column of gel.
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Appendix VI
Phosphatidic acid (Na salt)
(ex egg lecithin, lyophilised)
Phosphatidyl ethanolamine 
(ex E. coli)
L-a-pho sphat i dyl-DL-glyc erol (CÏÏC1^ /MeOH) 
(ex egg lecithin, ammonium salt)
L-a-phosphatidyl inositol (CHCl^)
(ex soybean, ammonium salt)
phosphatidyl-L-serine 
(ex bovine brain)
(CHClg)
cardiolipin (diphosphatidylglycerol) 
(ex bovine heart, Na salt) (EtOH)
sphingomyelin 
(ex bovine brain)
lecithin 
(ex egg yolk)
Sheep anti-whole human serum
Rabbit anti-a-lipoprotein
Rabbit anti-3-lipoprotein
(CHCl^)
Batch no. 62057 
Koch-Light
Batch no. 62510 
Koch-Light
Lot no. 150-8130 
Sigma, London
Lot no. 12%C-8i60 
Sigma, London
Lot no. 11%C-8260 
Sigma, London
Lot no. %3C-18%0 
Sigma, London
Lot no. 88B-0320 
Sigma, London
Lots K003%, K8152 
Wellcome Reagents, England
Boehringer, Mannheim
Boehringer, Mannheim
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Trypsin
Trypsin inhibitor
Papain
B. cereus phospholipase C 
CE.C.3.1.%.3)
Type 1: 2 x crystallised
from bovine pancreas.
Ethanol precipitate.
Activity; 10,000 BAEE units/ 
mg. Sigma, London
Tÿpe 1-5 : lyophilised from
soybean. Chromât o graphic ally 
prepared. 1 mg inhibits 
1-3 mg trypsin, activity of
10,000 BAEE units/mg protein. 
Sigma, London.
2 X crystallised from 
papaya latex, sodium acetate 
suspension. Activity 
l6-%0 BAEE units/mg.
Sigma, London.
In 3.2M ammonium sulphate 
%00 U/mg: lecithin substrate.
3T°C.
Boehringer, Mannheim.
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Appendix VII 
Stains
a) Protein Stains
i) Azocarmine
Azocarmine 1 g
IM Acetic acid %25 ml
O.IM Sodium acetate %25 ml
Glycerol 150 ml
Plates were washed in 2% acetic acid containing 15% glycerol to remove 
excess stain.
ii) Ami do black
Amido black 1 g
Solutions as for azocarmine.
b) Lipoprotein Stains
i) Oil Red 0
Oil red 0 1 g
60% ethanol 1000 ml
Saturation was accomplished at 3T^C with occasional stirring over 16-2% 
hours. After cooling to room temperature, the solution was filtered and 
stored in dark bottles,
ii) Sudan Black
Sudan black (l g) was suspended in the same way as for
Oil Red 0.
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c) Transferrin stain
Bathophenanthroline 2 mg
Deionised water 2 ml
0.02M sodium acetate l8 ml
After immersion of plates in the bathophenanthroline reagent for 2 hours, 
0.1 ml thioglycolic acid was added. After a further 5 min, plates were 
washed in 2% acetic acid. Transferrin was stained red.
d) Caeruloplasmin stain
0.2M Sodium acetate 50 ml
0.02M acetic acid 50 ml
p-phenylenediamine 21.6 mg
After warming to 37°C, plates were immersed for 2-3 hours and subsequently 
washed in 2% acetic acid. Caeruloplasmin-antibody precipitates were 
stained brown,
Fyronin Y
Pyronin Y 2 g
Dist. EgO 100 ml
Stored in dark bottles.
Bromophenol blue
Bromophenol blue 10 mg
Dist. HgO 100 ml
Neutralisation of Staphylococcal DeIta-haemolysin by Human Plasma 
Lipoproteins.
By D.D. Whitelaw and T.H. Birkbeck (Department of Microbiology, University 
of Glasgow, Garscube Estate, Bearsden, Glasgow g6i IQH)
Staphylococcal 6-haemolysin is neutralised by normal mammalian 
sera (l) and forms a precipitin line on gel diffusion with normal sera (2) 
but the serum factors involved have not hitherto been identified.
The inhibitory titre of normal human plasma assayed using 
purified 6-haemolysin with cod erythrocytes as indicators of haemolysis (3) 
was 1/500-1/1000. Fractionation of normal human plasma by Sephadex G150 
chromatography, ammonium sulphate precipitation and isoelectric focusing 
indicated that plasma lipoproteins were the inhibitors of 6-haemolysin. 
Purified high-density and low-density plasma lipoproteins were obtained by 
zonal ultracentrifugation (%) using potassium bromide density gradients in 
the MBE BXIV titanium zonal rotor, and characterised by ultracentrifugation, 
polyacrylamide gel electrophoresis (5), immunoelectrophoresis and gel 
diffusion using monospecific antisera. Both high-density and low-density 
lipoproteins neutralised 6-haemolysin and gave a precipitin line on gel 
diffusion but the fractions containing the remainder of the plasma proteins 
were non-inhibitory.
The inhibitory activity of lipoproteins was not diminished by 
treatment with papain or trypsin whereas Bacillus cereus phospholipase C 
(EC 3.1.%.3) destroyed inhibitory activity. In the latter case, 6-haemo- 
lysin was assayed using human erythrocytes since B. cereus phospholipase C 
was highly haemolytic for cod erythrocytes (25000 HU/mg) but inactive with
human erythrocytes. Phospholipase C also abolished the inhibitory 
activity of phosphatidyl choline and phosphatidyl glycerol providing 
further evidence that binding of 6-haemolysin to plasma lipoproteins was 
via the phospholipid moiety (cf. 6).
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Immimogenicity of Staphylococcal Delta-Haemolysin
By T.H. Birkbeck and D.D. Whitelaw (Department of Microbiology,
University of Glasgow, Garscube Estate, Bearsden, Glasgow G61 IQH).
The binding of serum lipoproteins to staphylococcal 6-haemolysin to 
neutralise cytolytic activity or to form precipitin lines on gel diffusion 
(l) has undoubtedly contributed to the difficulty in demonstrating the 
immunogenicity of 6-haemolysin although precipitinogens have been 
demonstrated in IgG fractions of hyperimmune rabbit sera (2).
We have immunised rabbits with purified soluble Staphylococcus aureus 
(strain NCTC 103%5) 6-haemolysin by subcutaneous (with or without Freund’s 
complete adjuvant) or intravenous (without adjuvant) routes, using a 
schedule similar to that of Fackrell and Wiseman (2), On immunodiffusion, 
immune sera gave two precipitin lines with purified 6-haemolysin, only one 
of which was present in pre-immune sera. After zonal centrifugation in 
potassium bromide density gradients lipoprotein-free pre-immune sera 
contained no precipitating or neutralising activity against 6-haemolysin but 
all immune sera gave a single precipitin line on immunodiffusion and 
neutralised 6 HU^^ 6-haemolysin at dilutions of up to 1/320. Highest 
neutralising titres were obtained in rabbits immunised subcutaneously with 
6-haemolysin emulsified in Freund's complete adjuvant (titres I/I60 and 
1/320) and lowest titres were obtained by intravenous immunisation (l/lO- 
1/20).
A single precipitin line with a reaction of complete identity was 
formed on immunodiffusion between lipoprotein-free immune serum and 
6-haemolysin purified by isoelectrofocussing (pi 10,0 strain Wood %6),
hydroxylapatite chromatography (strain NCTC 103%5) and concentrated 
crude culture supernatants of strain Wood %6. The neutralising and 
precipitating activities of lipoprotein-free immune sera were present in 
IgG fractions prepared hy precipitation with ammonium sulphate (33% 
saturation) and DEAE-cellulose chromatography. Other serum proteins 
were absent from the IgG fractions as judged by polyacrylamide gel 
electrophoresis or immunoelectrophoresis and it was concluded that 
staphylococcal 6-haemolysin was immunogenic in rabbits.
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Vol. % part 1, November 1976, pages 12-13.
Jklh
